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CONSTRUCTING THE ROD BIPOLAR CELL SIGNALPLEX USING ANIMAL MODELS 
OF RETINAL DYSFUNCTION 
 
Thomas A. Ray 
November 15, 2013 
 
Glutamate mediated neurotransmission from the rod photoreceptors to rod 
bipolar cells is critical for vision under low light levels.  Disruption of this pathway results 
in the blinding disorder Congenital Stationary Night Blindness (CSNB), which is 
hallmarked by the inability to see under dim light.  Mouse models of CSNB have been 
critical to identifying proteins required for glutamate signaling and understanding the 
mechanism of signaling.  Currently, our understanding of rod bipolar signaling is 
incompletely understood because not all of the protein components of the signalplex 
have been identified.  It was known that the glutamate receptor mGluR6 is coupled to 
the TRPM1 cation channel, via an unknown G protein mediated mechanism and that 
regulators of G protein signaling (RGS) are required to terminate signaling.  During my 
graduate work, I identified two new protein components of the rod bipolar cell signalplex 
that are critical to rod-mediated vision.  By mapping the mutation in a novel mouse 
model of CSNB, I identified Gpr179 as critical to rod bipolar cell signaling.  Using 
immunohistochemistry followed by confocal microscopy and protein interaction assays, I 
identified GPR179 as a signalplex component.  Further, we showed that mutations in 
GPR179 cause CSNB in humans.  I found that GPR179 functions as a hub by 
interacting with TRPM1 and recruiting the RGS protein complex to the signalplex, which 
serves to enhance the sensitivity of the system.  A report identified mutations in LRIT3 
cause CSNB in humans (Zeitz et al., 2013).  To determine how LRIT3 contributes to rod 
vision, I created an Lrit3-/- mouse model of CSNB and found that LRIT3 is required for 
localizing TRPM1 to the signalplex.  These findings add to our understanding of how the 
visual signal is passed through the retina, and more specifically, rod bipolar cell 
signalplex architecture, G protein signaling mechanisms, and the causes of CSNB. 
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CHAPTER I: INTRODUCTION 
 
Our ability to visualize the text before us and consistently and accurately convert 
contrast differences into meaningful symbols is made possible by the retina, a product of 
over 600 million years of evolution (Lamb et al., 2007).  The earliest photosensitive cells 
that eventually gave rise to the retina consisted of a single cell photoreceptor capable of 
phototaxis, shadow detection and entrainment of circadian rhythms that gave our ancient 
ancestors survival advantages (Lamb et al., 2007).  This once rudimentary system for 
detecting changes in ambient light evolved into a highly specialized multicellular tissue 
capable of image-formation during the Cambrian explosion 540 million years ago (Lamb 
et al., 2007).  In its current form, the human retina has evolved to function over a wide 
range of light intensities, provide both high sensitivity and high acuity, and carry out 
complex image processing. 
Humans are heavily invested in their visual system to function during daily life 
and blinding disorders have a dramatic effect on a person’s quality of life.  Because of 
this, it is of great interest to understand the circuitry of the retina and the mechanism of 
communication between retinal neurons in the healthy and diseased state.  Retinal 
structure and function has been studied for decades, but there are still cell types to be 
discovered, circuits to be identified and receptors that allow cells to communicate to be 
characterized.  Apart from gaining insight about vision, the retina is a great model 
system for studying general neural signaling and neural development.  The accessibility 
of the retina along with the ability to easily assess function makes it a great model 
system to study neuronal function. 
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Retina Anatomy 
The vertebrate retina is a light sensitive neural tissue at the back of the eye that 
consists of various synaptic and nuclear layers juxtaposed between an outer retinal 
pigmented epithelium (RPE) and an inner limiting membrane (ILM) (Cajal, 1892b).  The 
basic organization of the retina is remarkably similar across vertebrate species 
(Masland, 1986; Ehinger et al., 1988; Marc et al., 1990; Wassle and Boycott, 1991).  The 
first detailed anatomical view of the mammalian retina was produced by Santiago 
Ramón y Cajal in 1892 using golgi silver nitrate stained retinas (Cajal, 1892b).  He 
showed the retina consists of three nuclear layers; the outer nuclear layer (ONL), the 
inner nuclear layer (INL) and the ganglion cell layer (GCL) in which cell bodies reside, 
and two synaptic layers, the outer plexiform layer (OPL) and the inner plexiform layer 
(IPL) in which synapses are formed between various retinal neurons (Cajal, 1892b; Kolb, 
1970).  A simplistic depiction of retinal anatomy is shown in Fig.1. 
The photoreceptor cell bodies reside in the ONL and the outer segments of the 
photoreceptors are apposed to the RPE (Bok, 1993).  Bipolar cells (BCs), amacrine cells 
and horizontal cells reside in the INL and ganglion cells and displaced amacrine cells 
reside in the GCL (Cajal, 1892a; Cajal, 1892b; Hughes and Wieniawa-Narkiewicz, 
1980).  In the OPL, rod and cone photoreceptors form synaptic connections with BCs 
and horizontal cells (Kolb, 1970).  The IPL is divided into two different sublamina, A and 
B.  The OFF ganglion cells make contacts with OFF BCs in sublamina A and ON 
ganglion cells make contacts with ON BCs in sublamina B (Rodieck, 1973; Famiglietti et 
al., 1977; Nelson et al., 1978; Wassle and Boycott, 1991).  The ganglion cell axons form 
the optic nerve and transmit signals to the visual centers of the brain.  Each neuron type 
plays a specific role in extracting information from the visual environment and packaging 
that information into a neural code that is sent to the visual centers of the brain for 
interpretation.   
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In addition to the many neurons in the retina, there are three types of glial cells.  
Glial cells are non-neuronal cells that provide support to neurons.  The primary glial cell 
in the retina is the Müller glial cell, which spans the retina from the RPE to the ILM.  
Astrocytes envelope retinal vasculature and play an important role in the blood-retinal 
barrier (Ridet et al., 1997).  Microglial cells provide innate immune responses and can 
migrate to regions of damaged cells or exogenous pathogens (Aloisi, 2001; Lynch, 2009; 
Zinkernagel et al., 2013).  
The major excitatory neurotransmitter in the retina is glutamate and the major 
inhibitory neurotransmitters are gamma aminobutyric acid (GABA) and glycine.  
Excitatory and inhibitory neurotransmitters are needed to set up the excitatory vertical 
pathways through the retina and the lateral inhibitory pathways.  These excitatory and 
inhibitory pathways enable retinal cells to have a center-surround organization.  The 
classical view of center-surround organization is that a ganglion cell is excited or 
inhibited when a stimulus falls in the middle of its receptive field but the opposite is 
achieved when a stimulus falls in the surrounding region.  Center-surround organization 














Figure 1:  Fluorescent microscopy image and schematic of retinal layers.  (Left) 
Image of mouse retina cross section labeled for cones (purple), horizontal cells 
(orange), bipolar cells (green), amacrine and ganglion cells (magenta).  (Right) 
Schematic of the retinal layers and the cells that inhabit each layer.  The 
fluorescence microscopy image was adapted and modified from Morgan and 













Anatomy and Physiology of the Retina 
Retinal Pigment Epithelium 
 The RPE is a mono layer of pigmented cells that is apposed to the photoreceptor 
outer segments (OS) and is present in eyes from simple insects to higher vertebrates 
(Lamb et al., 2007).  The RPE contains long apical microvilli that surround the outer 
segments of the photoreceptors (Bok, 1993; Strauss, 2005). Interactions between the 
RPE and photoreceptor OS are essential for visual function (Steinberg, 1985; Bok, 1993; 
Strauss, 2005; Sparrow et al., 2010).  The RPE is responsible for delivering nutrients to 
the photoreceptors and uptake of metabolic end products secreted by the 
photoreceptors.  It is also responsible for the endocytosis of the continuously shed 
photoreceptor outer segments (Young, 1967; Steinberg, 1985; Bok, 1993; Dornonville de 
la Cour, 1993; Hamann, 2002).  In addition to the RPE providing metabolic support for 
the photoreceptors, the highly pigmented cells absorb light that passes through the 
retina.  This helps preserve visual acuity by preventing light from scattering back through 
the retina (Bok, 1993; Boulton and Dayhaw-Barker, 2001). 
The RPE plays a major role in supplying the photoreceptors with the visual 
photopigment, retinal.  Retinal (Vitamin A) is a photosensitive aldehyde that undergoes 
isomerization when it absorbs a photon and it is bound by the opsin G protein-coupled 
receptors of the photoreceptors.  The active form of retinal (11-cis retinal) is used by the 
photoreceptor opsins for the photoresponse.  Once 11-cis retinal absorbs a photon it is 
converted to the inactive form (all-trans retinal) and is released from the photoreceptors 
and taken into the RPE where it undergoes isomerization into the active form and 
subsequent release to be used again by the photoreceptors (Baehr et al., 2003; Besch 
et al., 2003; Thompson and Gal, 2003).  
Photoreceptors 
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The photoreceptors are the most abundant cells in the retina (Curcio et al., 
1990).  Light enters the eye through the iris and passes through all of the neural layers 
before it reaches the photoreceptors. Individual photons are absorbed by photopigments 
in the outer segments of the photoreceptors and the photoresponse is initiated.   The 
outer segments contain tightly packed disk membranes in which the photopigments 
reside (Sjostrand, 1953). There are two different classes of photoreceptors, the rod and 
the cone photoreceptors, named for the 3-dimensional shapes of their outer segments 
(Schultze, 1866).  In the human retina there are approximately 120 million rods and 6.4 
million cones or 95% of the photoreceptors are rods and 5% cones (Osterberg, 1937; 
Curcio et al., 1990).  The mouse retina contains a higher percentage of rods, with rods 
making up ~97% of the photoreceptors (Carter-Dawson and LaVail, 1979).  In the 
primate retina there is one type of rod photoreceptor but three different types of cones: 
L-type, M-type and S-type, which differ in the type of opsin that is expressed in the outer 
segments (Brown and Wald, 1963).  The mouse retina only contains two types of cones, 
S-type (Jacobs et al., 1991) and coexpressing S/M-type (Rohlich et al., 1994; Applebury 
et al., 2000). 
The inner segments of the photoreceptors are located in the ONL and contain the 
photoreceptor nuclei.  The axon terminals of photoreceptors form synapses in the OPL 
with bipolar cells and horizontal cells (Cajal, 1892b; Kolb, 1970).  The axon terminals of 
the photoreceptors contain a specialized structure termed a ribbon synapse (Sterling 
and Matthews, 2005).  The ribbon synapse facilitates tonic neurotransmitter vesicle 
release and is capable of dynamic adjustment of release over a wide range of light 
intensities (Schmitz, 2009).  The cone photoreceptor axon terminal is termed a cone 
pedicle, which is a wide synaptic terminal containing between 20 and 50 invaginations, 
each harboring synaptic ribbons (Wassle, 2004) and are filled by BC and horizontal cell 
dendrites (Kolb, 1970).  The cone pedicle is one of the most complex synapses in the 
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central nervous system (CNS), making as many as 500 post synaptic contacts 
(Haverkamp et al., 2000). The rod axon terminal is called a rod spherule and contains a 
single ribbon synapse with one invaginating rod BC and two horizontal cell dendrites 
(Kolb, 1970).  
Bipolar Cells 
BCs are the interneurons of the retina that connect photoreceptors to ganglion 
cells.  The BC dendrites project into the OPL and the ON BCs form invaginating 
synapses with the photoreceptor axon terminals and the OFF BC dendrites make 
synaptic contacts with cone pedicles.  Each bipolar cell makes synaptic connections with 
one to several different photoreceptors.  Overall, the mouse retina has a ratio of 
approximately 10 photoreceptors per bipolar cell (Jeon et al., 1998).  The axons of the 
BCs project into the IPL and make synaptic connections with amacrine cells and 
ganglion cells (Cajal, 1892b; Rodieck, 1973; Famiglietti and Kolb, 1975; Nelson et al., 
1978; Dacheux and Raviola, 1986; Wassle and Boycott, 1991).  
The visual response is split into two different pathways in the OPL, the ON 
(depolarizing) and the OFF (hyperpolarizing) pathways (Saito and Kaneko, 1983; Attwell 
et al., 1987; Nawy and Jahr, 1991; Masu et al., 1995).  These pathways are mediated by 
the response of the BCs to a decrease in glutamate release from the photoreceptors.  
Cones form synapses with both ON and OFF BCs.  ON BCs (DBCs) depolarize in 
response to light increments and OFF BCs (HBCs) hyperpolarize in response to light 
increments (Saito and Kaneko, 1983; Attwell et al., 1987; Nawy and Jahr, 1991; Masu et 
al., 1995).  The rod photoreceptors synapse with a single class of ON BCs, the rod BCs, 
which does not signal directly to ganglion cells (Cajal, 1892b; Boycott et al., 1969; 
Dacheux and Raviola, 1986).   
The difference in the ON and OFF type of BCs is accounted for by the type of 
glutamate receptor the BC expresses on its dendrites. The OFF BCs or HBCs utilize 
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ionotropic glutamate receptors of the AMPA/Kainate type (Slaughter and Miller, 1983) 
and the ON BCs or DBCs use the metabotropic glutamate receptor 6 (mGluR6) (Masu et 
al., 1995).  BCs that produce a sustained or transient response are differentiated by the 
expression of rapidly or slowly inactivating glutamate receptors (Awatramani and 
Slaughter, 2000; DeVries, 2000).   
In addition to BCs being divided into ON and OFF classes by physiology, they 
are also classified based on morphology.  In the mammalian retina twelve different types 
of bipolar cells have been identified based on morphology (Fig. 2) (Ghosh et al., 2004; 
MacNeil et al., 2004; Wassle et al., 2009; Helmstaedter et al., 2013).   Eleven of the BC 
types make contacts with cones and only the rod BCs make contacts with rods.  Each of 
the different classes of cone BCs is thought to parse specific information from the cone’s 
output and relay that information to the ganglion cells (Masland, 2012).  All of the ON 
bipolar cells stratify in the inner half (sublamina b) of the IPL and OFF bipolar cells 
stratify in the outer half (sublamina a) of the IPL (Famiglietti et al., 1977; Nelson et al., 
1978).   
Horizontal Cells 
Horizontal cells form lateral connections in the OPL.  At least two types of 
horizontal cells have been described in the primate retina, the HI and HII (Fig. 2) (Kolb et 
al., 1980; Kolb et al., 1994).  The HI horizontal cell has two distinct arbors.  The dendritic 
arbor associated with the cell soma makes synaptic contacts with cone pedicles and the 
remote axonal arbor makes synaptic connections with rods (Kolb, 1970; Masland, 2011).  
The HII horizontal cell has a broad, radial dendritic spread that makes synaptic contacts 
with cones (Kolb et al., 1980; Ahnelt and Kolb, 1994b, a; Masland, 2011).  The mouse 
retina only contains the HI type horizontal cell (Peichl and Gonzalez-Soriano, 1994).   
The horizontal cells form inhibitory contacts with rod spherules and cone pedicles 
and are electrically coupled to one another by gap junctions (Kolb, 1970; Klaassen et al., 
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2011; Sun et al., 2012).  It also has been suggested they form inhibitory connections 
with BC dendrites (Herrmann et al., 2011). Horizontal cells have center surround 
organization and are thought to be responsible for setting up receptive fields in the retina 
through lateral inhibitory synapses (Werblin and Dowling, 1969; Mangel and Miller, 1987; 
Mangel, 1991).  In addition to inhibition, horizontal cells provide lateral gain control to the 
outer retina by averaging the brightness within a local region and subtracting a 
proportional value from rod and cone output (Klaassen et al., 2011).  This ensures that 
the signal passed through the retina will be within the operating range of downstream 
neurons (VanLeeuwen et al., 2009; Masland, 2011). 
Amacrine Cells 
 Amacrine cells reside in the INL and provide lateral connections in the IPL.  
Amacrine cells are the most diverse cell type in the retina with ~50 distinct types being 
identified by morphology and physiology in the mouse (Fig. 2) (MacNeil and Masland, 
1998; MacNeil et al., 1999; Lin and Masland, 2006).  They can be organized into four 
general classes based on their dendritic spread; narrow field (30-150µm), small-field 
(150-300µm), medium-field (300-500µm), and wide-field (>500µm) (Kolb and Nelson, 
1981).  Amacrine cells are also classified based on their stratification within the IPL 
(Mariani, 1990; Kolb et al., 1992). 
 The functional roles of amacrine cells in the retina are as diverse as their 
structures.  The starburst amacrine cells serve to provide direction selectivity to a subset 
of ganglion cells (Euler et al., 2002; Fried et al., 2005).  The AII amacrine cells serve as 
a link between the rod BC and the ganglion cells (Strettoi et al., 1994; Trexler et al., 
2005).  The A17 amacrine cells make reciprocal synapses with rod BCs and provide 
feedback inhibition onto the rod BC axon terminal (Nelson and Kolb, 1985).  However, 
the majority of amacrine cells still have unresolved functions. 
Ganglion Cells 
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Ganglion cells are the output neurons of the retina and their axons exit the retina 
through the optic disc and bundle together to form the optic nerve.  There are 
approximately 15 to 20 different types of ganglion cells in the mammalian retina based 
on morphology and physiology (Fig 2) (Masland, 2001a; Rockhill et al., 2002; Wassle, 
2004; Masland, 2011).  Each type of ganglion cell is responsible for sending a unique 
feature of the visual field to specific retinorecipient nuclei in the brain (Roska and 
Werblin, 2001; Berson, 2008).   
The predominant type of ganglion cell in the human retina is the midget ganglion 
cell which contains a single dendrite extending from the cell soma and accounts for 
~80% of ganglion cells in the retina (Perry et al., 1984).  Midget ganglion cells receive 
input from one cone photoreceptor in the central retina and are capable of relaying color 
information (Wiesel and Hubel, 1966; Valois, 1973; Lennie, 1984). Parasol ganglion cells 
have dendritic trees much larger than the midget cells and they receive input from 
several photoreceptors of mixed spectral input, disabling them from relaying color 
information (Schiller and Logothetis, 1990; Wassle and Boycott, 1991). The midget and 
parasol ganglion cells are the predominant ganglion cell types in the primate retina 
(Schiller and Logothetis, 1990; Merigan and Maunsell, 1993; Dacey, 2004). 
There are several other types of ganglion cells, many of which we do not 
understand their role in vision.  Direction selective ganglion cells (DSGCs) respond 
preferentially to object movement in one of four directions, posterior, anterior, superior 
and inferior (Oyster and Barlow, 1967; Elstrott et al., 2008; Briggman et al., 2011; Sun et 
al., 2011).  Their discovery was quite revolutionary because it showed retinal neurons 
were capable of complex visual processing, previously thought to be carried out only in 
the higher visual centers of the brain (Hubel and Wiesel, 1959; Barlow and Hill, 1963; 
Barlow et al., 1964).   
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Apart from the photoreceptors, the only other known photosensitive cells in the 
retina are the intrinsically photosensitive retinal ganglion cells (ipRGCs).  The ipRGCs 
express the melanopsin photopigment on their dendrites and cell soma.  ipRGCs are 
responsible for non image forming light responses such as circadian photoentrainment, 
the pupillary light reflex and light suppression of locomotor activity (reviewed in (Sand et 
al., 2012)).  There is emerging evidence that ipRGCs have roles in image formation and 
are responsible for pattern recognition (Ecker et al., 2010; Hicks, 2011).  The ipRGCs 
project to several different regions of the brain.  Some projections target the 
suprachiasmatic nucleus of the hypothalamus, which helps the solar cycle synchronize 
with circadian rhythms (Gooley et al., 2001; Berson et al., 2002; Berson, 2003; Hirota 
and Fukada, 2004).  Another target is the intergeniculate leaflet, which also helps with 
circadian photoentrainment (Harrington, 1997; Hattar et al., 2002; Morin et al., 2003).  A 
third connection is made to the olivary pretectal nucleus, which mediates the pupillary 
light reflex (Trejo and Cicerone, 1984; Clarke and Ikeda, 1985; Hattar et al., 2002; Morin 
et al., 2003). 
Müller Cells 
 Müller cells are radial glial cells and are the primary glial cells in the retina.  They 
span the entire thickness of the retina and provide light guidance, structural support and 
nutrient support for their associated neurons (Bringmann et al., 2006; Agte et al., 2011; 
Reichenbach and Bringmann, 2013).  Müller cells orient in the direction of incoming light 
in the retina and behave as optical fibers to guide light to the photoreceptors (Franze et 
al., 2007).  It has been demonstrated in retinal slices that a thin laser beam traverses all 
retinal layers if it hits a Müller cell endfoot, but significant intraretinal scattering is 
observed if the laser hits an area devoid of Müller cells (Agte et al., 2011).  In the human 
retina there is approximately one Müller cell per cone photoreceptor allowing maximum 
possible resolution (Agte et al., 2011; Reichenbach and Bringmann, 2013).  There are 
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several rod photoreceptors per Müller cell that optimizes for maximum sensitivity to light 
(Agte et al., 2011; Reichenbach and Bringmann, 2013).  
Each Müller cell provides a structural core that encapsulates a column of retinal 
neurons (Hollander et al., 1991; Reichenbach and Robinson, 1995).  The structural core 
not only ensures the delivery of light to associated photoreceptors, but Müller cells have 
a symbiotic relationship with retinal neurons ensuring their viability.  Müller cells produce 
and secrete neurotransmitter precursors to be taken up by retinal neurons (Pow and 
Crook, 1996; Bringmann et al., 2009). They take up glutamate in the inner retina 
contributing to rapid removal of glutamate and termination of the excitation (Higgs and 
Lukasiewicz, 1999; Matsui et al., 1999).  Müller cells also protect retinal neurons from 
reactive oxygen species, which are frequently generated in the retina from light and 
oxygen consumption.  In response to oxidative stress Müller cells secrete glutathione, an 
antioxidant, to protect the retinal neurons (Schutte and Werner, 1998).  Müller cells also 
serve a critical role in ensuring photoreceptor viability and retinal ion homeostasis 





Figure 2: The diverse cell types of the retina.  Shown are representative drawings 













Convergence and Divergence 
Retinal cell type distribution across the retina plays an important role in shaping 
the visual field of animals.  Cell type distribution reflects the lifestyle of an animal and 
varies across species and within species with different lifestyles, allowing the retina to 
capture information most critical to the animal’s survival (Hughes et al., 1977; Stone, 
1983; Talbot and Marshall, 2011).  Nocturnal plains dwelling animals typically have a 
horizontal band extending naso-temporal across the retina with high ganglion cell 
density (Hughes, 1971; Provis, 1979).  This “visual streak” is thought to allow detection 
of moving objects in the periphery.  In contrast, most predatory animals, including 
humans, tend to have photoreceptors and ganglion cells concentrated around the central 
retina resulting in higher acuity vision (Hughes, 1975; Stone, 1978; Wassle et al., 1989).   
Human visual acuity, color vision and sensitivity are the result of the cell type 
distributions of the fovea and the connections they make (Wassle et al., 1989; Curcio 
and Hendrickson, 1991).  Near the center of the retina is a yellow-pigmented region, 
known as the macula.  The yellow pigmentation is due to the presence of the 
carotenoids lutein and zeaxanthin (Beatty et al., 1999; Beatty et al., 2004), which absorb 
short wavelength light and provide a level of protection against short wavelength light 
damage beyond what is provided by the lens (Snodderly et al., 1984a; Snodderly et al., 
1984b).  Within the macula is the fovea, consisting of the highest density of cone 
photoreceptors and lowest density of rods and is devoid of ganglion cell bodies and 
retinal vessels to improve visual acuity (Curcio and Hendrickson, 1991; Provis et al., 
1998).  Primates are the only mammals that possess a fovea, although it has evolved 
independently in some non-mammalian vertebrates (Inzunza et al., 1991; Moore et al., 
2012). 
When a signal is passed through the retina it can undergo convergence and 
divergence at each synaptic layer.  The convergence of signal comes from several 
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photoreceptors pooling their input onto a single ganglion cell.  The rod system has 
highest convergence, which increases the sensitivity of the system at the cost of visual 
acuity by pooling the input from a large area of the retinal surface.  In the cat, as many 
as 75,000 rods connect to 5,000 rod BCs which connect to 250 AII amacrine cells to a 
single alpha ganglion cell (Wassle et al., 1989).  The cone pathway through the retina is 
less convergent as a whole and the low convergence in the fovea accounts for the high 
visual acuity.  The other factor increasing visual acuity is the ability of cones to pack in 
close proximity.  In the fovea, cones are primarily connected to midget bipolar cells, 
which connect to midget ganglion cells, setting up a 1:1 cone to ganglion cell ratio (Kolb 
and Dekorver, 1991).  In general, convergence is greatest in the outer retina and lowest 
in the central retina (Schein, 1988; Curcio et al., 1991; Wa¨ssle et al., 1994).  The cell 
topography of the retina allows humans to have high acuity and good color vision at the 
center of the visual field and high sensitivity and reduced spatial resolution in the 
periphery. 
Rod Visual Circuit 
The rod visual circuit is believed to have developed evolutionarily after the cone 
pathway (Lamb, 2009).  Electron microscopy (EM) revealed that rod bipolar cells do not 
make direct synaptic contact with ganglion cells.  Instead, they make synaptic contacts 
with a specific class of amacrine cells, the AII amacrine cell (Kolb and Famiglietti, 1974; 
Famiglietti and Kolb, 1975; Strettoi and Masland, 1996) and utilized the preexisting cone 
BCs to connect to GCs (Strettoi et al., 1992)..   
The Rods can transmit their signal to the ganglion cells through two different 
pathways (Fig. 3).  In the primary rod pathway, rods signal to rod BCs, which make 
synaptic contacts with AII and A17 amacrine cells (Famiglietti and Kolb, 1975; Dacheux 
and Raviola, 1986; Raviola and Dacheux, 1987).  The A17 amacrine cells provide 
GABAergic feedback inhibition onto the rod BC synapses to modulate their output (Kolb 
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and Nelson, 1983; Dacheux and Raviola, 1986; Raviola and Dacheux, 1987; Protti and 
Llano, 1998; Zhang et al., 2002; Chavez and Diamond, 2008).  The AII amacrine cell is 
connected with other AIIs and the axon terminals of cone ON BCs by gap junctions 
(Famiglietti and Kolb, 1975; Strettoi et al., 1992; Strettoi et al., 1994; Mills and Massey, 
1995; Veruki and Hartveit, 2002; Petrides and Trexler, 2008).  It is through the cone ON 
BCs, via the AII, that the rod signal reaches the ON ganglion cell (Kolb, 1979).  The AIIs 
also make inhibitory synapses onto select OFF BC axon terminals and OFF ganglion 
cells, allowing the rod signal to integrate into the ON and OFF pathways (Tsukamoto et 
al., 2001; Murphy and Rieke, 2008; Munch et al., 2009).  In the secondary rod pathway 
the rod photoreceptors are connected to the cone photoreceptors through gap junctions 
and the cone ON BCs are used to transmit the signal to the ganglion cells (Raviola and 
Gilula, 1973; Nelson, 1977; Schneeweis and Schnapf, 1995). 
!! 17!
 
Figure 3: Rod Visual Circuits.  The primary rod pathway: rod photoreceptors 
synapse with the rod BCs, the rod BCs transmit signal to the AII amacrine cell, the 
AII amacrine cell is coupled to the cone ON BCs through gap junctions or the OFF 
BC axon terminals through glycinergic synapses, the cone ON BC signal to the 
ON ganglion cell (GC) and the OFF BC signal to the OFF GC.  Secondary rod 
pathway: the rods feed directly into cones via gap junctions, the signal is then 





Phototransduction is the process by which a light signal is converted into an 
electrical signal, which is passed through the retina by the retinal neurons.  
Phototransduction begins with the absorption of photons by 11-cis-retinal bound to one 
of the various retinal opsins.  Opsins are light sensitive G protein-coupled receptors 
(GPCRs) and each type of photoreceptor expresses a specific type of opsin.  The rod 
photorecptors express rhodopsin (RHO) and are most sensitive to 498 nm light, the L-
type cones express long-wave-sensitive opsin 1 (OPN1LW) and are most sensitive to 
564 nm light, the M-type cones express medium-wave-sensitive opsin 1 (OPN1MW) and 
are most sensitive to 533 nm light and the S-type cones express short-wave-sensitive 
opsin 1 (OPN1SW) and are most sensitive to 437 nm light (Brown and Wald, 1963).   
The ligand of the visual pigments of most vertebrates is 11-cis-retinal (Dartnall 
and Lythgoe, 1965). Absorption of a photon causes a conformation change in the opsin 
bound chromophore 11-cis-retinal (Wald, 1968).  The conformation change from 11-cis-
retinal to all-trans retinal subsequently activates the associated opsin (Wald, 1968).  
Activated opsin can then bind and activate the heterotrimeric G protein, transducin, 
resulting in a GDP for GTP exchange on Gαt (reviewed in Chen (2005)). Active Gαt 
binds and activates the cyclic guanosine monophosphate (cGMP) phosphodiesterase 
(PDE), which is anchored to the disk membrane by isoprenylation (Anant et al., 1992; 
Qin and Baehr, 1994).  Activated PDE catalyzes the hydrolysis of cGMP, the second 
messenger in phototransduction (Zhang and Cote, 2005; Lugnier, 2006; Conti and 
Beavo, 2007).  The decrease in cGMP causes cyclic nucleotide gated (CNG) ion 
channels to close, resulting in hyperpolarization of the cell (Fesenko et al., 1985; Haynes 
et al., 1986; Zimmerman and Baylor, 1986; Matthews, 1987; Haynes and Yau, 1990).   
Deactivation of phototransduction is the result in deactivation of activated opsins 
and transducin.  Deactivation of opsin begins with phosphorylation of 6 to 7 amino acids 
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on the cytoplasmic carboxy terminus (Hurley et al., 1998; Mendez et al., 2000; Kennedy 
et al., 2004) and is completely inhibited when arrestin binds the phosphorylated 
cytoplasmic domain and inhibits interaction with transducin (Xu et al., 1997; Chen et al., 
1999; Mendez et al., 2000; Doan et al., 2009).  The intrinsic rate of GαGTP to GDP 
conversion is relatively slow and is accelerated by interaction with RGS9 (He et al., 
1998).  RGS9 is a part of a multi-protein complex that includes R9AP (membrane 
anchor) and Gβ5 (Hu and Wensel, 2002).  Hydrolyzing GαGTP to GαGDP inhibits PDE 
activation and allows levels of cGMP to recover and effectively gate the CNG ion 
channels open. 
Deactivation of phototransduction in rods is slower (~200 ms) than the activation 
steps (~130 ms) (Krispel et al., 2006; Nikonov et al., 2006; Arshavsky and Burns, 2012).  
This is an important concept because the bipolar cell light response is similar to the 
deactivation of a G protein cascade and not the activation.  In mouse rod 
photoreceptors, the RGS9 complex rate limits the deactivation of the photoresponse 
(Krispel et al., 2006).  Overexpression of the RGS complex results in a faster 
photoresponse recovery (~74 ms) (Krispel et al., 2006; Chen et al., 2010; Gross and 
Burns, 2010).  In cones, which express more RGS proteins than rods (Cowan et al., 
1998; Zhang et al., 2003), deactivation of rhodopsin becomes the rate-limiting step in 
photoresponse deactivation (Gross and Burns, 2010; Matthews and Sampath, 2010).  
Hyperpolarization of the photoreceptor modulates the L-type voltage gated 
calcium channel (L-VGCC) and results in channel closure (Katz and Miledi, 1967; Smith 
and Augustine, 1988; Schmitz and Witkovsky, 1997; Bech-Hansen et al., 1998). The 
reduction in calcium entry decreases the release of the neurotransmitter glutamate into 
the synaptic cleft, in a stimulus intensity dependent manner (Trifonov, 1968a; Penn and 
Hagins, 1969; Ball and Gregg, 2002; Barnes and Kelly, 2002). Photoreceptors release 
neurotransmitter in a graded manner with a linear relationship to intracellular calcium 
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levels (Thoreson et al., 2004; Heidelberger et al., 2005; Thoreson, 2007). RIBEYE, the 
main protein component of ribbon synapses, forms complexes with proteins that regulate 
L-VGCCs to tightly correlate synaptic vesicle release to calcium entry (Schmitz et al., 














Figure 4: Phototransduction in the rod photoreceptor.  (A) Activation of rhodopsin 
by a single photon causes G protein activation.  Active Gα binds and activates 
PDE, allowing it to hydrolyze cGMP.  cGMP gated ion channels then open causing 
















ON Bipolar Cell signaling 
BCs are hypothesized to have evolved from photoreceptors due to the fact they 
share many common features including; microtubule arrangement, an output synapse 
with similar structure containing a ribbon synapse, and a similar G protein signal 
transduction cascade (Lamb et al., 2007).  While there are many similarities between 
these cell types, the ON BC signaling cascade is less well understood and it is emerging 
that the ON BC signaling cascade is markedly different from the signaling mechanism in 
the photoreceptors (Peachey et al., 2012b; Shen et al., 2012).   
Signaling from the photoreceptors to the bipolar cells requires glutamate 
receptors at the dendritic tips of the bipolar cells.  The ON bipolar cells express the 
metabotropic glutamate receptor 6 (mGluR6) and the OFF bipolar cells express different 
variations of ionotropic glutamate receptors (iGluR) of AMPA and kainate types 
(Slaughter and Miller, 1981; Saito and Kaneko, 1983; Masu et al., 1995; Puller et al., 
2013).  A decrease in glutamate release at the photoreceptor terminals cause the OFF 
BCs to hyperpolarize due to closure of the iGluR cation channel (Kaneko and Saito, 
1983; Saito and Kaneko, 1983).  The ON BCs depolarize in response to a reduction in 
glutamate by opening a non-specific cation channel, TRPM1, linked to the mGluR6 
glutamate receptor (Slaughter and Miller, 1981; Masu et al., 1995; Morgans et al., 2009; 
Shen et al., 2009; Koike et al., 2010b; Morgans et al., 2010).  
In the dark, photoreceptors tonically release glutamate from their axon terminals 
into the synaptic cleft (Trifonov, 1968b; Copenhagen and Jahr, 1989; Ayoub and 
Copenhagen, 1991).  Glutamate binding to mGluR6 activates the receptor, releasing the 
active heterotrimeric G proteins Gαo and Gβ3γ13 dimer (Dhingra et al., 2000; Huang et 
al., 2003; Okawa et al., 2010; Dhingra et al., 2012).  The activation of the G proteins 
results in the closing of the TRPM1 cation channel by an unknown mechanism (Morgans 
et al., 2009; Shen et al., 2009; Koike et al., 2010a; Koike et al., 2010b).  When the 
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photoreceptors hyperpolarize in response to light increments, glutamate release into the 
synaptic cleft is decreased (reviewed in Stryer (1991)).  The reduction in glutamate 
bound by mGluR6 causes a decrease in activated G proteins allowing the TRPM1 
channel to open and the cell to depolarize (Audo et al., 2009; Morgans et al., 2009; Shen 
et al., 2009; Koike et al., 2010b; Morgans et al., 2010).  The RGS proteins Gβ5, RGS7 
and -11 are thought to be critical in deactivating the G proteins allowing the TRPM1 
cation channel to open (Rao et al., 2007; Cao et al., 2012).  Several other proteins with 
unidentified functions also are critical to normal cascade function and include nyctalopin, 
GPR179 and LRIT3 (Gregg et al., 2003; Audo et al., 2012; Peachey et al., 2012b; Zeitz 





Figure 5: Schematic of depolarizing bipolar cell signaling.  In the dark glutamate is 
tonically released into the synaptic cleft where it was bound by mGluR6, 
activating a G protein cascade that results in the closure of the TRPM1 channel.  
In response to a light increment glutmate release into the synapse is decreased.  
The mGluR6 receptors are inactive because it is not bound to glutamate and the 
RGS proteins deactivate any remaining active G proteins and the TRPM1 channel 










Photoreceptor Light Sensitivity 
The retina is capable of operating over a range in illuminance of a factor of 1011 
(Burkhardt and Gottesman, 1987; Burkhardt, 1994; Stockman and Sharpe, 2006).  To 
achieve this, the retina uses two different types of photoreceptors with differing 
sensitivities to light (Fig. 6).  The rod photoreceptors are the most sensitive and function 
under scotopic lighting conditions (luminance 10-2 to 10-6 cd/m2) (Hood et al., 1979).  A 
cloudy night sky without moon is equivalent to ~10-4 cd/m2 and a clear night sky with full 
moon is equivalent to ~10-2 cd/m2 (Middleton and Mayo, 1952). In humans, a light 
stimulus of only a few photons is capable of creating a visual percept (Hecht et al., 1942; 
Van Der Velden, 1946; Sakitt, 1972).  Individual rods are capable of reliably responding 
to single photon stimuli and relaying this signal to retinal interneurons (Hecht et al., 
1942; Field et al., 2005).  Due to the rods only being active under scotopic conditions 
there is no color vision because rods only have one photopigment.  Visual acuity of rod-
mediated vision is poor because of the high degree of signal convergence.   
At the upper limit of rod sensitivity and lower limit of cone sensitivity is mesopic 
lighting conditions, with luminance from 10-2 to 1 cd/m2 (Hood et al., 1979).  Mesopic 
conditions are equivalent to a clear night sky with a full moon to a clear sky just after 
sunset (Middleton and Mayo, 1952).  Under mesopic conditions color vision is poor, but 
visual acuity is improved due to the use of the less convergent cone visual pathway.  
Under photopic lighting (1 to 106 cd/m2) conditions only the cone photoreceptors are 
functional (Jones et al., 1993; Burkhardt, 1994).  The photopic visual range is equivalent 
to just after sunset on a clear day to a bright sunny day.  Color vision and high visual 
acuity are possible because vision is primarily foveal (Middleton and Mayo, 1952; Hood 
et al., 1979). 
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Figure 6: Photoreceptor Illumination Sensitivity.  The diagram correlates typical 

















The activity of retinal neurons can be assessed non-invasively by the 
electroretinogram (ERG).  The ERG measures the gross potential of the corneal surface 
in response to a light stimulus and produces waveforms that reflect electrical activity of 
specific neural layers.  In 1933, Ragnar Granit reported that the ERG is composed of 
three components that last the entire duration of the light stimulus and can be isolated by 
deepening the state of anesthesia of the test animal (Fig. 7 and Granit (1933)).  Granit 
won the Nobel Prize in Physiology and Medicine in 1967 for his work on the ERG.  The 
first waveform produced by the ERG is the negative deflecting a-wave that reflects the 
hyperpolarization of the photoreceptors in response to an increase in luminance (Brown 
and Murakami, 1964; Brown, 1969; Penn and Hagins, 1969).  The second wave 
produced by the ERG is the corneal positive b-wave that is produced by the 
depolarization of the bipolar cells (Slaughter and Miller, 1981; Stockton and Slaughter, 
1989; Gurevich and Slaughter, 1993).  Only the ON BCs contribute to the b-wave of the 
ERG.  The OFF bipolar cells contribute to the repolarization of the ERG after the b-wave 
peak at light offset (Bush and Sieving, 1994).  The c-wave is a slow forming positive 
wave that originates from RPE and glial cells (Noell, 1954; Steinberg et al., 1970).   
The ERG can be measured under different lighting conditions to isolate specific 
neural pathways in the retina.  The scotopic ERG is used to measure rod responses.  By 
dark adapting the retina and using flash responses below cone threshold the rods and 
rod BC responses can be isolated.  The photopic ERG is used to measure cone and 
cone BC responses.  To measure the photopic ERG the test is performed in the 
presence of an adapting background that saturates the rods. 
The ERG has been an invaluable tool for assessing retinal function and 
identifying defects in humans and mice (Peachey and Ball, 2003).  A reduction in the a-
wave of the ERG is indicative of defects in phototransduction or a reduction in the 
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number of photoreceptor outer segment disks.  A reduction in the b-wave of the ERG 
may indicate a disruption in neurotransmission from the photoreceptors to the bipolar 
cells (Peachey and Ball, 2003).  This disruption may be caused by a defect on the pre or 
post-synaptic side of the synapse.  The absence of the b-wave in the ERG has been 
associated with the non-progressive disease congenital stationary night blindness 
(CSNB).  It has been reported that between 2.9 and 4.8% of the human population has a 
negative ERG and the underlying cause of the vast majority of negative ERGs is CSNB 










Figure 7:  Components and waveforms of the Electroretinogram.  The ERG 
response to a 2 sec stimulus (yellow).  The ERG waveforms (solid line) are labeled 
a, b, c, d and the individual components (broken lines) are labeled PI, PII and PIII.  















Congenital Stationary Night Blindness 
Congenital stationary night blindness (CSNB) is a non-progressive disease that 
results in the disruption of rod signal transmission through the inner retina.  Human 
patients with CSNB often have reduced visual acuity and reduced visual function under 
low light conditions (Miyake et al., 1986; Miyake et al., 1987; Audo et al., 2008).  CSNB 
in humans is classified into two groups.  Mutations that result in a complete ablation of 
the ERG b-wave are said to cause the complete form of CSNB (cCSNB) (Riggs, 1954; 
Miyake et al., 1986).  A number of genetic mutations have been identified in genes that 
cause cCSNB.  They include; Nyx (Pardue et al., 1998; Bech-Hansen et al., 2000; Pusch 
et al., 2000; Gregg et al., 2007), Grm6 (Masu et al., 1995; Dryja et al., 2005; Zeitz et al., 
2005; Pinto et al., 2007), Trpm1 (Audo et al., 2009; Morgans et al., 2009; Koike et al., 
2010b; Nakamura et al., 2010), Gpr179 (Audo et al., 2012; Peachey et al., 2012b) and 
Lrit3 (Zeitz et al., 2013b).   
The incomplete form of CSNB (iCSNB) is characterized by a reduced b-wave as 
measured by ERG (Miyake et al., 1987).  iCSNB is the result of disruptions in 
neurotransmitter release from the photoreceptor terminals and genes involved include 
Cacna1f (Strom et al., 1998), Cacnb2 (Ball et al., 2002; McCall and Gregg, 2008) and 
Cabp4 (Zeitz et al., 2006).   
A study by Bijveld et al., (2013) characterized the visual defects of people with 
cCSNB and iCSNB.  cCSNB patients report difficulty in performing tasks at night such 
driving, cycling, and maneuvering in dimly lit social settings such as movie theaters and 
pubs (Bijveld et al., 2013a).  Many cCSNB patients report being blind at night and 
dependent on others in dark circumstances (Bijveld et al., 2013a).  iCSNB patients 
report to having difficulty at the aforementioned tasks at a reduced rate and none felt 
they were always blind at night and dependent on others (Bijveld et al., 2013a).  
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The screening of mice with the ERG has been critical to identifying spontaneous 
mutant mice with DBC dysfunction.  Mapping and cloning the causative mutations has 
led to the identification of novel genes critical to the glutamate signaling cascade in 
DBCs (Pardue et al., 1998; Gregg et al., 2007; Peachey et al., 2012b).  The screening of 
human patients with previously unidentified causes of CSNB for the orthologous mouse 
gene has identified genes that cause CSNB (Bech-Hansen et al., 2000; Pusch et al., 
2000; Audo et al., 2009; Nakamura et al., 2010; Audo et al., 2012; Peachey et al., 
2012b). 
  cCSNB mouse models known to date have a normal retinal morphology as 
visualized at the light or electron microscope level (Masu et al., 1995; Pardue et al., 
1998; Tagawa et al., 1999; Dhingra et al., 2000; Pardue et al., 2001; Morgans et al., 
2009; Koike et al., 2010b).  iCSNB mouse models have abnormal retinal morphology 
highlighted by ectopic bipolar and horizontal cell dendrites that extend into the ONL (Ball 
and Gregg, 2002; Dick et al., 2003; Chang et al., 2006; Bayley and Morgans, 2007).   
G Protein-Couple Receptor Signaling 
GPCRs are critical for phototransduction and signaling through the inner retina.  
The retina is a very attractive system for studying GPCR signaling mechanisms because 
of the availability of mutant mice, accessibility and ability to functionally assess specific 
signaling events.  GPCRs are the target of approximately 30% of pharmaceutical drugs 
(Salon et al., 2011).  The more knowledge gained about these diverse signaling 
pathways the better we are able to develop effective therapies for diseases that impair 
vision.  All GPCRs are membrane proteins that contain an extracellular amino terminus 
followed by a 7 transmembrane (TM) domain and a cytosolic carboxy terminus.  GPCRs 
represent the largest class of signaling proteins in the human genome with more than 
800 members (Fredriksson et al., 2003).   
!! 32!
GPCRs have been classified into three main families based on shared homology.  
Class A are the rhodopsin like receptors, Class B are the secretin-like receptors and 
Class C are the metabotropic glutamate-like receptors (Foord et al., 2005).  The 
simplistic model of GPCR signaling is that binding of an extracellular ligand produces a 
conformational change in the receptor that activates heterotrimeric G proteins (Gαβγ) 
inside the cell.  The ligands for GPCRs are a diverse group including small compounds, 
ions, peptides and amino acids (Muller et al., 2008).  The majority of GPCRs initiate 
intracellular signaling through heterotrimeric G proteins but it is beginning to be 
understood that some operate through G protein-independent mechanisms (Galandrin et 
al., 2007; Altier and Zamponi, 2008).   
The extracellular domain of GPCRs consists of the amino terminus and the 
extracellular loops (ECLs) ECL1, ECL2 and ECL3.  There is large diversity in sequence 
length and composition among the receptors amino terminus (Lagerstrom and Schioth, 
2008).  Class A GPCRs form a ligand-binding pocket with the ECLs that can either be 
occluded or water-accessible (Palczewski et al., 2000; Hanson et al., 2012).  Class B 
GPCRs have an amino terminus ligand binding domain composed of an α-helix and two 
β-sheets stabilized by disulfide bridges (Parthier et al., 2009).  Class C GPCRs typically 
possess a large bilobed amino terminal ligand-binding domain coined the venus flytrap 
(VFT) domain (Chun et al., 2012).  The VFT ligand binding domain shares sequence 
homology with bacterial periplasmic binding proteins (PBP) (Zhang et al., 2008).  An 
accepted hypothesis for the origin of Class C GPCRs is that they are the result of a 
fusion between a rhodopsin-like receptor and a PBP (Pin et al., 2003). 
The 7TM helix region of GPCRs serves to relay extracellular information to the 
inside of the cell (Muller et al., 2008; Venkatakrishnan et al., 2013).    The crystallization 
of GPCRs bound to agonist and ligand free GPCRs provided detail about the 7TM 
movement that occurs when the receptor is activated (Audet and Bouvier, 2012).  
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Movement of the 7TM region cause a conformational change that allows the binding of 
heterotrimeric G proteins by the intracellular regions (IC) of the GPCR (Audet and 
Bouvier, 2012). 
The IC loops of GPCRs typically bind downstream signaling effectors such as G 
proteins, kinases and arrestins (Rasmussen et al., 2011; Katritch et al., 2012).  The IC 
regions undergo dramatic conformational changes in response to ligand binding (Park et 
al., 2008; Scheerer et al., 2008; Choe et al., 2011; Lebon et al., 2011; Rasmussen et al., 
2011; Standfuss et al., 2011; Xu et al., 2011).  The conformational change allows the 
binding of the receptor’s associated GDP bound heterotrimeric G proteins (Latek et al., 
2012).  The conformation of the GDP Gαβγ when bound to the GPCR facilitates GTP for 
GDP nucleotide exchange resulting in release of the activated GαGTP and dissociation 
from the Gβγ complex (Chung et al., 2011; Rasmussen et al., 2011).  
Some GPCRs are capable of functioning as monomeric receptors while others 
require assembly into dimers or larger complexes (Bouvier, 2001; Chabre and le Maire, 
2005; Milligan, 2006; Bayburt et al., 2007; Whorton et al., 2007; Rondard et al., 2008; 
Rondard et al., 2011; Yanagawa et al., 2011).  In addition to forming complexes with 
other GPCRs, they may also associate with other transmembrane proteins to form 
signaling complexes (Altier and Zamponi, 2008; Altier, 2012).  This is believed to 
enhance signaling kinetics. 
The rhodopsin GPCR signaling pathway is the prototypical GPCR pathway.  The 
first crystal structure of a GPCR was of bovine rhodopsin (Palczewski et al., 2000), since 
then the crystal structure of 18 different class A GPCRs has been solved 
(Venkatakrishnan et al., 2013).  As a result, much of what we know about GPCR 
signaling pertains to class A GPCRs and a one-size-fits all approach has typically been 
used when studying GPCRs from other classes.  While this approach has proven useful, 
it has become clear with the growing diversity of GPCRs that not all will fit that mold.  It 
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is important to identify these novel mechanisms of GPCR signaling to not only enhance 
our understanding of GPCR signaling but to unlock answers that may prove 
therapeutically beneficial. 
What we can learn from the retina 
 The retina is a model system that allows us to learn about more than just vision.  
It is the most accessible part of the CNS allowing us to more easily study the 
development of complex neural circuitry.  The retinal neurons offer a glimpse of neural 
signal processing that we understand must also take place in the brain, but are not as 
easily measured.  The retina can be easily genetically manipulated and the results of 
these manipulations can be functionally assessed with visual tests, allowing perhaps a 




CHAPTER II: GPR179 IS MUTATED IN THE NOB5 MOUSE 
 
Aim 1:  Identify the mutation responsible for the nob phenotype in the nob5 mouse 
Rationale:  Spontaneous mutant mice are important tools for identifying genes involved 
in disease.  The nob5 mouse lacks the ERG b-wave and is predicted to have a defect in 
the glutamate-signaling cascade of DBCs.  By identifying the mutation in the nob5 
mouse we can better understand how the glutamate receptor, mGluR6, gates the 
TRPM1 cation channel closed in the DBCs.  As a testament to our incomplete 
knowledge of the glutamate signaling cascade in the DBCs, there are patients with 
cCSNB that do not have mutations in the known cCSNB causing genes (Nakamura et 
al., 2010; Bijveld et al., 2013b).  Therefore, it is probable that there are cCSNB patients 
with a mutation in the nob5 ortholog.  Although there currently is no cure for cCSNB and 
patients have relatively minor lifestyle inconveniences (Bijveld et al., 2013a), identifying 
the cause of their disease can provide closure and the knowledge that they do not have 
a progressive retinal disease in addition to the scientific value of understanding a novel 
GPCR pathway. 
Hypothesis: The nob5 mouse has a mutation in a gene expressed in the ON BCs 
(DBCs) of the retina. 
Introduction 
The ERG is a common tool used to evaluate visual function in mice and can be 
used as a high-throughput method for identifying retinal dysfunction (Dalke et al., 2004).  
The screening of mice using the ERG has identified spontaneous mouse mutants with 
DBC dysfunction (Maddox et al., 2008; Peachey et al., 2012a; Peachey et al., 2012b).  
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In some of these cases, the mutated genes were novel (Bech-Hansen et al., 2000; 
Peachey et al., 2012b) and required various molecular biology techniques to locate the 
mutation within the genome.  In other cases, the mutations were in genes already known 
to cause the nob phenotype but offer unique insights into protein properties that the 
knockout model does not display (Maddox et al., 2008; Peachey et al., 2012a). 
The nob5 mouse is a spontaneous mutant that arose on a C3H/HeJ mouse 
strain.  The C3H/HeJ mouse strain carries a homozygous mutation in the rod 
phosphodiesterase gene, Pde6b, and was an early model for retinal degeneration 
(Sidman and Green, 1965; Pittler and Baehr, 1991).  This form of retinal degeneration 
progresses quickly and causes blindness by weaning age, because of a complete loss of 
photoreceptors (Farber and Lolley, 1974; Lolley and Farber, 1976).  The retinal 
degeneration in the C3H/HeJ mouse strain allowed the nob5 phenotype to go unnoticed 
until the C3H line was crossed to a congenic C3H line lacking the Pde6b mutation.  It 
was then that an ERG screen by Gianluca Tosini at Morehouse College of Medicine 
discovered the nob5 mutant.   
The nob5 mouse has a normal a-wave but lacks a b-wave in the scotopic ERG 
(Fig. 8A).  The scotopic ERG measures responses through the rod photoreceptor and 
rod BC pathway.  These data indicate that the rod photoreceptors are functioning 
normally, but the rod BCs are not.  The nob5 mouse has a normal a-wave in the 
photopic ERG but lacks a b-wave (Fig 8B).  The light adapted or photopic ERG 
measures responses mediated by cones. These data indicate the cone photoreceptor 
phototransduction is normal but cone DBC signaling is completely absent.  The ERG of 
the nob5 mouse (Fig. 8A,B) is similar to other cCSNB mouse models (Masu et al., 1995; 
Pardue et al., 1998; Pinto et al., 2007; Maddox et al., 2008; Morgans et al., 2009), which 
lead us to the hypothesis that  the causative mutation would be  in a gene expressed in 




Figure 8: Scotopic and photopic ERGs of WT and nob5 mice. (A) Scotopic ERGs 
of WT and nob5 mice show nob5 mice have a normal ERG a-wave in response to 
increasing flash intensity but are lacking a b-wave. (B) Photopic ERGs show the 
nob5 mice lack a cone mediated b-wave response.  Taken together these data 














The phenotype in the nob5 mice displays an autosomal recessive inheritance 
pattern.  To determine if the underlying mutation was in a gene known to cause DBC 
dysfunction, complementation crosses were performed at the Cleveland Clinic with 
established models of DBC dysfunction Grm6nob3, Nyxnob and Trpm1-/-.  The F1 offspring 
were assessed for retinal function using the ERG.  All offspring had normal ERGs 
indicating the mutant gene in nob5 mice was not Grm6, Nyx or Trpm1.   
To localize the nob5 mutation within the genome a mapping cross was set up at 
the Cleveland Clinic.  The nob5 mice were outcrossed to C57BL6/J mice producing 
nob5-/+ F1 offspring.  The F1 offspring were subsequently intercrossed to produce F2 
offspring with new allele combinations. The F2 offspring were phenotyped by ERG.  
DNA was pooled from 20 mice displaying the nob5 phenotype and genotyped at 
approximately 103 simple sequence repeat (SSR) polymorphic markers across the 
genome (Taylor et al., 1994)  Genomic regions that were heterozygous for both mouse 
strains (C3H/HeJ and C57BL6/J) were ruled out as containing the nob5 gene.  This 
strategy mapped the nob5 allele to a 4.1 megabase (MB) region (Chr11:94563438-
98683655) on chromosome 11.  
Results 
Linkage mapping reduced the nob5 critical region to 1.3 Mb 
 The SSR low-resolution genome mapping localized the nob5 phenotype between 
MIT Markers D11MIT288 (Chr11:94563438) and D11MIT14 (Chr11:98683655) on 
chromosome 11. The region between D11MIT288 and D11MIT14 spans 4.1Mb and is 
equivalent to 3.5 centimorgans (cM) (http://cgd.jax.org/mousemapconverter/). To reduce 
the region containing the nob5 mutation, which was thought to arise on a C3H 
background, crosses were set up in which the nob5 mouse was outcrossed with 
C57BL6/J mice.  These two strains can be easily differentiated with various SSR and 
single nucleotide polymorphism (SNP) markers, which allows for the detection of 
!! 39!
chromosomal crossovers to narrow the critical region.    The SSR and SNP genotyping 
markers were identified using the National Center for Biotechnology Information’s 
dbSNP database and confirmed by Sanger sequencing.  SNPs were genotyped using a 
high throughput method referred to as high resolution melting (HRM), which relies on 
melting curve analyses on an ABI 7900 HT real-time PCR machine.  SSR markers were 
genotyped by running amplified samples on agarose gels.  Because the nob5 critical 
region is small we expect only 5% of mice to have a crossover in the critical region. 
Therefore we used a two-step genotyping and phenotyping strategy.  
In total ~1000 F2 mice were generated from a backcross of F1 (nob5 x 
C57BL/6J) mice to nob5 mice. All 1000 mice were genotyped with D11MIT14 and 
D11MIT288 markers to identify animals with chromosomal recombination events within 
the nob5 critical region.  These animals with chromosomal crossovers then were 
genotyped using a combination of nine different MIT and SNP markers spanning the 
critical region to further localize the recombination event (Fig. 9B).  ERGs were 
performed on the mice with crossovers that should narrow the critical region.      
 Of the ~1,000 backcross progeny, 39 had crossovers between the D11MIT288 
and D11MIT14 markers, reducing the nob5 critical region to ~1.3 MB.  The ~1.3 MB 
region was situated in a highly gene rich region on chromosome 11 (Zody et al., 2006) 
containing ~80 predicted genes (Fig. 9B).  Due to the fact that 1000 mice were needed 
to reduce the region to a 1.3 MB region of high gene density, it became clear further 
refinement using this genetic approach was not feasible.  Therefore two strategies were 
used to identify the causative mutation in the nob5 mouse, a candidate gene search and 
next-generation sequencing of the region. 
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Figure 9:  Mapping panel of nob5 critical region.  (A) Chromosome map of mouse 
chromosome 11 with the protein coding gene density (top) mapped to the 
chromosome.  (B) Chromosome map of nob5 critical region including genotyping 
markers used to narrow the region.  (Bottom) The 1.3 Mb region between markers 













Genes located within the critical region were evaluated for possible roles in DBC 
signaling.  Genes that had known roles in signaling, such as ion channels or had 
expression in neuronal systems were considered candidates.  Genes for which knockout 
mice had already been made and showed a lethal phenotype were excluded as 
candidates because the nob5 mouse is otherwise healthy.  
To identify mutations in candidate genes RNA was isolated from nob5 mouse 
retinas and converted into cDNA.  Primers were made that flanked the open reading 
frame (ORF) and were used to amplify the ORF and clone it into a pCR4-TOPO vector 
(Invitrogen).  The ORFs were then sequenced and compared to the reference genome.  
Genes thought to be good candidates included Npepps, Arhgap23, Pip4k2b, Srcin1 and 
Cacnb1, however, none had mutations in the ORFs.  
Next generation sequencing identified an insertion in Gpr179 
Therefore, to identify the mutant gene we decided to sequence the entire 1.3 MB 
region using next generation sequencing.  This method requires capturing and 
amplifying genomic DNA from the critical region using microarray sequence capture 
(Albert et al., 2007).  The sequence capture array was designed and made off site by 
Roche NimbleGen and was designed to capture a 1.5 MB region of DNA that included 
the entire nob5 critical region plus upstream and downstream flanking regions, but 
excluded highly repetitive regions.  I used the UCSC genome browser to ensure the 
probes on the array design would capture all of the gene containing regions within the 
nob5 critical region.   
Sequencing of the captured DNA was performed on an Illumina GAIIx 
sequencing machine by Ambry Genetics.  Mouse liver genomic DNA was isolated from a 
nob5 mouse and a C3H control and shipped to Ambry Genetics for enrichment of the 
target region and sequencing using 54bp paired-end sequencing.  The bioinformatics 
report was prepared by Ambry Genetics and delivered to the lab, along with a hard drive 
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containing the raw FASTQ sequence files.  The bioinformatics report contained two 
points of interest.  There were no unique non-synonymous point mutations found in the 
nob5 sample compared to the control and there was a possible transposable element 
insertion in the nob5 sample that was not found in the control sample.  The sequence 
files identified two ~30 bp of junction fragments on the 5 prime and 3 prime ends of a 
possible insertion site at Chr11:97212072-97212086, which  is within intron 1 of the 
Gpr179 gene. 
To confirm the insertion and determine its size, primers were created that flanked 
the putative insertion and PCR was used to amplify the DNA fragment in the nob5 and 
control samples.  The PCR results showed that DNA from the nob5 mouse contained an 
insertion that is approximately 6.5 kb (Fig. 10A,B).  Sequence analyses of the PCR 
fragment indicated it was a retrotransposable element of the ERV2 class, although 







Figure 10: A transposable element disrupts Gpr179 expression.  (A) PCR 
amplification of the insertion followed by agarose gel electrophoresis revealed the 
insertion was approximately 6.5 kb in length.  (B) Schematic of Gpr179 exon map 
and insertion site.  Subsequent sequencing of the insertion fragment revealed it 
was a transposable element of the ERV2 class.  (C) Quantification of Gpr179 
expression at the exon 1-2 boundary using a taqman assay.  Gpr179 expression 
was normalized to 18S RNA and is relative to WT gene expression.  Error bars 
indicate mean and standard deviation for three mice.  Gpr179 expression is 












The transposon insertion dramatically decreases Gpr179 gene expression 
To understand how the transposable element affected Gpr179 gene expression 
in the nob5 sample two methods were used.  First, using primers nested in exon 1 and 
exon 11, I attempted to clone a cDNA fragment made from WT and nob5 retinal RNA. 
PCR amplification using cDNA from WT resulted in the expected fragment size of ~6.8 
kb, whereas the nob5 sample did not produce a PCR product.  Forward and reverse 
primers were then created across the gene designed to amplify smaller fragments of the 
predicted cDNA to see if any of the Gpr179 mRNA was expressed and processed in 
nob5 retinas.  Primers placed in exon 2 through exon 11 yielded PCR fragments of the 
expected size in the WT and nob5 sample.  Forward primers placed in exon 1 and 
reverse primers placed in any exon downstream of the transposon insertion (exons 2-
11), failed to produce a PCR fragment in the nob5 samples.  These experiments confirm 
that Gpr179 is expressed in the retina and that gene expression is altered in the nob5 
retina. 
To quantitatively measure Gpr179 gene expression in the nob5 sample I used 
two different TaqMan Assays (Life Technologies).  The first (Mm00615352_m1) spanned 
the exon1/2 boundary of Gpr179 and had an amplicon length of 83 bp.  The second 
(Mm04204651_m1) spanned the exon 5/6 boundary and had an amplicon length of 103 
bp.  The results of the experiment show that gene expression is virtually undetectable in 
the nob5 mouse using the exon1/2 TaqMan assay (Fig. 10C).  The exon5/6 TaqMan 
assay revealed that Gpr179 expression downstream of exon 1 showed only a slight 
increase compared to WT (data not shown).   
These experiments indicate that exons downstream of intron 1 are expressed 
and processed but intron 1 is not processed properly.  The transposable element 
insertion presumably interferes with processing of intron 1 because it likely contains 
many splice acceptor and splice donor sites that may result in a large number of different 
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mRNAs.  These splice variants would likely create transcripts that undergo nonsense-
mediated decay.  Exons downstream of exon 1 appear to be processed correctly.  It 
seems unlikely that the loss of exon 1 would cause a hypomorphic mutation because 
exon 1 contains the translation start site, the signal sequence and the majority of the 
protein’s extracellular amino terminus.  It would be unlikely that GPR179, a 7 TM 
spanning protein could have any function without these critical domains.   
In situ hybridization localizes Gpr179 mRNA to the INL of the retina 
 My RT-PCR experiments had determined that Gpr179 is expressed in the retina, 
but it was not known by which cells.  To localize Gpr179 gene expression I used in situ 
hybridization (ISH) on fixed retinal slices.  Antisense digoxigenin (DIG) labeled RNA 
probes were created by cloning a ~800 bp cDNA fragment encoded by Gpr179 into a 
pSPT18 vector and performing in vitro transcription using T7 RNA polymerase.  The ISH 
was performed on fixed retinal slices and visualized by probing for the DIG RNA with 
horseradish peroxidase (HRP) labeled antibodies followed by Cy3 tyramide signal 
amplification (TSA).  Immunostaining with PKC antibodies, which labels the rod BCs, 
was performed to give a cellular reference to identify in which cells the RNA was 
expressed.   
 The Gpr179 antisense probes annealed in the INL of the retina where the bipolar 
cell bodies reside (Fig. 11 A).  The antisense probes did not anneal to any of the other 
nuclear layers.  As a positive control, antisense probes were designed against Grm6 
mRNA, the glutamate receptor expressed in the DBCs with a known ISH expression 
profile (Kim et al., 2008).  The antisense Grm6 DIG probes labeled the INL of the retina 
as identified by co-labeling with PKC and gave a similar staining pattern as Gpr179 (Fig. 






Figure 11:  GPR179 is expressed in bipolar cells.  In situ hybridization localizes 
Gpr179 mRNA expression.  (Top) Antisense Gpr179 probes (red) hybridize to the 
INL and expression overlaps with the rod BC bodies (green).  Gpr179 expression 
mirrors the mRNA expression of Grm6 (bottom), a gene that is solely expressed in 







GPR179 is expressed on the DBC dendritic tips in human retinas 
 To localize GPR179 protein expression in the retina, immunostaining was 
performed using a commercially available antibody designed against a peptide 
(HPA017885 Sigma) that is located in the amino terminus of the extracellular domain of 
human GPR179.  The human peptide shares 84% sequence identity with the 
orthologous mouse peptide.  Immunostaining was performed on WT C57BL6/J retinal 
sections while co-labeling with peanut agglutinin (PNA), which binds to a lectin on cone 
pedicles in the OPL (Blanks et al., 1988; Haverkamp et al., 2001).  The staining for 
GPR179 showed a staining pattern inconsistent with the known pattern of proteins 
expressed in the DBCs (not shown).  Further, the pattern in WT and nob5 was 
indistinguishable suggesting the antibody was not recognizing mouse GPR179 (data not 
shown). 
To determine if the antibody used above gave the predicted staining in human, 
immunostaining was performed on transverse human retinal sections.  GPR179 staining 
in the human retinas showed a punctate staining pattern in the OPL typical of other 
proteins that are part of the DBC signal transduction cascade (Fig. 12).  Because the 
antibody only stained puncta, I could not be determine if the staining was pre synaptic or 
post synaptic, but taken with the ISH data and ERG phenotype of human patients with 
mutations in GPR179, I predict it will be located post-synaptically.  This was confirmed 
recently by immuno-electron microscopy of human retinas (Klooster et al., 2013).  These 
data also indicate that the staining in the mouse retina by the human GPR179 antibody 
is non-specific.  To study GPR179 protein expression in the mouse retina an antibody 
had to be developed that recognized the mouse protein. 
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Figure 12: GPR179 is expressed in the OPL in human retina.  GPR179 labeling 
(green) and DAPI (blue) in fixed transverse retinal sections from human retina 
gives a punctate staining pattern typical of proteins in the glutamate signaling 













GPR179 staining is absent in the OPL of the nob5 retina 
Due to the robust labeling of the human antibody in human retina, we used a 
portion of the orthologous mouse peptide sequence as the antigen 
(KVQEETPGEDLDRPVLQKR) for generation of our mouse antibody.   Double labeling 
using antibodies against PKC, a rod bipolar cell marker, and the GPR179 antibody 
specific to mouse shows that in WT mouse transverse retinal sections GPR179 shows 
punctate staining at the tips of the rod bipolar cells in the OPL (Fig. 13), consistent with 
the pattern seen in the human retina (Fig. 12), and with other proteins expressed at the 
tips of the DBCs including TRPM1, GRM6 and NYX (Gregg et al., 2007; McCall and 
Gregg, 2008; Koike et al., 2010b; Orlandi et al., 2012; Peachey et al., 2012b; Zeitz et al., 
2013b).  Immunostaining of the nob5 retinas with PKC and the mouse GPR179 antibody 
revealed the absence of GPR179 expression in the OPL of the nob5 retina (Fig. 12) and 
(Peachey et al., 2012b).  These data indicate that GPR179 is expressed in the DBCs 
and localizes to the DBC dendritic tips.  The mutation in Gpr179 in the nob5 mouse 
disrupts GPR179 protein expression and further supports the hypothesis that GPR179 is 
required for DBC function. 
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Figure 13: GPR179 immunostaining in WT and nob5 retinal slices. (A) WT retinas 
were labeled with antibodies against PKC (red) and GPR179  (green).  WT retinas 
show robust labeling of GPR179 in the OPL. (B) In contrast, nob5 retinas are 










GPR179 is expressed at the tips of the DBCs 
To determine a more precise localization for GPR179 expression I co-labeled 
retinas with antibodies against GPR179 and several that label other cell type and have 
dendrites or axon terminals in the OPL.  The horizontal cells form invaginating synapses 
with rod and cone photoreceptors, along with the ON bipolar cells (Kolb, 1970).    To 
determine if GPR179 was expressed in the horizontal cells of the retina I double labeled 
retinal sections for GPR179 and calbindin, a horizontal cell marker.  The staining shows 
GPR179 expression is juxtaposed to calbindin staining in the OPL, but they do not 
colocalize (Fig. 14A). This result indicates that GPR179 is not expressed in the 
horizontal cells (Fig. 14A).  
 To determine if GPR179 is expressed in the Müller cell processes in the OPL 
retinas were double labeled for GPR179 and glutathione synthetase (GS) a Müller cell 
marker.  Müller cells have processes throughout the INL and OPL that aid in uptake and 
release of neurotransmitters, ions and other metabolic molecules (Bringmann et al., 
2006; Bringmann et al., 2009; Agte et al., 2011).  The immunostaining shows that 
GPR179 expression is restricted to the tips of the DBCs in the OPL and does not 
colocalize with GS (Fig. 14B). There also is no GPR179 staining in the vicinity of the 
Müller cell endfeet (Fig. 14B).     
GPR179 was expected to be expressed post synaptically on the DBCs.  The ISH 
data along with the normal ERG a-wave and absent b-wave suggested the protein was 
expressed in the DBCs.  To further test this hypothesis I double labeled fixed transverse 
retinal sections with the presynaptic marker RIBEYE, which stains ribbon synapses, and 
GPR179 (Fig. 14C).  RIBEYE is expressed pre-synaptically in the OPL and forms a 
“horseshoe” shaped pattern at the axon terminals of rod BCs. The immunostaining 
shows that GPR179 and RIBEYE do not colocalize, but appose one another, indicating 
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that GPR179 is expressed post synaptically (Fig. 14C) and (Orlandi et al., 2012; 






Figure 14: GPR179 is expressed post synaptically at the tips of the DBCs. (A) WT 
retinas are labeled with antibodies against GPR179 (green) and calbindin (red).  
Visualization of labeled proteins shows GPR179 and calbindin staining do not 
colocalize.  (B) WT retinas are double labeled with antibodies against GPR179 
(green), PKC (red) and GS (blue).  The PKC staining localizes the GPR179 puncta 
at the tips of the rod BCs in the OPL.  GPR179 labeling does not colocalize with 
GS labeling indicating that GPR179 is not expressed in the müller cells. (C) WT 
retinas are double labeled with antibodies against GPR179 (green) and RIBEYE 
(red).  The RIBEYE staining localizes GPR179 to the postsynaptic side of the 
synapse. 
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If GPR179 is expressed on the tips of the DBCs it should colocalize with 
mGluR6.  Double labeling transverse retinal sections with antibodies against GPR179 
and mGluR6 followed by confocal microscopy shows robust colocalization in the OPL 
(Fig 15).  Because mGluR6 is known to colocalize with TRPM1 (Koike et al., 2010b) and 
TRPM1 with nyctalopin (Pearring et al., 2011), GPR179 is expected to colocalize with 
nyctalopin and TRPM1.  These data support the hypothesis that GPR179 is expressed 
at the tips of the DBCs and is part of the postsynaptic signalplex, which is the 











Figure 15:  GPR179 colocalizes with mGluR6.  (A) WT transverse retinal sections 
were labeled with antibodies against GPR179 (green) and mGluR6 (red) and 
visualized using confocal microscopy.  GPR179 puncta appear to overlap with all 
mGluR6 puncta.  (B) A 2.4 µm line was drawn through a puncta and fluorescence 
was measure across the line.  The GPR179 signal colocalizes with mGluR6.  Scale 













Morpholino Knockdown of GPR179 greatly reduces ERG b-wave 
 To determine the effect of disruption of GPR179 protein translation on zebrafish 
vision, we used morpholinos to knockdown GPR179 expression.  Morpholinos are 
antisense oligomers made complementary to an mRNA sequence that interferes with 
either protein translation or RNA processing (Bill et al., 2009). 
 GPR179 blocking morpholinos (Gene Tools, Philomath, OR) were injected into 
single cell embryos and ERGs were recorded 4-6 days post injection. The zebrafish 
injected with GPR179 blocking morpholinos show a significantly decreased b-wave 
compared to those injected with scrambled morpholino at all flash intensities (Fig. 16) 
and (Peachey et al., 2012b).   Morpholinos against nyctalopin were injected as a positive 
control (Bahadori et al., 2006) and show a reduced b-wave, similar in magnitude to the 







Figure 16: Morpholino knockdown of GPR179 in zebrafish.  (A) ERG responses to 
various flash intensity stimuli from zebrafish injected with scrambled morpholinos 
(left).  ERG responses to various flash intensity stimuli injected with morpholinos 
against GPR179 (right).  ERG b-wave is severely decreased in zebrafish injected 
with morpholinos against GPR179 compared to scrambled morpholinos.  (B) 
Morpholinos against nyctalopin cause a similar decrease in b-wave amplitude 







Human CSNB patients identified with mutations in Gpr179 
 To determine if human cCSNB patients had mutations in GPR179 our 
collaborators screened all 11 exons of Gpr179 in 44 patients with cCSNB of unknown 
cause.  Two unrelated probands were identified with putative inactivating mutations (Fig. 
17B,C) (Peachey et al., 2012b).  The first proband was a compound heterozygote that 
carried two frameshift mutations, pLeu63Serfs*12 and pSer329Leufs*4, terminating 
translation (Fig. 17B).  The second proband had the pSer329Leufs*4, the same as 
proband 1 on one allele and a missense mutation pTyr220Cys on the other allele (Fig.  
17C).  The missense mutation changes an amino acid in a highly conserved region of 
the protein and is predicted to be a null allele (Fig. 17D).  Neither of the probands had 
other known health problems.  In addition to the two patients our collaborators identified, 




Figure 17: Human cCSNB patients with mutations in Gpr179.  (A) ERGs from 
patient with cCSNB and mutations in Gpr179.  (B) Proband 1 is a compound 
heterozygote with two frameshift mutations.  (C) Proband 2 is a compound 
heterozygote with frameshift mutation and a missense mutation.  (D) The 
missense mutation changes an amino acid in a highly conserved region of the 








The Gpr179nob5 mouse is an insertion mutation and there is the possibility that a 
small amount of normal splicing does occur, making this a hypomorphic allele.  To 
determine if the Gpr179nob5 mouse is a null we will compare the phenotype to a Gpr179 
knockout mouse.  A Gpr179 knockout mouse is currently in the pipeline.  Embryonic 
stem cells containing a conditional knockout allele were available from the University of 
California Davis Knockout Mouse Project (KOMP) Repository.  The Gpr179tm1e(KOMP)Mbp 
have conditional potential because LoxP sites were engineered into the  gene and flank 
exon 2.  The deletion of exon 2, which encodes 109 nucleotides in the gene will cause a 
frameshift mutation, resulting in a truncated protein, which would most likely undergo 
nonsense-mediated decay.  The ES cells were purchased and used to create a mouse 
line at the University of Cincinnati.  The colony is currently being established at the 
University of Louisville. We currently have 1 viable mouse carrying the knockout allele 
that we are breeding.  Once the knockout allele is made homozygous, an ERG will be 
performed to confirm GPR179 is critical for DBC function.  
Discussion 
 It was previously thought that the major components in the DBC signaling 
cascade had been identified such as the glutamate receptor mGluR6 and the cation 
channel TRPM1.  Much of the recent effort has been to identify the molecules that are 
activated by the mGluR6 receptor such as G proteins and second messengers that are 
responsible for gating of the TRPM1 channel (Okawa et al., 2010; Dhingra et al., 2012; 
Shen et al., 2012).   In this chapter I have shown that a novel GPCR, GPR179, is the 
likely cause of cCSNB in human patients and is mutated in a new model of cCSNB 
(Peachey et al., 2012b).  The discovery of a second GPCR in the system adds another 
level of complexity to the signaling mechanism and appears to be quite unique among 
GPCR cascades.  
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GPR179 is classified as a class C orphan GPCR based on sequence identity 
(Rondard et al., 2011).  Despite this categorization, it does not share the typical 
characteristics of other Class C receptors.  In silico analyses of GPR179 shows it lacks 
the extracellular venus fly trap (VFT) ligand binding domain that the vast majority of 
class C GPCRs possess (Fig. 18), including mGluR6 (Soding, 2005).  The VFT domain 
is required for ligand binding and plays a role in receptor dimerization (Ray et al., 1999; 
Awatramani and Slaughter, 2000; Kennedy et al., 2004).  The extracellular amino 
terminus of GPR179 contains a calcium-binding EGF-like domain of unknown function.  
This domain is commonly found in membrane bound or extracellular proteins that require 
calcium for their tertiary protein structure, which is thought to facilitate protein 
interactions (Selander-Sunnerhagen et al., 1992).   
The carboxy terminus IC domain of GPR179 is unique among Class C receptors.  
The IC domain is large (~1700 amino acids) and composed of a highly repetitive amino 
acid sequence CPWE that is conserved across species.  This sequence does not share 
homology with other known proteins; therefore, the function is unknown.  The tertiary 
structure of the carboxy terminus of GPR179 is predicted to be disordered and contain 
several internal repeats (Letunic et al., 2012).   The IC loops of GPR179 are predicted to 
couple to Gi/o G proteins (Sgourakis et al., 2005a; Sgourakis et al., 2005b), potentially 
allowing it to activate G proteins in the DBCs. 
Interestingly, none of the Gpr179 mutations reported to date in patients with 
cCSNB reside in the carboxy terminus (Audo et al., 2012; Peachey et al., 2012b), which 
comprises 73% of the amino acid sequence.  Perhaps mutations in the carboxy terminus 
of GPR179 that inhibit function are more rare because the it is highly redundant and has 
enough structural flexibility that a missense or nonsense mutation is unlikely to adversely 
affect function.  This suggests that the extracellular amino terminus is critical to function 
because mutations in the extracellular amino terminus cause cCSNB. 
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Figure 18:  Protein domains of GPR179.  GPR179 is predicted to be a 7 TM protein 
with an extracellular calcium-binding EGF like domain.  The large cytoplasmic 
carboxy terminus of GPR179 contains intermittent regions of low complexity.  

































 There are a number of important directions for future studies on GPR179.  One 
direction that needs to be explored is the expression profile of Gpr179 in other tissues.  
Despite the fact that nob5 shows no other phenotypes and human patients with 
mutations in Gpr179 are healthy (Audo et al., 2012; Peachey et al., 2012b), it is possible 
that Gpr179 is expressed in other tissues and cell types.  Finding Gpr179 in other cell 
types may allow a tissue culture system to be utilized with endogenous expression of 
Gpr179, allowing its function to be more easily studied. 
 In conclusion, we mapped the mutation responsible for DBC dysfunction in the 
nob5 mouse.  Using next generation sequencing we identified a new gene, Gpr179, 
critical to glutamate signaling in the DBCs.  We found human patients with cCSNB 
carrying mutations in GPR179, validating our hypothesis that Gpr179 is critical to DBC 
function and we localized mRNA and protein expression to the DBCs using ISH and 
immunohistochemistry.  A Gpr179-/- mouse was created to confirm Gpr179 is the cause 
of DBC dysfunction in the nob5 mouse and that the nob5 mouse is not a hypomorph. 
Methods 
Animals 
All procedures involving animals were performed in accordance with the policies 
on the use of animals in research and each local Institutional Animal Care Use 
Committees. Descriptions of all mice used have been published previously (Masu et al., 
1995; Pardue et al., 1998; Gregg et al., 2007; Pearring et al., 2011; Cao et al., 2012; 
Peachey et al., 2012b) and each line was either generated on, or backcrossed onto a 
C57BL6/J background for at least 6 generations. All mice were housed in local AAALAC 
approved facilities under a 12 h light/12 h dark cycle.  Mice were euthanized by CO2 
inhalation followed by cervical dislocation.    
DNA isolation 
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For mouse genotyping, 5mm tail biopsies were collected from mice and placed in 
0.7 mL microcentrifuge tube, and lysed with 200 µL of DirectPCR (Viagen Biotech) 
containing 2 µL proteinase K (20 mg/ml).  Samples were incubated for at least 4 h at 
55oC in a dry bath with brief vortexing every h.  After the tail sample was adequately 
digested, proteinase K was inactivated by heating to 85oC for 30 min.  Samples were 
then ready for PCR. 
For next generation sequencing, DNA was isolated from mouse liver.  Liver 
samples were collected from mice and placed into a 1.5 mL microcentrifuge tube and 
digested in 300 µl of cell lysis solution (Qiagen) plus 3 µl proteinase K (20mg/ml).  
Samples were incubated at least 4 h and vortexed until fully digested.  Protein was 
precipitated from solution using protein precipitation solution (Qiagen)  and DNA was 
recovered by ethanol precipitation.  
General Polymerase Chain Reaction  
Polymerase Chain Reaction (PCR) was generally performed using Phire II or 
Phusion taq polymerase (Thermo Scientific).  Reactions were made to 20 µl consisting 
of 0.5 µM of each forward and reverse primers, 200 µM of dNTPs, 4 µl of 5X reaction 
buffer, and either 0.4 µl of Phire II or Phusion DNA Polymerase.  Template DNA amount 
and water varied by application.  Reactions were run on a Bio Rad C1000 Touch 
Thermal Cycler. 
High Resolution Melting analysis 
High Resolution Melting (HRM) analyses were performed according to Applied 
Biosystems High Resolution Melting Getting Started Guide (Applied Biosystems).  
Briefly, primers were designed by the web program Primer3 (Untergasser et al., 2012) to 
flank a SNP and produce a 60-100bp amplicon product.  Reactions were set up in 96-
well Fast reaction plates with a 10 µl reaction volume consisting of 5 µm of each forward 
and reverse primers, 5 µl of MeltDoctor™ 2X HRM Master Mix (Applied Biosystems), 1 
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µl of genomic DNA and PCR grade water to 10 µl.  The reaction was run on a 96-well 
Fast plate on an Applied Biosystems 7900 HT Fast Real-Time PCR system.  After PCR 
amplification DNA was denatured at 95oC and annealed at 37oC before high resolution 
melting at 1% ramp rate on a 96-well Fast block.  Melting curves were analyzed using 
HRMv2.0.1 software.  
Next Generation Sequencing 
Samples were prepared using the Illumina protocol “Preparing Samples for 
Paired-End Sequencing (Part# 1005063 Rev. A June 2008).  Genomic DNA samples 
were sheared to an average size of ~300bp using sonication.  DNA fragment ends were 
repaired and phosphorylated using Klenow, T4 DNA Polymerase and T4 Polynucleotide 
Kinase.  An adenine base was added to the 3’ end of the blunted fragments, followed by 
ligation of Illumina Paired-End adapters via T-A mediatied ligation.  The library was 
hybridized to the sequence capture array on a Nimlegen Hybridization System 4 for ~64 
h at 42oC.  The array was washed to remove non-hybridized DNA and captured DNA 
was eluted using the Nimblegen Elution System.  The eluted DNA was amplified by PCR 
using Illumina Paired-End primers and size selected for 300bp fragments via gel 
electrophoresis.  The library size and concentration were determined using an Agilent 
Bioanalyzer. 
RNA isolation from Retina 
Mice were euthanized by CO2 inhalation and cervical dislocation.  Eyes were 
extracted and enucleated and the retinas were removed and stored at -80oC in RNAlater 
(Ambion) until needed.  RNA was isolated according to manufacturers protocol for the 
PureLink® RNA Mini Kit (Ambion).  Briefly, retinal tissue was removed from RNAlater 
and homogenized in 10-20 volumes of Tri Reagent (Ambion) by pipetting.  The 
homogenized mixture was incubated for 5 min at room temperature then 200 µl 
chloroform per ml of homogenate was added and the mixture vortexed, and incubated 
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for an additional 5 min at room temperature; followed by centrifugation at 12,000 x g for 
10 min at 4oC.  The aqueous phase volume was transferred to a new 1.5 ml centrifuge 
tube and 200 µl of 100% ethanol was added to the sample and vortexed for 15 sec.  The 
sample was placed in a filter cartridge (Ambion) and centrifuged at 12,000 x g for 30 sec.  
Flow through was discarded and 500 µl wash solution was applied to the filter cartridge 
and centrifuged at 12,000 x g for 30 sec.  The wash step was repeated and the filter 
cartridge was transferred to a new microcentrifuge tube and 100 µl of Elution buffer was 
applied to elute the RNA.  The RNA was collected by centrifugation for 30 sec at 12,000 
x g.  The RNA was stored at -80oC. 
Antibodies 
The following primary antibodies and their concentrations were used: sheep anti-
GPR179 (peptide KVQEETPGEDLDRPVLQKR), 1:2,000 (Peachey et al., 2012b); 
mouse monoclonal anti-ctbp2/Ribeye (BD Bioscience), 1:1,000; guinea pig anti-mGluR6 
1:1,000 (Koike et al., 2010b); sheep anti-TRPM1 1:1,000 (Cao et al., 2011); rabbit anti-
GFP (MBL), 1:800 and Rhodamine Peanut Aglutinin (PNA) conjugate 566 (Vector Labs), 
1:1,000; goat anti-Gβ5 (peptide MATDGLHENETLASLKC), 1:1,000 (Morgans et al., 
2007); goat anti-R9AP 1:1,000 (Hu and Wensel, 2002); mouse anti-DIG HRP, 1:1,000 
(Perkin Elmer); mouse anti-GFP, 1:1,000 (Molecular Probes); sheep anti-RGS11 
(peptide CSPALQSTPREPAATSSPEGADGE), 1:1,000 (Martemyanov et al., 2005); 
sheep anti-RGS7 1:1,000 (Morgans et al., 2007); mouse anti-RIBEYE 1:1,000 (BD 
Transduction Labs); rabbit anti-PKC 1:1,000 (Sigma Aldrich). 
Secondary antibodies (Invitrogen, 1:1,000) appropriate to each primary antibody 
included: donkey anti-sheep Alexa-488, donkey anti-rabbit Alexa-680, donkey anti-rabbit 
Alexa-546, donkey anti-mouse Alexa-647 and donkey anti-guinea pig Cy3 (Millipore, 
1:1,000). In lieu of an antibody specific to nyctalopin, we used Tg(Gabrr1-YFP/nyx)Rgg1 
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transgenic mice that express a yellow fluorescent protein (YFP) tagged nyctalopin 
(Gregg et al., 2007). They are labeled WT in the figures. 
Retinal dissections for in situ hybridization 
Mice were sacrificed by carbon dioxide gas inhalation followed by cervical 
dislocation.  The eyes were enucleated and the cornea, iris and lens were removed and 
the eyecup was rinsed in ice cold PBS-Diethylpyrocarbonate (Diethylpyrocarbonate 
(DEPC) was added to PBS at a dilution of 1:1,000, solution was mixed vigorously, 
incubated overnight then autoclaved).  Eyecups were immediately fixed in 4% 
formaldehyde PBS-DEPC for 1 h at room temperature.  Eyecups were then washed 
twice in PBS-DEPC then cryoprotected in 15% sucrose PBS-DEPC at 4°C until sucrose 
fully penetrated and were then moved into a 30% sucrose PBS-DEPC solution at 4°C 
overnight. 
DIG labeling RNA 
DIG RNA labeling was performed as described in the Roche DIG RNA Labeling 
Kit (SP6/T7).  In brief, purified template DNA (1 µg) was added to a sterile, RNase-free 
PCR tube.  The volume was brought to 13 µl with sterile, RNase free DEPC treated 
water.  To the reaction tube, 2 µl of 10X NTP labeling mixture, 2 µl of 10X Transcription 
buffer, 1 µl of Protector RNase inhibitor, and either SP6 or T7 RNA Polymerase (2 µl) 
were added and mixed gently.  Reaction was incubated at 37oC for 2 h on a PCR 
thermal cycler.  DNase I (2 µl) was added to the reaction tube and incubated for 15 min 
at 37oC.  RNA was analyzed by native agarose gel electrophoresis.  The reaction 
volume was brought to 100 µl with sterile, RNase free, DEPC treated water containing 
10 mM DTT and stored at -80oC. 
In situ hybridization 
Day One 
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Slides were removed from -80°C storage and dried at 65°C in hybridization oven 
for 30 min.  Sections were fixed for 20 min at -20°C in methanol then washed three times 
for 5 min each with PBST-DEPC (PBS-DEPC + 0.1% tween twenty).  Slides were 
incubated in proteinase K solution (1.2µg/ml Proteinase K in 50mM Tris-HCl pH 7.5 + 
5mM EDTA) for 12 min, washed in PBST for 5 min and fixed again with 4% 
formaldehyde PBS-DEPC for 5 min.  Sections were rinsed in PBST-DEPC then washed 
2 more times for 5 min.  Sections were then acetylated in acetylation solution (73.75mL 
H20-DEPC, 1mL Triethanolamine, 135µL HCl and 188 µL acetic anhydride).  Sections 
were washed in PBST-DEPC 3 times for 5 min then incubated in PBST-DEPC + 3% 
H2O2 for 30 min.  Sections were air dried for ~10 minutes.  Subsequently hybridization 
solution was removed from the freezer and brought to 65°C.  DIG RNA probes were 
thawed on ice.  Probes were diluted 1:100 in 100 µL of hybridization solution and heat 
denatured for 10 min at 85°C.  Sections were placed in hybridization chamber that was 
dampened with 50% formamide/5X SSC.  Probe solution was removed from heat and 
100 µL was placed directly on slide and a glass coverslip was added to slide.   Sections 
were incubated overnight in a hybridization oven at 65°C.   
Day Two 
The coverslip was removed by immersing the slide in 2X SSC and slides were 
incubated in fresh 2X SSC for 20 min at 65°C, then were washed in coplin jars 
containing 0.2X SSC at 65°C over a period of 3-4 h, changing the solution every 30 min.  
Slides were then washed 3 times for 5 min in maleic acid buffer supplemented with 0.1% 
Tween-20 (MABT, pH 7.5) then incubated for 1 h in MABT + 5% normal donkey serum.  
Mouse anti DIG HRP antibody was diluted 1:1000 and added to slides and incubated 
overnight in humidity chamber at 4°C.  If double labeling with a cell marker antibody, it 
was applied to the solution at this time.  
Day Three 
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Slides were washed 3 X 10 min in PBST.  Cy3-TSA staining solution (Roche) 
was prepared at 1:100 dilution and immediately added to slides and incubated for 50 
min.  Sections were washed 3 X 10 min in PBST.  If fluorescent staining for a cell 
marker, dilute fluorescent antibody was incubated for 1 h at room temperature then was 
3 X 10 min in PBST.  Slides were mounted with glass coverslips using Immu-Mount 
(Thermo Scientific) and imaged on a FV-1000 confocal microscope. 
Immunohistochemistry 
Mice were euthanized with CO2 followed by cervical dislocation.  Their eyes were 
enucleated and the lens was removed. Eyecups were washed in phosphate buffered 
saline (PBS) then fixed for 30 min in a 4% paraformaldehyde PBS solution (pH 7.4). 
Eyecups were washed 3 times with PBS then cryoprotected in increasing concentrations 
of sucrose in PBS (10%, 15% for 1 h each and 30% overnight). Eyecups were 
embedded in 2:1 OCT/ 20% sucrose PBS solution frozen in a liquid nitrogen cooled bath 
of isopentane. Eyecups were sectioned (18 µm) using a Leica 1850 cryostat.  Sections 
were mounted on glass slides (SuperFrost) and allowed to dry for 10 minutes at room 
temperature before being stored at -80oC. Sections were air dried at 37oC for 15 min and 
washed with PBS and PBS containing 0.05% Triton X-100 (PBX) for 5 min each, then 
blocked in blocking solution (PBX plus 5% normal donkey serum) for 1 h. Sections were 
incubated overnight at room temperature in the presence of the primary antibody diluted 
in blocking solution, then washed 3 times for 10 min each with PBX followed by 
incubation in secondary antibody in blocking solution for 1 h at room temperature. 
Sections were washed 2 X 10 min in PBX and 1 X PBS. Slides were cover-slipped using 
Immu-Mount (Thermo Scientific) and slides were imaged using an Olympus FV1000 




CHAPTER III: CONSTRUCTING THE DEPOLARIZING BIPOLAR CELL SIGNALPLEX 
 
Aim 2:  Determine signlaplex architecture and the role of GPR179 by identifying the 
interplay of DBC signalplex proteins in various mouse models of DBC dysfunction. 
Rationale:  All known mouse models of cCSNB have normal retinal structure (McCall 
and Gregg, 2008) but the synapse proteome is often affected by the loss of one or more 
proteins (Maddox et al., 2008; Jeffrey et al., 2010; Cao et al., 2011; Pearring et al., 2011; 
Orlandi et al., 2012; Xu et al., 2012).  Many of the proteins expressed at the dendritic tips 
of the DBCs are dependent on expression of other proteins for trafficking or localization 
(Jeffrey et al., 2010; Cao et al., 2011; Pearring et al., 2011; Xu et al., 2012).  Proteins co-
dependent on one another for trafficking and localization often interact.  To understand 
the arrangement of signalplex proteins in the DBCs, we can use immunohistochemistry 
and confocal microscopy to determine their interdependency for localization.  Elucidating 
signalplex architecture is a step toward understanding the signaling mechanism that 
couples mGluR6 to the TRPM1 channel. 
Hypothesis: GPR179 is a protein hub and is responsible for the recruitment and 
localization of signalplex proteins in the DBCs. 
Introduction 
The ability of cells to respond to external stimuli is fundamental to life and is 
possessed by all cells from the simplest of single cell organisms to all cells in 
vertebrates.  At the most fundamental level, this ability requires the expression of a 
membrane receptor and its associated intracellular proteins.  In neuronal systems, it is 
imperative that the postsynaptic neuron is able to faithfully relay the message from the 
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presynaptic neuron, or when necessary, parse the neuronal code to relay a subset of the 
presynaptic message.  To achieve this, the postsynaptic neuron must express a highly 
ordered and efficient signaling complex that captures the external signal and instructs 
the cell to respond in an appropriate manner. 
The ~12 types of BCs in the retina respond to light induced decreases in 
glutamate release from the photoreceptors in four general ways, a transient 
hyperpolarizing response, a sustained hyperpolarizing response, a transient depolarizing 
response and a sustained depolarizing response (Werblin and Dowling, 1969; Kaneko, 
1970).  Each of these responses requires a unique set of receptors and signaling 
proteins expressed at the plasma membrane of the post synaptic dendrite (Masu et al., 
1995; DeVries and Schwartz, 1999; DeVries, 2000).   Although physiologists have 
described the BC responses in detail, the molecular architecture of signaling proteins 
that give rise to these responses is largely unknown.   
Rod BCs respond to a decrease in glutamate release from the photoreceptors 
with a transient depolarizing response (Dacheux and Raviola, 1986).  Because ~95% of 
the photoreceptors in the human retina are rods (Osterberg, 1937; Curcio et al., 1990) 
and rods only synapse with rod BCs, understanding how information is processed in the 
rod BCs denotes an understanding of how the majority of the ON BCs respond to light.  
Determining the interdependency of signalplex proteins should offer clues as to how the 
proteins are arranged at the synapse and how they may carry out signal transduction.  
The glutamate receptor on the rod BCs is mGluR6 and binds glutamate, which 
activates a G protein cascade by promoting GαoGDP to GαoGTP exchange.  Activation 
of Gαo results in dissociation of the Gβγ complex.  It is understood that one of the G 
protein subunits, Gαo or Gβγ, is responsible for gating the TRPM1 channel closed, by 
either direct interaction or though an effector protein.  Recently, Shen et al. (2012) 
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published that the Gβγ dimer is responsible for gating the TRPM1 channel through direct 
interaction or an effector protein. 
The RGS proteins, which inactivate GαGTP are known to be critical to DBC 
function but little is known about their molecular arrangement.  The R7 family of RGS 
proteins (RGS6, RGS7, RGS9 and RGS11) are GTPase activating proteins (GAP) and 
are expressed almost exclusively throughout the nervous system.  They are critical for 
setting the speed of G-protein signaling cascades in general because they speed up 
GαGTP to GαGDP hydrolysis (Koelle and Horvitz, 1996; Gold et al., 1997; Berman and 
Gilman, 1998; Burchett, 2000; Ross and Wilkie, 2000).  The molecular arrangement of 
these proteins including interaction with a membrane anchor is critical to their function 
(Porter and Koelle, 2010).  They are thought to organize into heterotrimeric complexes 
consisting of a membrane anchor protein, Gβ5 and the RGS protein (Cabrera et al., 
1998; Anderson et al., 2009).  There are two RGS membrane anchors expressed in 
DBCs, R9AP and R7BP (Cao et al., 2008; Jeffrey et al., 2010).   
Several RGS knockout mouse models have been created to understand the 
arrangement and function of RGS proteins in the DBCs.  The R9AP-/-, R7BP-/- and 
RGS7-/-/RGS11-/- mouse models were all intended to disrupt DBC function but only the 
RGS7-/-/RGS11-/- mouse succeeded (Cao et al., 2008; Cao et al., 2009; Jeffrey et al., 
2010; Cao et al., 2012).  From these models we learned RGS7 and RGS11 are the main 
GAP proteins in the DBCs (Cao et al., 2012) but the membrane anchors R9AP and 
R7BP are not the only RGS anchors (Cao et al., 2008; Jeffrey et al., 2010).  In the 
R9AP-/- retina, RGS11 did not localize properly at the dendritic tips of the DBCs but 
RGS7/Gβ5 did (Jeffrey et al., 2010).  R7BP deletion did not affect the localization of 
RGS7, RGS11 or Gβ5 (Cao et al., 2008).  These data indicate that in the DBCs there is 
new mechanism for RGS protein localization to the DBC dendritic tips or R7BP and 
R9AP are redundant to one another.  
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 To better understand the architecture of the DBC signaling proteins I used 
mutant mice with DBC dysfunction to examine synaptic protein localization using 
immunohistochemistry and confocal microscopy.  The proteins mGluR6, GPR179, 
TRPM1, RGS11, RGS7, nyctalopin and R9AP were examined in all of the available 
mouse models of DBC dysfunction.  Proteins that were co-dependent for localization at 
the DBC dendritic tips were examined for interaction using Duolink and Membrane Yeast 
Two-Hybrid (MYTH) assay.  From these data, a model of signalplex protein arrangement 
was built. 
Results 
GPR179 localizes to the DBC dendritic tips in mouse models of DBC dysfunction 
To determine if GPR179 is localized at the dendritic tips of the DBCs in the 
absence of other signalplex proteins, it was visualized by immunohistochemistry 
followed by confocal microscopy in cCSNB mouse models.  Fixed transverse retinal 
sections were prepared from WT, Grm6-/-, Trpm1-/-, RGS7-/-/RGS11-/- and Nyxnob mice 
and were labeled with antibodies against GPR179 and the lectin peanut agglutinin 
(PNA).  PNA labels the cone pedicles in the OPL and co-localizes with postsynaptic 
signalplex proteins on cone ON BCs (Blanks et al., 1988; Haverkamp et al., 2001).  
Visualization of the labeled proteins using confocal microscopy revealed that GPR179 is 
properly localized to the DBC dendritic tips in the Grm6-/-, Trpm1-/-, RGS7-/-/RGS11-/- and 
Nyxnob retinas (Fig. 19).  These data indicate that GPR179 is not dependent on mGluR6, 
TRPM1, RGS7/RGS11 or nyctalopin for proper localization at the DBC dendritic tips.  It 







Figure 19: GPR179 expression in various mouse models of DBC dysfunction.  (A-
E) GPR179 (green) localizes to the DBC dendritic tips and co-localizes with PNA 
(red) in the mouse models of DBC dysfunction (B) Grm6-/-, (C) Nyxnob, (D) Trpm1-/- 
and (E) RGS7-/-/RGS11-/-. (F) GPR179 expression is absent in the Gpr179nob5 retina. 
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The Gpr179nob5 mouse retina retains key signaling components including mGluR6, 
TRPM1 and nyctalopin 
 To determine the dependency of signalplex proteins on the expression of 
GPR179, I used the Gpr179nob5 mouse model, which lacks expression of GPR179 at the 
DBC dendritic tips (Fig. 17 and Peachey et al. (2012b)).  Because we do not have a 
suitable antibody against nyctalopin for immunohistochemistry, I crossed the Gpr179nob5 
with the Tg(Gabrr1-YFP/nyx)Rgg1 mouse, which expresses a yellow fluorescent protein 
(YFP) tagged nyctalopin (Gregg et al., 2007) to visualize nyctalopin expression in the 
Gpr179nob5 mouse.  Fixed transverse retinal sections from Gpr179nob5 mice were 
prepared in conjunction with WT retinas and labeled with antibodies against mGluR6, 
TRPM1 and YFP-nyctalopin.  The confocal microscopy revealed that mGluR6, TRPM1 
and nyctalopin are properly localized on the DBC dendritic tips in the absence of 
GPR179 (Fig. 20).  These data indicate GPR179 expression is not critical for the 
localization of mGluR6, TRPM1 and nyctalopin at the DBC dendritic tips. 
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Figure 20: Expression of major signaling components in the Gpr179nob5 retina.  
Expression of TRPM1 (green), mGluR6 (blue) and EYFP-Nyx (red) in WT (A) and 
Gpr179nob5 (B) retinas.  Protein expression is not different compared to WT. Scale 
bar is 5 µm. From (Ray et al., 2013) 
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The absence of TRPM1 does not affect other signalplex proteins 
Localization of signalplex proteins was examined in Trpm1-/- retinas.  The 
proteins mGluR6 and nyctalopin are known to be expressed and localize correctly in the 
Trpm1-/- DBCs (Pearring et al., 2011) and I showed that GPR179 expression and 
localization is not dependent on normal TRPM1 expression (Fig. 19).  To determine if 
other signalplex proteins are dependent on TRPM1 expression for proper localization, 
immunohistochemical staining for RGS7, RGS11, R9AP, and Gβ5 was performed on 
fixed transverse retinal sections from Trpm1-/- mice and visualized by confocal 
microscopy.  In the Trpm1-/- retinas RGS7, RGS11, R9AP, and Gβ5 all localized 
correctly to the DBC dendritic tips (Fig. 21), suggesting that they localize independently 
of TRPM1.  Therefore, TRPM1, although critical for DBC function, does not play a critical 
structural role in the assembly of signalplex proteins.   
Nyctalopin is critical for TRPM1 localization  
From previous studies we know that TRPM1 is dependent on expression of 
nyctalopin for proper localization (Pearring et al., 2011) and the two proteins interact in 
vivo (Cao et al., 2011; Pearring et al., 2011). The mechanism of this dependency has not 
been resolved, therefore, I investigated the expression of mGluR6, GPR179, RGS7, 
RGS11, Gβ5 and R9AP in the Nyxnob mice, which lack expression of nyctalopin (Pardue 
et al., 2001).  Immunohistochemistry on fixed transverse retinal sections followed by 
confocal microscopy showed that the proteins mGluR6, GPR179, RGS7, RGS11, Gβ5 
and R9AP all localized properly in the absence of nyctalopin (Fig. 22).  These data 
indicate that nyctalopin plays a specific role in recruiting the TRPM1 channel to the DBC 
dendritic tips but is not important for the localization of mGluR6, GPR179, RGS7, 
RGS11, Gβ5 or R9AP. 
RGS7 and RGS11 deletion does not effect localization of TRPM1, GPR179 or 
mGluR6 
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 Using the RGS7-/-/RGS11-/- mouse model, which lacks expression of RGS7 and 
RGS11 in the DBCs, I examined the expression pattern of mGluR6, TRPM1, GPR179, 
R9AP and Gβ5.  Immunohistochemical staining for mGluR6, TRPM1, GPR179, R9AP 
and Gβ5 was performed on fixed transverse retinal sections from RGS7-/-/RGS11-/- mice 
then visualized using confocal microscopy (Fig. 22).  I found that expression mGluR6, 
TRPM1 and GPR179 at the DBC dendritic tips was normal, and as expected Gβ5 
expression was absent (Fig. 22 and Cao et al. (2012)).  Surprisingly, R9AP expression 
was absent in the RGS7-/-/RGS11-/- DBCs, suggesting that the formation of the complete 
RGS complex may be critical for complex localization. 
 Localization of the RGS proteins to the DBC dendritic tips is lost in the Gpr179nob5 
mice  
To determine if the absence of GPR179 affected the localization of the RGS 
proteins, immunohistochemical staining for RGS7, RGS11, Gβ5 and R9AP was 
performed in Gpr179nob5 fixed retinal sections and the proteins were visualized by 
confocal microscopy.  These data revealed that RGS7 and RGS11 are absent from the 
DBCs of the Gpr179nob5 retina (Fig. 21) and (Orlandi et al., 2012).  In addition to RGS7 
and RGS11 not localizing to the DBC dendritic tips of the Gpr179nob5 retina, the RGS 
membrane anchor R9AP and Gβ5 also do not localize to the DBC dendritic tips (Fig. 21).  
These data suggest that GPR179 either acts as an RGS protein anchor in addition to 
R9AP, or GPR179 is required to recruit another unidentified RGS anchor to the DBC 
dendritic tips.  These data also suggest that the disruption in DBC signaling in the 




Figure 21: Signlaplex protein expression in mouse models of DBC dysfunction I.  
Immunohistochemical labeling of signlaplex proteins mGluR6, TRPM1, GPR179, 
RGS11, RGS7, nyctalopin and R9AP in fixed retinal sections from WT and cCSNB 
mouse models Grm6-/-, Gpr179nob5 and Trpm1-/-. The image of TRPM1 staining in 
the Grm6-/- mice is adapted from (Xu et al., 2012).  Open box indicates that this 
particular experiment has not been done.  Scale bar is 5 µm. 
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Figure 22: Signlaplex protein expression in mouse models of DBC dysfunction II.  
Immunohistochemical labeling of signlaplex proteins mGluR6, TRPM1, GPR179, 
RGS11, RGS7, nyctalopin and R9AP in fixed retinal sections of WT and cCSNB 
mouse models RGS7-/-/11-/- and Nyxnob.  Data for R9AP-/- mice adapted from (Cao et 
al., 2009).  Open box indicates that this particular experiment has not been done.  
Scale bar is 5 µm. 
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Screening of GPR179 interacting partners using the Membrane Yeast-Two Hybrid 
 To determine the role of GPR179 in the DBC signalplex I screened for proteins 
that may interact with GPR179.  My first attempt at identifying interacting partners relied 
on the membrane yeast two-hybrid (MYTH) system (Iyer et al., 2005).  The MYTH 
system requires cloning your genes of interest into two different yeast expression 
vectors, bait and prey (Fig 23AB).  The bait and prey vectors each contain a yeast 
membrane signal sequence, multiple cloning site and split ubiquitin.  In addition, they 
contain genes involved in the de novo synthesis of leucine or tryptophan, which allows 
for selection of yeast carrying both plasmids on –leu/-trp selective media.  The bait 
vector expresses your membrane protein of interest fused to the carboxy terminus of a 
split ubiquitin and the artificial transcription factor LexA-VP16 (Fig. 23C).  The prey 
vector expresses a second TM protein of interest fused to the amino terminus of a split 
ubiquitin (Fig. 23C).  The bait and prey vectors are co-transfected into yeast and plated 
on –Leu/-Trp selective media to select for yeast containing the bait and prey vectors.  
The yeast containing both plasmids are then plated on –leu/-trp/-his/-ade selective 
media.  If the proteins interact, the split ubiquitins can dimerize, which recruits the cell’s 
ubiquitin specific proteases to cleave the bait protein and release the transcription factor.  
The transcription factor will enter the nucleus and promote transcription of genes 
responsible for de novo synthesis of histidine and adenine in the genetically engineered 
NMY32 yeast strain allowing growth of yeast that contain interacting bait and prey 
proteins (Fig. 23C). 
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Figure 23: Schematic of MYTH assay.  (A) Bait vector contains CYCI promoter, 
Cub split ubiquitin and LexA VP16 transcription factor.  The bait vector also 
contains a gene critical for de novo leucine synthesis.  (B) The prey vector 
contains the ADH1 promoter and NubG split ubiquitin.  The prey vector also 
contains a gene critical for de novo synthesis of tryptophan (C) Bait and prey 
vectors containing genes encoding membrane proteins are co-expressed in yeast.  
The bait and prey vectors also contain genes critical for de novo amino acid 
synthesis that allows positive selection.  (D) If the bait and prey proteins interact 
the split ubiquitin molecule dimerizes and proteases cleave the bait protein, 
releasing the synthetic transcription factor.   The transcription factor controls 
expression of genes needed for de novo synthesis of histidine and adenine in 
transgenic NMY32 yeast strain, allowing for positive selection of protein 
interaction.  Modified from (Iyer et al., 2005). 
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To screen for interactions, Gpr179 was cloned into bait and prey vectors.  The 
size of the Gpr179 ORF (~7.1 kb) and the size of the bait vector (~7.7 kb) made cloning 
difficult.  Therefore, I cloned truncated genes into bait vectors that would help identify 
regions critical for interactions with other signalplex proteins.  The clone Gpr179 TM1 
contains 211-1,938 bp of the ORF and encodes a protein that contains the 7 TM 
domains and a truncated 17 amino acid carboxy terminus (Fig. 24A).  The clone Gpr179 
TM2 contains 82-2,782 bp of the ORF minus the signal sequence and encodes a protein 
that contains the entire amino terminus, 7 TM domain and truncated carboxy terminus 
(Fig. 24B).  The clone Gpr179 Cterm contains 1,885-7,101 bp of the ORF and encodes 
the 1,739 amino acid carboxy terminus (Fig. 24C).  The clone Gpr179 contains the entire 
ORF and encodes the full-length protein (Fig. 24D).   Our lab was already in possession 
of prey vectors containing the genes Grm6, Trpm1, Gαo and Gβ5 which I used to screen 
for interactions with GPR179. 
 To test for correct expression and stability of the different Gpr179 bait constructs, 
I cotransfected them with ALG5 or FUR4 positive and negative control vectors.  ALG5, 
localizes to the endoplasmic reticulum (ER) and FUR4 localizes to the plasma 
membrane (PM).   The positive control vector contains the WT amino terminus of the 
split ubiquitin, NubI, and will reconstitute with any bait protein in the same cellular 
compartment allowing yeast to grow on selective media.  The negative control prey 
vector contains a mutated version of the split ubiquitin amino terminus, NubG, and will 
only reconstitute with Cub if the bait and prey proteins interact.  Co-transfection of 
Gpr179 TM1 bait vector with the positive control prey vectors yielded positive growth on 
selective media (Fig. 24A), indicating that the bait protein was being translated in yeast 
and expressed in the ER and at the PM.  Co-transfection of Gpr179 TM1 bait vector with 
the negative control prey vectors also yielded growth on interaction selective media (Fig. 
22A), indicating that the bait protein was likely self-activating.  This likely occurs because 
!! 84!
the protein is being translated but is not able to be processed properly in the yeast, 
resulting in proteolysis.  The proteolysis liberates the transcription factor allowing the 
yeast to grow on interaction selective media.  The other reason for growth on the 
selective media is that GPR179 TM1 interacts with ALG5 and FUR4.  GPR179 TM1 was 
deemed unsuitable for screening with signalplex proteins. 
Co-transfection of the Gpr179 TM2 bait vector with the positive control prey 
vectors yielded growth on interaction selective media (Fig. 24B), indicating that the bait 
protein was being translated in yeast and expressed in the ER and at the PM. Co-
transfection of Gpr179 TM2 bait vector with the negative control prey vector that 
localizes to the PM yielded growth on interaction selective media (Fig. 24B).  However, 
co-transfection of Gpr179 TM2 bait and the negative control prey that localizes to the ER 
did not yield growth on the selective media.  This result was puzzling, but due to the 
growth with one of the negative controls I determined the truncated protein was not 
suitable for screening for interactions.   
 Co-transfection of the full length Gpr179 Cterm bait vector with the positive 
control prey vectors yielded positive growth on interaction selective media (Fig. 24C), 
indicating that the bait protein was being translated in yeast and expressed in the ER 
and at the PM. Co-transfection of Gpr179 Cterm bait with both ER and PM negative 
control prey did not yield growth on interaction selective media (Fig. 24C), indicating that 
GPR179 Cterm is suitable for screening in the MYTH system. 
 Co-transfection of the Gpr179 bait vector with the positive control prey vectors 
yielded positive growth on selective media (Fig. 22D), indicating that the bait protein was 
being translated in yeast and expressed in the ER and at the PM.  Co-transfection of 
Gpr179 bait vector with the negative control prey vectors did not yield growth on 
interaction selective media (Fig. 24D), indicating that the full-length protein is suitable for 
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screening in the MYTH system.  Therefore, I also cloned the full length Gpr179 ORF into 






Figure 24:  Screening Gpr179 bait vectors for use in MYTH system.  (A) The 
Gpr179 TM1 bait vector encodes a truncated GPR179 protein that does not contain 
the large cytoplasmic domain.  The protein was self-activating when expressed in 
the MYTH system.  (B) The Gpr179 TM2 bait vector encodes a truncated GPR179 
protein that contains a small portion of the cytoplasmic domain.  The protein was 
self-activating when expressed in the MYTH system.  (C) The Gpr179 Cterm bait 
vector encodes the cytoplasmic domain of the GPR179 protein and is suitable for 
screening in the MYTH system.  (D) The Gpr179 bait vector encodes the entire 
GPR179 protein and is suitable for screening in the MYTH system. 
!! 87!
 The GPR179 bait protein was co-expressed with TRPM1, Nyctalopin, Gβ5, Gαo 
or mGluR6 prey proteins (Fig. 25 rows 1-5) and plated on interaction selective media to 
test for interactions.  The bait GPR179 did not test positive for interactions with TRPM1, 
Nyctalopin, Gβ5, Gαo or mGluR6 prey proteins.  GPR179 was tested for interaction with 
mGluR6 again by co-expressing the GPR179 prey protein with the mGluR6 bait protein.  
The yeast did not grow on interaction selective media (Fig. 25 row 6) indicating that the 
proteins do not interact.  
The GPR179 bait protein was tested for self-interaction with the GPR179 prey 
protein.  The screen resulted in positive growth on the interaction selective media 
indicating that the proteins interact (Fig. 25 row 7).  This indicates that GPR179 may be 
capable of forming homodimers or homooligomers in the yeast system.  To test whether 
this interaction may be occurring through the cytoplasmic protein domain or the TM and 
extracellular domain, I tested the GPR179 Cterm protein for interaction with the GPR179 
prey protein (Fig. 25 row 8).  Yeast co-transfected with the Gpr179 Cterm bait and the 
Gpr179 prey vector did not grow on interaction selective media, indicating that the 
interaction that allows GPR179 to form homodimers in yeast does not take place on the 
carboxy terminus of the protein.   This means the interaction among GPR179 proteins 






Figure 25:  Screening for interactions with the MYTH system.  The GPR179 bait 
protein was tested for interaction with TRPM1, Nyctalopin, Gβ5, Gαo and mGluR6 
bait proteins (Rows 1-5).  The mGluR6 prey protein was tested for interaction with 
GPR179 prey protein (Row 6).  Self-interaction was tested with GPR179 bait and 
prey proteins (Row 7).  The self-interaction between GPR179 proteins is not 








The second method I used to screen for GPR179 interacting partners was the 
Duolink Proximity Ligation Assay (PLA).  The Duolink PLA assay is an antibody ligation 
assay that produces a positive fluorescent signal only when proteins localize within a 
critical radius of ~40 nm of one another.  The assay is performed in vitro or in vivo by 
probing for proteins of interest with primary antibodies produced in different species (Fig. 
26A).  The primary antibodies are probed for with (+) and (-) PLA probes that consist of 
secondary antibodies conjugated to an oligonucleotide.  The (+) PLA probe 
oligonucleotides will circularize with the (-) PLA oligonucleotides in the presence of a 
ligation mixture if the probes are located within 40 nm of one another.  A DNA 
amplification solution is added to initiate rolling circle amplification of the circularized 
DNA.  The newly synthesized DNA is bound by fluorescent probes, which produce a 
fluorescent signal that can be visualized by confocal microscopy.  
To evaluate the system, I tested whether Grm1, which encodes the protein 
mGluR1, a Class C GPCR that has been shown to form homodimers in vitro 
(Doumazane et al., 2011), will interact in this system.  Myc and FLAG tagged Grm1 
vectors were co-transfected in COS-7 cells and 24 h post transfection the PLA assay 
was performed using mouse anti-myc and rabbit anti-FLAG antibodies.  Confocal 
microscopy revealed that the cells co-expressing mGluR1-myc and mGluR1-FLAG 
produced positive PLA signals, indicating formation of mGluR1 homodimers (Fig. 26B).  
As a negative control, the assay was performed but application of the primary antibodies 
was withheld.  The negative control shows very little PLA fluorescent signals as 
expected (Fig. 26C). 
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Figure 26:  In vitro Duolink PLA assay.  (A) Schematic of the Duolink PLA assay.  
(B) As a positive control, cells were co-transfected with vectors containing Grm1-
myc and Grm1-FLAG and the Duolink assay was performed.  A representative 
confocal microscopy image shows positive PLA fluorescence is present in cells 
co-transfected with Grm1-myc and Grm1-FLAG.  (C) As a negative control the 












To test for interaction between GPR179 and mGluR6, I co-transfected Gpr179-
myc and Grm6-FLAG expression vectors into COS-7 cells.  The Duolink PLA assay was 
performed and confocal microscopy revealed cells were co-expressing GPR179-myc 
and mGluR6-FLAG (Fig. 27A,B,C) and that there is a positive PLA fluorescent signal 
(Fig. 27D).  These data indicated that GPR179 and mGluR6 localize within close 
proximity to one another and likely interact in this system. 
To test for protein interactions between GPR179 and TRPM1, I co-transfected 
Gpr179-myc and Trpm1-FLAG into Cos-7 cells.  After performing the PLA assay 
confocal microscopy revealed cells were co-expressing GPR179-myc and TRPM1-FLAG 
(Fig. 27E,F,G) and that a positive PLA fluorescent signal is present (Fig. 27H).  These 
data indicate that GPR179 and TRPM1 localize within close proximity to one another 




Figure 27:  GPR179 interacts with mGluR6 and TRPM1 in vitro.  (A-C) GPR179 and 
TRPM1 are co-expressed in Cos-7 cells and co-localize.  (D) PLA fluorescence is 
present in cells that co-express GPR179 and TRPM1, indicating the proteins 
interact.  (E-g) GPR179 and mGluR6 are co-expressed in Cos-7 cells and co-
localize.  (H) PLA fluorescence is present in cells that co-express GPR179 and 
mGluR6, indicating the proteins interact. 
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To test if GPR179 and TRPM1 form complexes in vivo, I used the Duolink PLA 
assay on fixed transverse retinal sections.  I used WT retinal sections and antibodies 
against GPR179 and TRPM1.  The PLA assay was performed in conjunction with 
fluorescent immunostaining for GPR179 and TRPM1 followed by analysis using confocal 
microscopy.  WT retinas labeled with GPR179 and TRPM1 antibodies showed the 
proteins were localized to the DBC dendritic tips (Fig 28A,B) and there is positive PLA 
fluorescence in the OPL (Fig. 28C).  The PLA fluorescent signal co-localizes with the 
GPR179 and TRPM1 staining (Fig. 28D), indicating that the signal is specific to regions 
where both proteins are expressed.   
As a negative control, the assay was performed on transverse retinal sections 
from Nyxnob mice.  In the Nyxnob retinas TRPM1 does not localize to the DBC dendritic 
tips (Fig. 28E) but GPR179 is expressed normally (Fig. 28F), as expected.  However, 
there were no consistent PLA signals present in the OPL that co-localize with GPR179 
(Fig. 28G), indicating that a positive PLA signal is dependent on GPR179 and TRPM1 
expression at the DBC dendritic tips. 
A notable feature of the positive signal from Fig. 28C is that they are not present 
at every DBC dendritic tip where GPR179 and TRPM1 are expressed.  This suggests 
that the antibody epitopes for GPR179 and TRPM1 may reside close to the critical 
distance for the assay, which would lower the efficiency of a positive reaction.  The 
protein dense environment where GPR179 and TRPM1 reside could also decrease the 







Figure 28:  TRPM1 and GPR179 localize within the Duolink critical radius. (A) WT 
retina slices labeled with antibodies against GPR179 (blue) and TRPM1 (green) 
and PLA assay was performed.  Red puncta indicate positive interactions. (B) PLA 
assay was performed in nyxnob retinas (negative control) which lack TRPM1 
expression at the DBC dendritic tips. (C) A 4.5 µm line was drawn through a cone 
pedicle in (A) and fluorescence was plotted across the line.  GPR179, TRPM1 and 
the PLA flurescence overlap, indicating the PLA fluorescent signal is specific to 







 The immunohistochemistry data shows GPR179 is critical for the localization of 
RGS7, RGS11, Gβ5 and R9AP (Fig. 21 and Orlandi et al. (2012)).  We also showed that 
GPR179 physically interacts with the RGS7/Gβ5 and RGS11/Gβ5 protein complexes 
(Orlandi et al., 2012).  These data indicate that GPR179 may act as a scaffolding protein 
for both RGS7 and RGS11 in the DBCs and that the interaction is dependent on the 
expression of Gβ5.  We know that the RGS proteins are critical to setting the light 
response in the DBCs (Cao et al., 2012).  One aspect of my data that has not been 
studied further is the absence of the membrane anchor R9AP in the Gpr179nob5 DBCs.  It 
is unknown whether R9AP interacts directly with GPR179.  Further, it appears that 
RGS7/Gβ5 or RGS11/Gβ5 binding with R9AP is required for R9AP localization at the 
DBC dendritic tips because R9AP is absent in RGS7-/-/RGS11-/- retinas (Fig. 22).  It will 
also be important to determine whether R7BP, another RGS anchor expressed in the 
DBCs, is affected by GPR179 expression.  It seems likely that GPR179 may act as a 
hub to recruit a large number of RGS proteins to the DBC dendritic tips so that a large 
number of GAP proteins are localized to the signalplex to set the speed of the BC light 
response.  The large cytoplasmic tail on GPR179 is an ideal domain to act as a hub.  
Large, unstructured protein domains are known to act as protein scaffolds (Dyson and 
Wright, 2005; Coletta et al., 2010).  
It was previously reported that RGS7, RGS11, Gβ5 and TRPM1 expression were 
decreased or absent in the Grm6-/- retina (Morgans et al., 2007; Cao et al., 2009; Xu et 
al., 2012).  Immunolabeling GPR179 in the Grm6-/- retina reveals that GPR179 is 
properly localized to the dendritic tips of the DBCs.  The dependence of TRPM1 
localization on mGluR6 is controversial. Cao et al. (2011) reported TRPM1 was absent 
from the OPL in Grm6nob3 retinas, a Grm6 spontaneous mutant, whereas Xu et al. (2012) 
found it was present but greatly decreased.  Other proteins absent from the DBC 
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dendritic tips in Grm6-/- retinas include Gβ5, RGS7, RGS11 and R9AP (Fig. 21) and 
(Morgans et al., 2007; Xu et al., 2012).  These data indicate that Gβ5, RGS7, RGS11 
and R9AP localization is dependent on mGluR6 expression, whereas GPR179 is not 
(Fig. 21).  When taken together with the data from the Gpr179nob5 retinas, which also 
lose localization of Gβ5, RGS7, RGS11 and R9AP but maintain mGluR6 localization, the 
mechanism by which the proteins do not localize in the Grm6-/- retinas is unclear.  The 
creation of a dominant negative mGluR6 mouse in which it traffics to the DBC dendritic 
tips would help sort out whether the loss of proteins is because they are physically 
dependent on mGluR6 for trafficking or if the signalplex is downregulated by another 
mechanism.  
 The MYTH assay to test for protein interactions between GPR179 and other DBC 
signalplex proteins did not produce positive data that GPR179 interacts with other 
signalplex proteins.  This could be due to the fact that yeast and BCs are such different 
systems that proteins may not behave the same way in each system.  In the DBCs there 
are likely additional proteins that traffic and add posttranslational modifications to DBC 
signalplex proteins.  This facilitates organization and trafficking of signalplex proteins at 
the dendritic tips in an ordered complex.  In contrast, the MYTH system requires two 
exogenous mammalian fusion proteins to be expressed in a foreign system.  The yeast 
may not be able to add the correct post-translational modifications to the exogenous 
proteins.  They also lack expression of the rest of the signalplex proteins, which may 
facilitate protein localization.  
 The in vitro Duolink assay suggested that GPR179 forms complexes with 
mGluR6 and TRPM1.  The downside to the assay is that the positive signal could be due 
to the overexpression of two membrane proteins, which could cause false positive 
signals because the cell is being overloaded with proteins, which may force proteins to 
localize within the Duolink distance.  I think these experiments should be performed 
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under more stringent conditions by driving gene expression using a weak gene promoter 
to reduce false positives due to high protein concentration.   
The in vivo Duolink assay suggests that GPR179 and TRPM1 are a part of the 
same protein complex in the DBCs.  Therefore, I performed the assay on retinal sections 
to determine if GPR179 is in the same complex as mGluR6 and nyctalopin.  I did not get 
positive interaction data for these experiments, but I think the reason for this is not 
because GPR179 does not localize in close proximity with these proteins.  Instead, I 
think the negative results reflect the shortcomings of the assay.  If the protein epitopes 
are on opposite sides of the membrane, as they are with mGluR6 and GPR179, then the 
assay efficiency is likely decreased dramatically.  If the antibody epitopes are on distal 
regions of the proteins they may be too far apart for the PLA probes to ligate.  Finally, 
the dense protein matrix at the DBC signalplex may inhibit the assay, accounting for the 
reason the assay was more robust in the in vitro system. 
To further examine the positive interaction data between GPR179/TRPM1 and 
GPR179/mGluR6 Dr. Nazarul Hasan, a postdoc in the lab, performed 
immunoprecipitation (IP) experiments in parallel.  Using antibodies against GPR179, the 
GPR179 protein complex was immunoprecipitated from retinal lysates and the 
precipitate was examined by mass spectrometry.  These experiments showed that 
TRPM1 interacts with GPR179 (Ray et al., 2013 and Appendix III).  Performing the IP 
with antibodies against TRPM1 identified GPR179 in the proteins that were precipitated.  
To validate the mass spectrometry identification that GPR179 and TRPM1 were in the 
same protein complex Co-IP experiments were performed in mammalian cell lines.  The 
Co-IP experiments showed positive interaction between GPR179 and TRPM1 (Ray et 
al., 2013 and Appendix III).  IP experiments from retinal lystates also suggested that 
TRPM1 and GPR179 directly interact (Ray et al., 2013 and Appendix III).   
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 The self-interaction between GPR179 bait and prey vectors should be further 
studied.  It is well accepted that many GPCRs are known to form homo and 
heterodimers and even higher order oligomers (Bouvier, 2001; Milligan, 2006; Filizola, 
2010).   The ability of GPR179 to form dimers or oligomers would enable it to be the 
focal point of the signalplex protein structure, especially if it is found to interact with more 
DBC signaling proteins. 
The interaction between GPR179 and TRPM1 likely enhances the sensitivity of 
the glutamate signaling cascade by bringing the RGS machinery in close proximity to the 
TRPM1 channel.  This enables the TRPM1 channel to quickly respond to changes in 
glutamate release from the photoreceptors because the RGS proteins continuously 
hydrolyze GαoGTP to GαoGDP, which presumably inhibits G protein closure of the 
TRPM1 channel.  Our collaborator Neal Peachey observed a small ERG b-wave 
response in the Gpr179nob5 mouse that was not present in other cCSNB mouse models 
(Ray et al., 2013 and Appendix III).  When the ERG flash duration was increased, the b-
wave response increased in the Gpr179nob5 mouse but the Trpm1-/- did not have a b-
wave.  These observations were the catalyst for performing single cell recording 
experiments that identified a role for GPR179 beyond anchoring RGS proteins.    
 The immunohistochemistry revealed that mGluR6 and TRPM1 localized correctly 
in the Gpr179nob5 DBCs and the ERG suggested these mice had a small b-wave.  
Therefore, we asked whether mGluR6 could gate the TRPM1 channel in the Gpr179nob5 
retina.  To answer that question we used single cell recordings from rod BCs and found 
that CPPG, an mGluR6 antagonist, could illicit a response in the Gpr179nob5 rod BCs that 
was significantly decreased from WT but significantly greater than the Trpm1-/- rod BC 
response (Ray et al., 2013 and Appendix III).  We followed that experiment up by directly 
testing the gating of the TRPM1 channel in the Gpr179nob5 rod BCs using single cell 
recordings and the drug Capsaicin, a TRPM1 channel modulator, to gate the channel 
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open.  We found that in the Gpr179nob5 rod BCs there was a significantly decreased 
capsaicin response compared to WT.  These data suggested that the TRPM1 channel is 
not as sensitive to gating in the absence of GPR179.   
 We hypothesized that the interaction between GPR179 and TRPM1 enhanced 
the TRPM1 sensitivity to gating by changing the state of the channel in the membrane 
through physical interaction.  To determine if GPR179 was required for the high 
sensitivity of the TRPM1 channel to capsaicin we performed the capsaicin experiments 
in the RGS7-/-/RGS11-/- rod BCs, which do not express the RGS protein complex but 
retain all other signalplex components (Fig. 22).  We found that the RGS7-/-/RGS11-/- rod 
BCs had a capsaicin response similar to WT and significantly greater than the response 
in the Gpr179nob5 rods BCs (Ray et al., 2013 and Appendix III).  These data suggested 
that GPR179 is required to enhance the sensitivity of the TRPM1 channel to gating. 
Channel variance can be measured when the retinal sections are bathed in L-
AP4 and indicate the state of the TRPM1 channel when the glutamate signaling cascade 
is maximally active.  High variance indicates the channels are in a state of constant 
opening and closure, whereas low variance indicates the channels are either maximally 
open or maximally closed.  In WT retinal sections variance should be low under L-AP4 
due to G protein closure of the TRPM1 channel.  We observed significantly lower 
channel variance in Gpr179nob5 rod BCs compared to WT.  The channel variance in the 
Gpr179nob5 rod BCs was similar to the variance in Trpm1-/- rod BCs.  These data suggest 
that in WT rod BCs the TRPM1 channel is constantly opening and closing in response to 
free Gβγ, presumably because Gβγ gating of the TRPM1 channel is a transient process.  
In the Gpr179nob5 rod BCs the variance is decreased similar to the RGS7-/-/RGS11-/- rod 
BCs (Ray et al., 2013 and Appendix III).   We attribute these results to the mislocalized 
or absent RGS proteins in the Gpr179nob5 and RGS7-/-/RGS11-/- rod BCs that allows a 
build up of active G proteins shifting the equilibrium of TRPM1 channels to more closed. 
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 We were able to show that GPR179 plays a structural role in the DBCs by 
recruiting the RGS proteins to the signalplex.  We also found that GPR179 directly 
interacts with TRPM1 and that this interaction is critical to the gating sensitivity of the 
TRPM1 channel.  The disruption in glutamate signaling in the Gpr179nob5 rod BCs 
appears to be the compound result of a loss of RGS proteins and decreased TRPM1 
channel sensitivity.   A recent publication also reported that GPR179 physically interacts 
with mGluR6 in the DBCs (Orlandi et al., 2013).  Taken together, these data suggest that 
GPR179 is a hub for DBC signalplex components.  Although GPR179 is not critical for 
the localization of mGluR6 and TRPM1 to the DBC dendritic tips, it may play an 
important role in recruiting these proteins into a larger oligomeric structure.   
 There is still disagreement about whether Gαo or Gβγ is responsible for gating 
the TRPM1 channel (Koike et al., 2010a; Koike et al., 2010b; Shen et al., 2012) and 
there is almost nothing known about the detailed mechanism of gating.  Whole cell patch 
clamp experiments in rod BCs suggest that introduction of Gβγ into the rod BCs via the 
patch pipette closes the TRPM1 channel, whereas Gα0 does not (Shen et al., 2012).  
These data suggest that the rod BCs respond to glutamate by mGluR6 binding 
glutamate and activating the heterotrimerc G proteins through GαoGDP to GαoGTP 
exchange, which subsequently causes GαoGTP to release from the Gβγ complex.  The 
Gβγ dimer binds and directly closes the TRPM1 channel or closes the TRPM channel 
through an effector protein.   
Methods 
Antibodies 
The following primary antibodies and their concentrations were used: sheep anti-
GPR179 (peptide KVQEETPGEDLDRPVLQKR), 1:2,000 (Peachey et al., 2012b); 
mouse monoclonal anti-ctbp2/Ribeye (BD Bioscience), 1:1,000; guinea pig anti-mGluR6 
1:1,000 (Koike et al., 2010b); sheep anti-TRPM1 1:1,000 (Cao et al., 2011); rabbit anti-
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GFP (MBL), 1:800 and Rhodamine Peanut Aglutinin (PNA) conjugate 566 (Vector Labs), 
1:1,000; goat anti-Gβ5 (peptide MATDGLHENETLASLKC), 1:1,000 (Morgans et al., 
2007); goat anti-R9AP 1:1,000 (Hu and Wensel, 2002); mouse anti-DIG HRP, 1:1,000 
(Perkin Elmer); mouse anti-GFP, 1:1,000 (Molecular Probes); sheep anti-RGS11 
(peptide CSPALQSTPREPAATSSPEGADGE), 1:1,000 (Martemyanov et al., 2005); 
sheep anti-RGS7 1:1,000 (Morgans et al., 2007); mouse anti-RIBEYE 1:1,000 (BD 
Transduction Labs); rabbit anti-PKC 1:1,000 (Sigma Aldrich). 
Secondary antibodies (Invitrogen, 1:1,000) appropriate to each primary antibody 
included: donkey anti-sheep Alexa-488, donkey anti-rabbit Alexa-680, donkey anti-rabbit 
Alexa-546, donkey anti-mouse Alexa-647 and donkey anti-guinea pig Cy3 (Millipore, 
1:1,000). In lieu of an antibody specific to nyctalopin, we used Tg(Gabrr1-YFP/nyx)Rgg1 
transgenic mice that express a yellow fluorescent protein (YFP) tagged nyctalopin 
(Gregg et al., 2007). They are labeled as WT in the figures.  
Immunohistochemistry 
Mice were euthanized with CO2 followed by cervical dislocation.  Their eyes were 
enucleated and the lens was removed. Eyecups were washed in phosphate buffered 
saline (PBS) then fixed for 30 min in a 4% formaldehyde PBS solution (pH 7.4). Eyecups 
were washed 3 times with PBS then cryoprotected in increasing concentrations of 
sucrose in PBS (10%, 15% for 1 h each and 30% overnight). Eyecups were embedded 
in 2:1 OCT/ 20% sucrose PBS solution frozen in a liquid nitrogen cooled bath of 
isopentane. Eyecups were sectioned (18 µm) using a Leica 1850 cryostat.  Sections 
were mounted on glass slides (SuperFrost) and allowed to dry for 10 mintues at room 
temperature before being stored at -80oC. Sections were air dried at 37oC for 15 min and 
washed with PBS and PBS containing 0.05% Triton X-100 (PBX) for 5 min each, then 
blocked in PBX plus 5% normal donkey serum blocking solution for 1 h. Sections were 
incubated overnight at room temperature in the presence of the primary antibody diluted 
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in blocking solution, then washed 3 times for 10 min each with PBX followed by 
incubation in secondary antibody in blocking solution for 1 h at room temperature. 
Sections were washed 2 X 10 min in PBX and 1 X PBS. Slides were cover-slipped using 
Immu-Mount (Thermo Scientific) and slides were imaged using an Olympus FV1000 
confocal microscope.  Images were universally adjusted for brightness using Photoshop. 
In-Fusion HD Cloning 
PCR fragments were amplified using primers designed to have 14-18 bp 5’ 
overhangs that share homology with the cut site on a linearized vector.  PCR fragments 
were treated with Cloning Enhancer (Clontech) and incubated at 37oC for 15 min then at 
80oC for 15 min on a thermal cycler.  Linearized vector, treated PCR fragment and water 
was added to 5X In-Fusion HD Enzyme Premix according to the manufacturers protocol 
(Clontech).  The reaction was mixed by pipetting and incubated for 15 min at 50oC on a 
thermal cycler.  The reaction mix was placed on ice until transformation or stored at -
20oC. 
Plasmid Isolation 
Plasmid purification was performed using the Wizard Plus SV Minipreps DNA 
Purification System (Promega) according to the manufacturers protocol.  Single colonies 
from transformed bacteria were selected from agarose plates using a sterile toothpicks 
and used to inoculate 2 mL of Circlegrow media supplemented with 100 µg/mL 
kanamycin.  The culture was grown overnight at 37oC while shaking at 225 RPM.  The 
bacterial cells were transferred to a 2 mL centrifuge tube and pelleted by centrifugation 
at max speed for 5 minutes to pellet cells.  The supernatant was discarded and the cells 
were resupsended by vortexing in 250 µl of Cell Resuspension Solution.  250 µl of Cell 
Lysis Solution and 10 µl Alkaline Protease Solution was added, and mixed by inverting 
tubes several times, then incubated at room temperature for 5 min.  350 µl of 
Neutralization Solution then was added and mixed by inverting several times.  Tubes 
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were centrifuged at 12,000 x g for 10 min to pellet cellular debris and the supernatant 
was decanted into a spin column.  The spin column was placed into a collection tube 
and centrifuged for 1 min at 12,000 x g.   The flow through was discarded and the 
plasmid bound to the column was washed 2 times by adding 500 µl of Column Wash 
Solution followed by centrifugation for 1 min at 12,000 x g.  The spin column was 
transferred to a clean microcentrifuge tube and 100 µl of sterile water was added to the 
column to elute plasmid DNA.  The water was incubated on the column for 1 min at room 
temperature then centrifuged for 1 min at 12,000 x g to collect DNA.  DNA was stored at 
-20oC. 
Cell culture, transfection and immunocytochemistry 
COS-7 (African green monkey kidney) cells were cultured in high glucose DMEM 
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 IU/ml penicillin and 
50 µg/ml streptomycin.  25 h prior to transfection, cells were seeded on 1 cm2 chamber 
slides (Lab-Tek).  Expression plasmids were transfected into COS-7 cells using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.  24 h after 
transfection, cells were washed in PBS and fixed in ice-cold methanol for 5 min then ice-
cold methanol/acetone (50:50) for 5 min.  Cells were washed in PBS and blocked for 1 h 
in blocking solution (PBS containing 0.01% Triton X-100 and 5% normal donkey serum).  
Antibodies were diluted in blocking solution and incubated on cells overnight at 4oC, then 
washed with PBS.  Fluorescent secondary antibodies were diluted 1:1,000 and added to 
slides.  Cells were incubated for 1 h with secondary antibodies at room temperature then 
washed with PBS.  Slides were mounted with coverslips using Vectashield mounting 




Duolink assay was performed as described in the Duolink II Fluorescence user 
manual (OLink Bioscience).  Retina sections were prepared for immunohistochemistry 
as previously described.  Sections were air dried at 37oC for 15 min and washed with 
PBS and PBS containing 0.05% Triton X-100 (PBX) for 5 min each and then blocked in 
PBX containing 5% normal donkey serum for 1 h.  Primary antibodies were diluted in 
blocking serum and incubated on sections overnight at room temperature.  Slides were 
washed 3 X 10 min in PBX.  In the meantime, PLA probes specific to the primary 
antibodies were mixed 1:5 in blocking solution and incubated at room temperature for 20 
min.  After the slides were washed, the solution containing the PLA probes was applied 
and incubated at 37oC in a humidity chamber for 1 h.  Slides were washed 2 X 5 min in 
PBX.  In the meantime, Ligation stock was diluted 1:5 in PCR grade water and mixed.  
Just before adding to slides, Ligase was added to the Ligation mixture at a 1:40 dilution, 
mixed gently.  Slides were incubated at 37oC in a humidity chamber for 100 min.  Slides 
were washed 2 X 10 min in PBX and 1 X 10 min in PBS.  For fluorescent 
immunostaining, fluorescent secondary antibodies were diluted in blocking solution and 
incubated for 1 h at room temperature.  Slides were washed 2 X 10 min in PBX and 1 X 
10 min in PBS.  Slides were mounted with glass coverslips using Duolink Mounting 
Medium containing DAPI then visualized on a confocal microscope. 
Membrane yeast-two hybrid 
Yeast were grown overnight in 10 ml YPD media (Clontech) to A600 0.5 to 1.0.  
Yeast were pelleted for 5 min at 1500 x g.  The pellet was washed with ddH20 and 
centrifuged again for 5 min at 1500 x g.  The pellet was re-suspended in (100 µl or 200 l 
per tube) of TE buffer (10mM Tris-HCl, 0.1mM EDTA) pH 7.5 containing 0.1M lithium 
acetate (LiAC).  Yeast solution was transfered to a microfuge tube (200ul per tube) and 
1 ug of bait and prey plasmid DNA was added in addition to 5 µl (50 µg) carrier DNA 
(salmon sperm, denatured for 5 min at 99oC put on ice, denatured again then place on 
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ice).  To the tube, 300 µl 40% polyethylene glycol (250 µl 50%) in TE containing 0.1M 
LiAC was added and vortexed to mix well.  Solution was incubated for 30 min at 30oC, 
then DMSO added to 10%v/v.  Cells were heat shocked for 10 min at 42oC then 
centrifuged for 15 sec at 10,000 x g.   The supernatant was removed and the cells were 
resuspended in 100 µl of ddH20 and plated on selective plates (Minimal SD agar, -His/-
Ade selective DO supplement, Clontech).  Plates were incubated at 30oC for 2-3 days.  
After 2-3 days, yeast colonies were selected with a sterile pipette tip and re-suspended 
in 20 µl of ddH20.  Yeast were spotted on interaction selective plates (Minimal SD agar, -
His/-Ade/-Leu/-Trp selective DO supplement, Clontech) and incubated at 30oC for 2-3 
days. 
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CHAPTER IV: LRIT3 IS REQUIRED FOR NORMAL DBC FUNCTION 
 
Aim 3: Determine the mechanism by which LRIT3 contributes to glutamate 
signaling in the DBCs 
Rationale: Zeitz et al. (2013b) reported that LRIT3, a gene of previously unknown 
function, was critical to the glutamate signaling cascade in the DBCs.  Two human 
patients with cCSNB of a previously unknown cause were found to have mutations in the 
LRIT3 (Zeitz et al., 2013b).  The mechanism by which LRIT3 contributes to the 
glutamate signaling cascade remains unknown.  To determine the role LRIT3 plays in 
the glutamate signaling cascade of the DBCs, we developed a Lrit3-/- mouse model.  An 
ERG will be performed on the Lrit3-/- mouse to confirm a disruption in LRIT3 causes a no 
b-wave phenotype.  Using the Lrit3-/- mouse model immunohistochemistry will be 
performed to determine the effect deletion of LRIT3 has on signalplex proteins. 
Hypothesis: LRIT3 is critical to DBC signalplex maintenance and Lrit3-/- mice will have a 
no b-wave ERG.  
Introduction 
Despite many of the molecules critical for glutamate signaling in the DBCs having 
been identified (Masu et al., 1995; Pardue et al., 1998; Bech-Hansen et al., 2000; Pusch 
et al., 2000; Gregg et al., 2007; Audo et al., 2009; Cao et al., 2009; Shen et al., 2009; 
van Genderen et al., 2009; Koike et al., 2010b; Okawa et al., 2010; Audo et al., 2012; 
Cao et al., 2012; Dhingra et al., 2012; Orlandi et al., 2012; Peachey et al., 2012b; Shen 
et al., 2012), there are likely additional proteins that are required to develop and maintain 
a functional synapse between the photoreceptors and ON BCs.  At the presynaptic and 
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postsynaptic membrane, proteins are arranged into a dense network consisting of 
scaffolding proteins, receptors, ion channels and signaling machinery.   These protein 
networks are likely organized by scaffolding proteins that ensure the pre- and 
postsynaptic protein architecture are aligned to facilitate efficient signal transmission 
(Waites et al., 2005; McAllister, 2007; Jin and Garner, 2008).  The protein network on 
the postsynaptic side, termed the postsynaptic density (PSD), is highly complex and 
consists of ~1,000 different proteins from a broad array of functional classes (Yamauchi, 
2002; Yoshimura et al., 2004; Collins et al., 2005).  Given that there are 10 proteins 
known to be critical to the mGluR6 to TRPM1 glutamate signaling cascade, additional 
proteins are expected to be required for structural support and organization.  The 
absence of some of these proteins would be expected to cause cCSNB.  
One such protein is LRIT3, a leucine-rich repeat, immunoglobulin like and 
transmembrane domain 3 protein that when absent causes cCSNB (Zeitz et al., 2013b).   
LRIT3 is the second leucine-rich-repeat (LRR) protein identified as being critical to the 
glutamate signaling cascade in the DBCs, the other being nyctalopin (Pardue et al., 
1998; Bech-Hansen et al., 2000; Pusch et al., 2000; Pardue et al., 2001; Gregg et al., 
2007; Cao et al., 2011; Pearring et al., 2011).  Nyctalopin contains an extracellular LRR 
domain and is connected to the plasma membrane by a single pass transmembrane 
domain or a GPI anchor, depending on the species (O'Connor et al., 2005; Bojang and 
Gregg, 2012).  Nyctalopin is required for the recruitment of TRPM1 to the DBC dendritic 
tips by an unknown mechanism (Gregg et al., 2007).  The function of the LRR domain in 
nyctalopin remains to be discovered, but the importance of it can be highlighted by the 
fact that in humans twenty one of the thirty five cCSNB causing mutations in NYX, the 
gene that encodes nyctalopin, reside in regions encoding the LRR domain (Matsushima 
et al., 2005).   
!! 108!
The LRR domain is one of the most common protein domains in mammals and is 
highly conserved across species (Hynes and Zhao, 2000; Bjorklund et al., 2006).  There 
are ~330 LRR-containing proteins in the human proteome, many of these being 
expressed in neuronal systems (Ko, 2012).  The LRR domain consists of 20-29 amino 
acid motif that contains a conserved LxxLxLxxN/CxL amino acid sequence that is 
typically repeated in a tandem array from 2-52 times (Kobe and Deisenhofer, 1994; 
Matsushima et al., 2005).  The first crystal structure of a LRR protein, ribonuclease 
inhibitor, revealed the tandem array of repeats forms a characteristic horseshoe shaped 
structure (Kobe and Deisenhofer, 1993) that all known LRR proteins adopt (Matsushima 
et al., 2005).  The concave side of this structure is formed by continuous β-sheets and 
the convex side often consists of α-helices, but the composition can vary (Bella et al., 
2008).  LRR proteins may interact with ligands or other LRR proteins through the 
concave and convex surface of the horseshoe shaped structure (Matsushima et al., 
2005).  The LRR domain is capable of interacting with a wide range of ligands by varying 
the length and number of tandem repeats, which affects its curvature (Buchanan and 
Gay, 1996; Bella et al., 2008).   
The majority of LRR proteins are expressed in the nervous system, often giving 
very restrictive expression patterns among neurons of the same functional type (Lauren 
et al., 2003; Beaubien and Cloutier, 2009; Homma et al., 2009; Hong et al., 2009).  LRR 
proteins have been shown to play critical roles in the nervous system.  TrkA, TrkB and 
TrkC are critical for axon guidance during development; NGL1, NGL2 and NGL3 are 
critical for synaptic contact formation; LGI1 is critical for stabilization of mature neurons 
at synapses; and NGL-3 is critical for recruitment of AMPA receptors at glutamatergic 
synapses (Linhoff et al., 2009; Woo et al., 2009; Siddiqui et al., 2010; de Wit et al., 
2011).  Mutations in LRR containing proteins lead to several neuronal diseases such as 
schizophrenia, epilepsy, autism, Tourette’s syndrome and Alzheimer’s disease (Fig. 29).  
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The mechanism of how LRR proteins recruit and maintain signal complex proteins has 
not been determined.  Further, the function and ligands of many of these LRR proteins 











Figure 29: Overview of LRR proteins in neural circuits.  LRR proteins are grouped 
by their known roles in neural circuits including axon guidance (A), target 
selection (B), synapse formation (C), myelination (D), limiting plasticity (E) and 
nervous system disorders (F).  Different protein domains are overviewed in the 
diagram key (bottom left).  Domain abbreviations: LRRNT and LRRCT, LRR N- and 
C-terminal flanking domains; Ig, immunoglobulin-like; CT3, cysteine knot; TyrK, 
tyrosine kinase; EPTP, epitempin; Laminin G, laminin globular; TIR, 
Toll/interleukin-1 receptor; EGF, epidermal growth factor-like; FN3, fibronectin 
type III; GPI-anchor, glycophosphatidylinositol; PDZ-IS, postsynaptic density 






Human patients with mutations in Lrit3 have cCSNB but are otherwise healthy, 
suggesting that Lrit3 may have a limited expression pattern.  Because the human 
patients are healthy we do not need to make a conditional knockout mouse, which can 
be more costly and time consuming.  To develop an Lrit3-/- mouse, Zinc Finger Nuclease 
(ZFN) technology will be utilized.  ZFNs are synthetic DNA binding proteins that are 
fused with a non specific endonuclease (Chandrasegaran and Smith, 1999).   The ZFN 
proteins consist of a chain of two finger modules with specificity for a DNA hexamer.  
The modules can be paired together to form specificity up to 24 bp.  The DNA binding 
zinc finger modules are fused with the DNA cleavage domain of the restriction 
endonuclease FokI.  The FokI restriction endonuclease must dimerize to cleave DNA 
(Bitinaite et al., 1998).  To produce target specificity, two ZFNs must be designed on 
opposite strands with a 5-7 bp separation for DNA cleavage (Carroll, 2011).  When the 
two ZFNs bind to the target site, the FokI dimerizes and cleaves the DNA.  The 
dependency of the restriction endonuclease to dimerize allows ZFNs to target highly 
specific regions within the genome and reduces off target effects.  The double stranded 
DNA breaks created by the ZFNs induce a DNA repair mechanism, most commonly non-
homologous end joining (NHEJ), to repair the DNA double stranded break.  The result of 
NHEJ repair can be the insertion or deletion of one to several DNA base pairs.  By 
careful placement of target sites in an exon, some of the events will cause a frameshift 
resulting in a null allele.   
 To make a ZFN knockout mouse, ZFN mRNA is injected into a fertilized mouse 
single cell embryo.  The mRNA is translated into the functional ZFN proteins by the 
embryo’s cell machinery.  The ZFNs then bind and cleave the targeted DNA causing 
double stranded breaks, followed by DNA repair.  The injected embryos are transplanted 
into a foster mother for development.  Once the pups are born they are screened for 
mutations at the ZFN target site by sequencing genomic DNA.   
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Results 
Lrit3-/- mouse model is created using ZFN technology  
 To begin the design process for generating a Lrit3 knockout mouse we cloned 
Lrit3 cDNA from the retina, to ensure the retinal isoform matches that present in the 
NCBI database.  To clone Lrit3 from the retina, I designed In-Fusion Cloning (Clontech) 
primers that annealed to the predicted Lrit3 start and stop sites and used PCR to amplify 
the ORF from mouse retinal cDNA.  I predicted the Lrit3 ORF in the retina was larger 
than the NCBI database annotated ORF based on next-generation transcriptome 
sequence analysis from retina (Brooks et al., 2011).  The amplified PCR fragment was 
cloned into a pcDNA3.1 mammalian expression vector and sequenced using both 
internal and pcDNA3.1 vector primers.  The sequencing results revealed the retinal 
isoform of Lrit3 is 363 bp larger than the NCBI database version.  The additional base 
pairs reside on the 5’ end of exon 4 (Fig. 30A).  
 I used the SMART online resource (http://smart.embl.de/) (Letunic et al., 2012) to 
predict the domain structure of LRIT3 (Fig. 30B).  The predicted protein structure was 
used to determine which protein domains may be most critical function and therefore be 
targeted by ZFNs to make the Lrit3-/- mouse.   The NCBI database isoform of Lrit3 is 560 
aa in length and produces a protein predicted to have six extracellular LRR domains, an 
immunoglobulin (Ig) like domain, a fibronectin type 3 domain followed by a 
transmembrane (TM) domain and a 76 aa cytoplasmic carboxy terminus (Fig. 30B).  The 
retention of part of intron 3 in the retinal isoform changes the prediction of the Ig like 
domain to an Ig C-2 Type domain and inserts regions of low complexity following the Ig 
domain (Fig. 30B).  Regions of low complexity may provide flexibility to the extracellular 
domain allowing the LRR domain to bind ligands more easily. 
 Based on the predicted protein structure, the most critical functional domain, 
therefore the most desirable domain to disrupt would be the single TM domain.  
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Designing ZFNs to target DNA that encodes for the TM domain would likely disrupt 
protein function if a missense or nonsense mutation was introduced.  Targeting the 
ZFNs to the LRR domains would also likely knockout protein function if a missense 
mutation was introduced into the region because the LRR domain is likely critical to 
binding an extracellular ligand.  Based on the predicted protein structure it was decided 
that ZFNs should most ideally be designed to target the LRR or TM domain to effectively 










Figure 30: Predicted LRIT3 protein domains.  (A) The NCBI database Lrit3 gene is 
363 bp shorter than the isoform cloned from mouse retina.  The increase in size is 
the result of an alternative splice acceptor site in intron 3.  (B) The increased size 
in the retinal isoform changes the IG like domain to a IG C-2 domain and inserts a 










To produce a Lrit3 knockout mouse (Fig. 31), we contracted a team at Sigma-
Aldrich to produce ZFNs.  They designed and tested several ZFNs in mammalian cell 
lines to identify those most likely to target regions of the gene that would result in a 
knockout.  The ZFN pair provided to us targeted the first nucleotides that encode the 
second LRR domain (Fig. 31).  This DNA sequence encodes an amino acid sequence 
that is highly conserved across species (Fig 32B).  At this location, missense mutations 
have a high probability of causing a deleterious allele by changing the secondary 
structure of the conserved LRR domain.  The ZFN mRNAs were sent to the Fox Chase 






Figure 31:  Workflow of the generation of a ZFN KO mouse model.  ZFN mRNA 
pairs targeted against exon 2 of Lrit3 were injected into fertilized single cell 
embryos.  In the embryos the mRNA is translated and the ZFNs can make double 
stranded breaks in the target sequence.  The fertilized embryos are transferred to 





Genotyping ZFN induced mutations in Lrit3 
To genotype the mice, tail biopsies were obtained and genomic DNA was 
isolated.  Primers were designed that flanked the ZFN target site and PCR products from 
each mouse were sequenced.  Two sets of primers were designed; primer set 1 
annealed ~200 bp upstream and ~200 bp downstream of the ZFN target site, primer set 
2 annealed ~400 bp upstream and ~400 bp downstream of the target site (Fig. 32A).  
The second primer set was used to account ensure large deletions could be detected.  
PCR products from mice with deletions resulted in low quality sequence in regions 
where mutations resided.  To get sequence for the individual alleles the PCR fragments 
were cloned into a pCR-Blunt cloning vector (Invitrogen).  Several clones from each 
mouse were screened for mutations using Sanger Sequencing to ensure both clones of 
both alleles were identified.    
 A total of 363 embryos were injected and implanted into 9 Swiss Webster 
mothers.  44 offspring were obtained, 15 of which had mutations on at least one allele 
(Fig. 32C).  The mutations ranged from a single to a 40 bp deletion.  4 of the mice were 
compound heterozygotes and were predicted to be Lrit3-/- due to the mutations being 
located in a gene region that encodes a highly conserved peptide.  Mouse G48 
contained a 4 bp deletion that will result in a frameshift and a 15 bp deletion that will 
cause a loss of 5 highly conserved amino acids.  Mouse G49 contained a complex DNA 
inversion that disrupts a highly conserved amino acid encoding region and a single base 
pair deletion that will result in a frameshift.  Mouse G50 contains a 3 bp deletion that 
deletes a conserved tyrosine before the second LRR domain and a single bp deletion 
that results in a frameshift.  Mouse J7 contains a 15 bp deletion that will cause a loss of 
highly conserved amino acids and a single bp deletion that will result in a frameshift. 
To generate a knockout line we chose to breed mouse G47 because he carried a 
40 bp deletion on one allele, which deletes critical amino acids and produces a 
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frameshift.  The 40 bp deletion also allows easy genotyping of the offspring by agarose 








Figure 32: ZFN mutations disrupt a highly conserved protein-coding region.  (A) 
gene map of Lrit3 including primer annealing sites used to capture ZFN targeted 
region (*).  (B) LRIT3 amino acid alignment using the Profile Alignment (PRALINE) 
application (Simossis and Heringa, 2005).  The ZFNs flank and cut the DNA 
sequence ACCT which partially encodes the Tyr/Lys amino acids (black line) that 
reside in a peptide sequence that is highly conserved across species. (C) 
Sequences from Lrit3 ZFN mutant offspring.  Mutations range from single bp 
deletions to 40 bp deletions.  Sequence was aligned using the Clustal V sequence 
alignment (Higgins, 1994).  Mouse G49b had a large inversion on one allele and is 





ERG analysis reveals ZFN Lrit3 compound heterozygotes have a no b-wave ERG  
 From the sequence alignment I predicted the two founder mice G48 and G49 
who had a mutation on both alleles would be null for the LRIT3 protein.  These were 
tested for visual function using the ERG.  We performed a dark adapted ERG with a -0.4 
log cd*s*m-2 flash stimulus.  This stimulus intensity elicits a response from both rod and 
cone ON BCs (Stockman and Sharpe, 2006).  Both mutants lacked b-waves in the 
ERGs, whereas littermate controls had normal ERGs (Fig. 33).  These data demonstrate 
that similar to human (Zeitz et al., 2013b), LRIT3 is required for normal function of the 








Figure 33: Predicted Lrit3-/- mice have a no b-wave ERG phenotype.  ERG from G51 
littermate WT (blue) and G48 Lrit3-/- (red) mice.  Waveforms reflect response from 
dark adapted mice subjected to a 200 msec -0.4 log cd*s*m-2 strobe flash.  WT 
mice have a normal ERG a- and b-wave.  The Lrit3-/- mice lack the ERG b-wave, 

















TRPM1 does not localize to the DBC dendritic tips in the Lrit3-/- retina 
 Data from human patients with cCSNB indicated LRIT3 was critical to DBC 
signaling and that it was expressed at the DBC dendritic tips (Zeitz et al., 2013b).  
However, the mechanism by which the absence of LRIT3 disrupts glutamate signaling in 
the DBCs remains unknown.  To determine if LRIT3 plays a critical role in localizing 
other proteins to the DBC dendritic tips, immunostaining for DBC components was 
performed on WT and Lrit3-/- retinas. 
Due to the similarities between LRIT3 and nyctalopin, we first investigated the 
expression of TRPM1 in the Lrit3-/- retina.  Fixed transverse retinal sections from Lrit3-/- 
and WT mice were labeled with antibodies against TRPM1 and mGluR6 and the proteins 
were visualized by confocal microscopy.  As expected, TRPM1 immunostaining labeled 
the DBC bodies and gave punctate labeling in the OPL of WT mice.  In the Lrit3-/- retina, 
TRPM1 was not localized to the DBC dendritic tips, although the bipolar cell bodies were 
positive for TRPM1 protein expression (Fig.  34).  These results are similar to the 




Figure 34:  TRPM1 is not localized correctly in Lrit3-/- DBCs.  Fixed transverse 
retinal sections were labeled with antibodies against TRPM1 (green) and mGluR6 
(red) and visualized with confocal microscopy.  As expected, TRPM1 is expressed 
in the cell bodies and at the dendritic tips of the DBCs in WT retina and it co-
localizes with mGluR6.  In the Lrit3-/- and Nyxnob retinas, TRPM1 is expressed in the 
cell bodies but does not localize to the DBC dendritic tips and does not colocalize 











Other known signalplex proteins are present in the Lrit3-/- retina 
 To determine if the absence of LRIT3 impacted additional signalplex proteins I 
labeled Lrit3-/- and WT transverse retinal sections with antibodies against GPR179, 
mGluR6, Gβ5, RGS7 and RGS11 and visualized the staining with confocal microscopy. 
These studies showed that GPR179, mGluR6, Gβ5, RGS7 and RGS11 all localized 
properly in the absence of LRIT3 (Fig. 35).  These results mirror the expression pattern 
of these proteins in the Nyxnob mouse model (Fig. 21 and (Cao et al., 2011; Pearring et 
al., 2011)).  These data suggest that the defect in glutamate signaling in the Lrit3-/- 
mouse is caused by the inability of TRPM1 to be localized at the DBC dendritic tips.  
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Figure 35: GPR179, mGluR6, Gβ5, RGS7, RGS11 and R9AP localization is normal 
in Lrit3-/-.  DBC signalplex proteins were labeled with antibodies in WT and Lrit3-/- 
retinal slices and visualized using confocal microscopy.  The proteins GPR179, 




 My experiments show that LRIT3 is required for normal DBC function in mice, 
consistent with the report that mutations in human Lrit3 cause cCSNB (Zeitz et al., 
2013b).  LRIT3 is an extracellular LRR protein with an Ig C-2 domain, fibronectin type 3 
domain, and a single TM domain (Fig 30B).  The molecular function of LRIT3 in the 
DBCs is unclear, however, I show that its expression is required for localization of the 
TRPM1 cation channel to the DBCs dendritic tips (Fig. 34).  Like other LRR proteins (de 
Wit et al., 2009; Linhoff et al., 2009; Siddiqui et al., 2010), LRIT3 appears to be critical 
for the recruitment of synaptic components and synaptic maintenance. 
Based on the immunohistochemistry data showing that TRPM1 is not localized in 
the Lrit3-/- DBCs, we anticipated the rod BCs would not respond to the mGluR6 
antagonist, CPPG, or the TRPM1 modulator, capsaicin.   To test whether the rod BCs 
respond to CPPG in the Lrit3-/- retina, transverse retinal sections were prepared for 
single cell recordings.  Retinal slices were bathed in a solution containing L-AP4, which 
maximally activates the glutamate signaling cascade and closes the TRPM1 channel.  
Application of 0.6 mM CPPG for 200 msec elicited a response in the Lrit3-/- retina that 
was significantly decreased compared to WT.  This response was not significantly 
different than the response from Trpm1-/- rod BCs but was significantly smaller than the 
response generated in the Gpr179nob5 rod BCs (Fig. 36A,B).  These results support our 
data that the TRPM1 channel is not localized to the DBC dendritic tips in the Gpr179nob5 
retinas. 
 To further test whether TRPM1 is not localized to the DBC dendritic tips in the 
rod BCs of the Lrit3-/- retina we measured the rod BC response to exogenous capsaicin 
application.  Capsaicin is a modulator of the TRPM1 channel.  If the channel is localized 
to the plasma membrane of the rod BC dendritic tips in the Lrit3-/- retina it should have a 
capsaicin response greater than the Trpm1-/- capsaicin response.  We found that the 
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capsaicin response in rod BCs from Lrit3-/- retina were no different than the capsaicin 
response in the Trpm1-/- rod BCs, and as expected both responses are significantly 
decreased compared to WT (Fig. 36C,D).  The capsaicin response in the Lrit3-/- rod BCs 
was not significantly different from the response in Gpr179nob5 rod BCs (Fig. 36D).  
These data further support that in the Lrit3-/- retina the absence of TRPM1 channel 











Figure 36:  Lrit3-/- rod BC response to CPPG and capsaicin.  Whole cell recordings 
from WT, Gpr179nob5, Trpm1-/- and Lrit3-/- rod BCs in the presence of L-AP4.  (A) 
Representative traces of WT and Lrit3-/- rod BCs in response to CPPG.  (B) Scatter 
diagrams of peak amplitude responses.  One way ANOVA (***): Trpm1-/- is 
significantly decreased in amplitude compared to Gpr179nob5.  (*) Lrit3-/- is 
significantly decreased in amplitude compared to Gpr179nob5.  LRIT3 does not 
significantly differ from Trpm1-/-.  (C) Representative traces of WT and Lrit3-/- rod 
BCs in response to capsaicin.  (D) Scatter diagrams of peak amplitude responses.   
One way ANOVA (**): Gpr179nob5 and Trpm1-/- are significantly different.  Lrit3-/- 
does not significantly differ from either Gpr179nob5 or Trpm1-/-.  Experiments 









Like LRIT3, nyctalopin is critical for the localization of TRPM1 at the DBC 
dendritic tips.  It will be important to determine the mechanism by which LRIT3 is 
responsible for the localization of TRPM1, whether the function of LRIT3 is redundant 
with nyctalopin, and if LRIT3 serves a purpose beyond localization of the TRPM1 
channel.  Determining the mechanism by which LRIT3 localizes the TRPM1 channel to 
the DBC dendritic tips will be important because the general mechanism by which LRR 
proteins recruit other proteins to the synapse is largely unknown. 
Leucine-rich repeat transmembrane protein 1 (LRRTM1) is responsible for the 
assembly of excitatory synapses.  LRRTM1 plays a role in recruiting the AMPA receptor 
to the plasma membrane and is responsible for long-term potentiation in pyramidal 
neurons (Soler-Llavina et al., 2013).  In the BCs, we know that the number of TRPM1 
channels at the DBC dendritic tips rate limits the response (Peachey et al., 2012a).  It 
will be important to determine if LRIT3 plays a role in regulating the number of TRPM1 
channels at the DBC dendritic tips, possibly shaping DBC plasticity.   
LRR proteins are known to have roles in synapse maintenance (de Wit et al., 
2011), therefore, It will be important to perform electron microscopy (EM) on the Lrit3-/- 
retinas to ensure they are formed properly and maintained through adulthood.  The Lrit3-
/- line should also be crossed with the Nyxnob mouse and EM performed.  Deleting both 
LRIT3 and nyctalopin from the DBC dendritic tips may cause the synapse to be less 
stable, especially if both proteins have non-redundant roles in synapse maintenance.  
These experiments would help us understand if LRIT3 has a function beyond recruiting 
the TRPM1 channel to the DBC dendritic tips.   
To study LRIT3 function further an antibody must be made or a transgenic 
mouse expressing a tagged LRIT3 protein produced to do immunohistochemistry and 
biochemistry.  With the emergence of new genome editing techniques this can be 
efficiently accomplished and provide a reliable method of detecting LRIT3 in vivo.  The 
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tag would ideally be placed on the carboxy terminus.  The carboxy terminus is a short 
intracellular domain likely only needed for anchoring the protein to the membrane and 
addition of a protein tag should not interfere with protein function. 
There are several protein domains in LRIT3 in which a functional role needs to 
be identified, including the LRR domain, Ig C-2 domain and Fibronectin type 3 domain 
(Fig. 30).  The extracellular LRR domain is likely critical for ligand binding in the EC 
matrix. The Ig C-2 domain of LRIT3 likely is a protein interaction domain.  Ig domains of 
synaptic proteins have been demonstrated to be critical for stabilization of synaptic 
protein complexes (Rapti et al., 2011).  Fibronectin type 3 domains have been shown to 
play critical roles in neural synaptic plasticity (Strekalova et al., 2002; Dityatev et al., 
2010), calcium channel potentiation and integrin binding to the EC matrix (Dityatev et al., 
2010).  Genome editing techniques can be used to create dominant negative LRIT3 
transgenic mice that contain mutations in the different protein domains.  Ideally, these 
mutations would disrupt a protein domain but allow the protein to localize properly.  
These experiments would help differentiate which domains are critical for TRPM1 and 
LRIT3 localization.   
Methods 
DNA isolation 
For mouse genotyping, tail samples were collected from mice and placed in a 0.7 
mL microcentrifuge tube.  To the tube, 200 µL of DirectPCR (Viagen Biotech) was added 
along with 2 µL proteinase K (20 mg/ml).  Sample was incubated for at least 4 h at 55oC 
in a dry bath with brief vortexing every h.  After the tail sample was adequately digested, 
the sample was heated to 85oC for 30 min to inactivate the proteinase K.  Samples were 
then ready for PCR. 
General PCR  
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PCR was performed using either Phire II or Phusion taq polymerase (Thermo 
Scientific).  Reactions were made to 20 µl consisting of 0.5 µM of each forward and 
reverse primers, 200 µM of dNTPs, 4 µl of 5X reaction buffer, and either 0.4 µl of Phire II 
or Phusion DNA Polymerase, template DNA and water varied by application.  Reactions 
were run on a Bio Rad C1000 Touch Thermal Cycler. 
RNA Isolation from Retina 
Mice were euthanized by CO2 inhalation and cervical dislocation.  Eyes were 
extracted and enucleated and the retinas were removed and stored at -80oC in RNAlater 
(Ambion). RNA was isolated according to the manufacturers protocol for the PureLink® 
RNA Mini Kit (Ambion).  Briefly, retinal tissue was removed from RNAlater and 
homogenized in 10-20 volumes of Tri Reagent (Ambion) by pipetting.  The homogenized 
mixture was incubated for 5 min at room temperature then 200 µl chloroform per ml of 
homogenate was added and the mixture vortexed, and incubated for an additional 5 min 
at room temperature; followed by centrifugation at 12,000 x g for 10 min at 4oC.  The 
aqueous phase volume was transferred to a new 1.5 ml centrifuge tube and 200 µl of 
100% ethanol was added to the sample and vortexed for 15 sec.  The sample was 
placed in a filter cartridge (Ambion) and centrifuged at 12,000 x g for 30 sec.  Flow 
through was discarded and 500 µl wash solution was applied to the filter cartridge and 
centrifuged at 12,000 x g for 30 sec.  The wash step was repeated and filter cartridge 
was transferred to a new microcentrifuge tube and 100 µl of Elution buffer was applied to 
elute the RNA.  The RNA was collected by centrifugation for 30 sec at 12,000 x g, and 
stored at -80oC. 
Zero Blunt pCR Cloning 
pCR-Blunt cloning was performed according the manufacturers instructions 
(Invitrogen MAN0007763).  In brief, ligation reactions were set up containing 1 µl pCR-
Blunt vector, 1 µl of blunt-end PCR product, 2 µl 5X ExpressLink T4 DNA Ligase Buffer, 
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5 µl sterile water and 1 µl ExpressLink T4 DNA Ligase.  The ligation reaction was gently 
mixed and incubated at room temperature for 10 minutes.  In the meantime, One Shot 
Top10 cells (Invitrogen) were thawed on ice.  2.5 µl of the ligation reaction was added to 
one vial of One Shot Top10 cells and mixed by swirling.  Cells were incubated on ice for 
15 min then heat shocked for 30 sec at 42oC and returned to ice for at least 1 minute.  
250 µl of SOC medium was added to the transformed cells and they were incubated at 
37oC while shaking at 225 rpm for 1 h.  Cells were then plated on Circlegrow agarose 
plates (MP Biomedicals) supplemented with kanamycin 100 µg/mL. 
In-Fusion HD Cloning 
PCR fragments were amplified using primers designed to have 14-18 bp 5’ 
overhangs that share homology with the cut site on a linearized vector.  PCR fragments 
were treated with Cloning Enhancer (Clontech) and incubated at 37oC for 15 min then at 
80oC for 15 min on a PCR thermal cycler.  Linearized vector, treated PCR fragment and 
water was added to 5X In-Fusion HD Enzyme Premix according to manufacturers 
suggestion (Clontech).  The reaction was mixed by pipetting and incubated for 15 min at 
50oC on a thermal cycler.  The reaction mix was placed on ice or stored at -20oC until 
transformation. 
Plasmid Isolation 
Plasmid purification was performed using the Wizard Plus SV Minipreps DNA 
Purification System (Promega) according to the manufacturers protocol.  Single colonies 
from transformed bacteria were selected from agarose plates using a sterile toothpicks 
and used to inoculate 2 ml of Circlegrow media supplemented with 100 µg/ml 
kanamycin.  The culture was grown overnight at 37oC while shaking at 225 RPM.  The 
bacterial cells were transferred to a 2 ml centrifuge tube and pelleted by centrifugation at 
max speed for 5 minutes to pellet cells.  Supernatant was discarded and cells were 
resupsended by vortexing in 250 µl of Cell Resuspension Solution.  250 µl of Cell Lysis 
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Solution and 10 µl Alkaline Protease Solution was added, and mixed by inverting tubes 
several times then incubated at room temperature for 5 min.  350 µl of Neutralization 
Solution then was added to the tube and mixed by inverting several times.  Tubes were 
centrifuged at 12,000 x g for 10 min to pellet cellular debris and the supernatant was 
decanted into a spin column.  The spin column was placed into a collection tube and 
centrifuged for 1 min at 12,000 x g.   The flow through was discarded and the plasmid 
bound to the column was washed 2 times by adding 500 µl of Column Wash Solution to 
the column and centrifugation for 1 min at 12,000 x g.  The spin column was transferred 
to a clean microcentrifuge tube and 100 µl of sterile water was added to the column to 
elute plasmid DNA.  The water was incubated on the column for 1 min at room 
temperature then centrifuged for 1 min at 12,000 x g to collect DNA.  DNA was stored at 
-20oC. 
Antibodies 
The following primary antibodies and their concentrations were used: sheep anti-
GPR179 (peptide KVQEETPGEDLDRPVLQKR), 1:2,000 (Peachey et al., 2012b); 
guinea pig anti-mGluR6 1:1,000 (Koike et al., 2010b); sheep anti-TRPM1 1:1,000 (Cao 
et al., 2011); goat anti-Gβ5 (peptide MATDGLHENETLASLKC), 1:1,000 (Morgans et al., 
2007); goat anti-R9AP 1:1,000 (Hu and Wensel, 2002); sheep anti-RGS11 (peptide 
CSPALQSTPREPAATSSPEGADGE), 1:1,000 (Martemyanov et al., 2005); sheep anti-
RGS7 1:1,000 (Morgans et al., 2007). 
Secondary antibodies (Invitrogen, 1:1,000) appropriate to each primary antibody 
included: donkey anti-sheep Alexa-488, donkey anti-rabbit Alexa-680, donkey anti-rabbit 




Mice were euthanized with CO2 followed by cervical dislocation.  Their eyes were 
enucleated and the lens was removed. Eyecups were washed in phosphate buffered 
saline (PBS) then fixed for 30 min in a 4% formaldehyde PBS solution (pH 7.4). Eyecups 
were washed 3 times with PBS then cryoprotected in increasing concentrations of 
sucrose in PBS (10%, 15% for 1 h each and 30% overnight). Eyecups were embedded 
in 2:1 OCT/ 20% sucrose PBS solution frozen in a liquid nitrogen cooled bath of 
isopentane. Eyecups were sectioned (18 µm) using a Leica 1850 cryostat.  Sections 
were mounted on glass slides (SuperFrost) and allowed to dry for 10 mintues at room 
temperature before being stored at -80oC. Sections were air dried at 37oC for 15 min and 
washed with PBS and PBS containing 0.05% Triton X-100 (PBX) for 5 min each, then 
blocked in PBX plus 5% normal donkey serum blocking solution for 1 h. Sections were 
incubated overnight at room temperature in the presence of the primary antibody diluted 
in blocking solution, then washed 3 times for 10 min each with PBX followed by 
incubation in secondary antibody in blocking solution for 1 h at room temperature. 
Sections were washed 2 X 10 min in PBX and 1 X PBS. Slides were cover-slipped using 
Immu-Mount (Thermo Scientific) and slides were imaged using an Olympus FV1000 
confocal microscope.  Images were universally adjusted for brightness using Photoshop. 
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CHAPTER V: SUMMARY 
 
I showed in Aim I that a mutation in Gpr179 was the cause of the no b-wave 
phenotype in the Gpr179nob5 mouse.  The Gpr179nob5 mouse contains a ~6.5 kb insertion 
in intron 1 of the gene Gpr179 that is thought to disrupt mRNA processing between exon 
1/2.  Analysis of gene expression using qRT-PCR revealed exon 1/2 expression was 
greatly decreased in the Gpr179nob5 mouse.  Morpholino disruption of GPR179 protein 
translation in zebrafish resulted in a greatly diminished ERG b-wave compared to 
scrambled control.  Human patients with cCSNB were screened for mutations in Gpr179 
and two patients were identified with inactivating mutations on each allele.  These data 
indicate that Gpr179nob5 is a new model of cCSNB. 
I determined Gpr179 is expressed in the INL of the retina using in situ 
hybridization.  Immunohistochemistry followed by confocal microscopy revealed the 
protein is localized to the tips of the DBCs in the OPL and GPR179 puncta juxtapose 
RIBEYE staining and colocalize with mGluR6.  Finally, we generated a Gpr179-/- mouse 
model to confirm its role in DBC function.  The line is currently being generated at the 
University of Louisville. 
In Aim II I examined the interdependency of DBC signalplex components on the 
expression of other cascade components using immunohistochemistry and confocal 
microscopy.  I found that the localization of RGS7, RGS11, Gβ5 and R9AP to the DBC 
dendritic tips was dependent on expression of GPR179 (Fig. 21).  Through collaboration 
we showed that GPR179 interacts with RGS7/Gβ5, RGS11/Gβ5 (Appendix II and 
Orlandi et al., (2012)), further supporting our hypothesis that GPR179 acts to 
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recruit and localize the RGS proteins to the DBC signalplex.  I showed that GPR179 
forms complexes with mGluR6 and TRPM1 using the Duolink PLA Assay.  Similar 
conclusions were made by Orlandi et al. (2013).  In Ray et al. (2013) (Appendix III) we 
showed that GPR179 and TRPM1 IP together from retinal lysates.  Taken together, it 
appears GPR179 acts as a hub and recruits the RGS proteins to the DBC signalplex and 
brings them within close proximity of mGluR6 and TRPM1.  Localizing all of the 
signalplex components into a macromolecular complex enhances the efficiency and 
fidelity of signaling between the mGluR6 receptor and the TRPM1 channel. 
The finding that R9AP does not localize in the RGS7-/-/RGS11-/- DBCs is an 
interesting finding and suggests that the RGS complex consisting of R9AP, Gβ5 and 
RGS7 or 11 must form in an intracellular compartment before the complex can localize 
at the DBC dendritic tips. The RGS complex cannot form and does not localize properly 
if Gβ5 (Chen et al., 2003) or RGS7/11 are absent (Fig. 22).  It was previously reported 
that R9AP localization in the DBCs was decreased in a hypomorphic RGS7-/-/RGS11-/- 
mouse (Zhang et al., 2010) but It was later determined that the mouse still retained 
RGS7 function.  
The small ERG b-wave response in the Gpr179nob5 mice suggested that mGluR6 
was capable of signaling to TRPM1 in the absence of GPR179 (Ray et al. 2013 and 
Appendix III).  Using whole cell patch clamp we confirmed that mGluR6 could signal to 
TRPM1, albeit with reduced sensitivity in both the Gpr179nob5 and RGS7-/-/RGS11-/- rod 
BCs (Ray et al., 2013 and Appendix III).  This reduced response is the result of the 
absence of RGS proteins in both models.  The capsaicin response in the rod BCs 
displays another role for GPR179 in the DBCs.  In the Gpr179nob5 rod BCs the capsaicin 
response is significantly decreased compared to WT, whereas in the RGS7-/-/RGS11-/- 
rod BCs the capsaicin response is no different than WT.  These data indicate that 
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TRPM1 has reduced sensitivity to capsaicin because the TRPM1 interaction with 
GPR179 enhances the sensitivity of the channel to gating.  
In Aim III we created a new mouse model of cCSNB based on a report of a newly 
identified gene being involved in DBC function in humans (Zeitz et al., 2013b).  The new 
mouse model was created using ZFNs, which allowed the quickest and most efficient 
generation of a knockout animal.  Using ZFN technology, we created several compound 
Lrit3 mutants that had a no b-wave ERG.  We selected a Lrit3 mutant with a 40 bp 
deletion to generate the knockout line. 
The gene Lrit3 encodes a single pass transmembrane protein with an 
extracellular LRR domain, similar to another LRR containing protein critical to DBC 
function, nyctalopin.  We found that LRIT3 may serve a similar role as nyctalopin in the 
DBCs because both are required for TRPM1 localization at the DBC dendritic tips.  We 
confirmed that TRPM1 is absent from the DBC dendritic tips in the Lrit3-/- mouse using 
whole cell recordings in response capsaicin puffs.  These experiments indicate the 
disruption in the LRIT3 mutant is due to the absence of the TRPM1 channel.  The 
mechanism by which LRIT3 controls TRPM1 localization to the DBC dendritic tips will be 
an important further line of investigation.  Because the amount of TRPM1 at the DBC 
dendritic tips is known to set the light response amplitude (Peachey et al., 2012a), it will 
be important to determine if LRIT3 can actively change the amount of TRPM1 at the 
DBC dendritic tips in response to changes in light levels. 
Model of DBC signaling 
 Using the knowledge gained from this project, we have developed a more 
thorough understanding of the rod BC signalplex protein arrangement and mechanism of 
signaling.  When I started the project we had a very limited understanding of how the 
mGluR6 receptor signaled to the TRPM1 cation channel in the DBCs (Fig 5).  Over the 
last 4 years we identified 2 new proteins, GPR179 and LRIT3, involved in DBC signaling 
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(Peachey et al., 2012b) and characterized the interdependency of the DBC signalplex 
proteins (Orlandi et al., 2012). We used physiology in models of DBC dysfunction to 
understand the role of individual DBC signalplex proteins (Appendix III and Ray et al., 
(2013)).  These data were used to assemble a more accurate model of the DBC 
signalplex and how it may function (Fig. 37) 
 We propose that GPR179 is the focal point of the signalplex protein scaffold.  
GPR179 interacts with TRPM1, mGluR6 and is responsible for recruiting the RGS 
machinery in close proximity to TRPM1 and mGluR6.  The LRR proteins nyctalopin and 
LRIT3 play a critical role in recruiting TRPM1 to the DBC dendritic tips and they likely 
interact with extracellular matrix proteins to position TRPM1 at the synapse.  The 
glutamate receptor mGluR6 is physically associated with this complex and likely 
interacts with one or more proteins through a transmembrane domain.  The G proteins 
are tethered to the membrane through posttranslational modifications. 
 In the dark, photoreceptors are continuously releasing glutamate into the 
synaptic cleft where it becomes bound by mGluR6.  This induces a conformational 
change in the receptor that allows it to bind GαoGDP and activate it to GαoGTP by GTP 
exchange.  The newly formed GαoGTP is released from the receptor and the 
heterotrimeric G protein dissociates into GαoGTP and the Gβγ dimer.  The Gβγ complex 
binds and gates the TRPM1 channel closed in a transient manner.  The RGS proteins 
through their constitutive GTPase activity immediately inactivate the GαoGTP subunit.  
The GαoGDP subunit reforms the heterotrimeric complex with Gβγ. For gating of the 
TRPM1 channel to occur, activation of Gαo must outpace the constitutive RGS GTPase 
activity.  Once the equilibrium shifts in favor of the RGS proteins through a decrease in 
glutamate release by the photoreceptors, the TRPM1 channel opens, causing the cell to 
depolarize. 
!! 139!
Whether the cell is depolarized or hyperpolarized depends on the equilibrium of 
open to closed TRPM1 channels.  When the glutamate signaling cascade is maximally 
activated by the presence of glutamate in the synaptic cleft, the equilibrium favors closed 
TRPM1 channels because G protein activation out paces the constitutive RGS activity.  
In the absence of glutamate in the synaptic cleft, G protein activation ceases and the 
RGS proteins quickly deactivate any remaining active G proteins.  The equilibrium shifts 















Figure 37: Model of DBC signaling.  The ratio of free Gβγ to GαoGβγ determines 
the gating of the TRPM1 channel.  In the dark glutamate in the synaptic cleft 
activates the mGluR6 receptor, which activates G proteins.  Free Gβγ transiently 
binds and gates the TRPM1 channel closed.  In order for TRPM1 channels to be 
gated closed and keep the cell hyperpolarized G protein activation must outpace 
the constitutive RGS deactivation of G proteins.  When glutamate is decreased in 
the synaptic cleft, G protein activation by mGluR6 is halted and the RGS proteins 
quickly deactivate any remaining active G proteins.  G protein suppression of the 
TRPM1 channel is relieved causing the channel to open and the cell to depolarize.  
GPR179 serves to anchor the RGS complex in close proximity with the TRPM1 
channel for increased gating sensitivity.  GPR179 interaction with TRPM1 
enhances the sensitivity of the channel to gating.  LRIT3 and nyctalopin serve to 










This study has answered many questions regarding glutamate signaling in the 
DBCs.  Just as important, it creates new questions that, upon answering, will give rise to 
a greater understanding of DBC function.  It will be important to explore the role of the 
extracellular EGF domain of GPR179.  Instead of GPR179 binding a ligand, this domain 
may be critical for interaction with the extracellular matrix or other proteins on the pre or 
postsynaptic side of the synapse.  The large intracellular carboxy terminus of GPR179 is 
a large and contains an amino acid sequence of low complexity that likely gives it a 
disordered secondary structure.  The current literature suggests that large scaffolding 
proteins often contain a disordered structure in solution, but upon binding their 
interacting partners they create a highly ordered protein scaffold (Dyson and Wright, 
2005; Xie et al., 2007; Coletta et al., 2010; Ferreon et al., 2013).  It will be important to 
identify the carboxy terminus-binding partners to gain a deeper understanding of 
signalplex architecture. 
 The GABAB1 and GABAB2 GPCRs form a heterodimer and are both required to 
carry out signaling by a trans-activating mechanism that involves one receptor binding 
the ligand and the other receptor activating the G proteins (Margeta-Mitrovic et al., 2000; 
Pagano et al., 2001; Rondard et al., 2008; Monnier et al., 2011).  It will be interesting to 
determine if GPR179 and mGluR6 are capable of functioning in this manner.  While it 
seems unlikely that GPR179 binds glutamate due to its lack of extracellular glutamate 
binding domain, it is possible that it can still play a role in the activation of G proteins 
because it is predicted to couple to Gαi/o G proteins.   
The gating mechanism of Gβγ on the TRPM1 channel will be important to 
determine.  At this time it is unknown where the Gβγ binding site on TRPM1 is located 
and what its stoichiometry is with TRPM1.  Biophysical techniques such as fluorescent 
spectroscopy may be able to characterize this interaction.   
!! 142!
The extracellular LRR domains of LRIT3 and nyctalopin are likely critical to 
protein function, yet nothing is known about their function in the DBCs.  Understanding 
what these proteins interact with in the extracellular matrix will provide a greater 
understanding about how they coordinate the localization of proteins on both sides of the 
synapse.  Crossing the Lrit3-/- mouse with various mouse models of cCSNB and 
transgenic models can help pinpoint the function of LRIT3.  It will be important to cross 
the LRIT3 mouse with the Tg(Gabrr1-YFP/nyx)Rgg1 mouse, which expresses a YFP 
tagged nyctalopin protein (Gregg et al., 2007), to determine if nyctalopin is localized to 
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Complete congenital stationary night blindness (cCSNB) is a clinically and 
genetically heterogeneous group of retinal disorders characterized by nonprogressive 
impairment of night vision, absence of the electroretinogram (ERG) b-wave, and variable 
degrees of involvement of other visual functions. We report here that mutations in 
GPR179, encoding an orphan G protein receptor, underlie a form of autosomal-
recessive cCSNB. The Gpr179nob5/nob5 mouse model was initially discovered by the 
absence of the ERG b-wave, a component that reflects depolarizing bipolar cell (DBC) 
function. We performed genetic mapping, followed by next-generation sequencing of the 
critical region and detected a large transposon-like DNA insertion in Gpr179. The 
involvement of GPR179 in DBC function was confirmed in zebrafish and humans. 
Functional knockdown of GPR179 in zebrafish led to a marked reduction in the 
amplitude of the ERG b-wave. Candidate gene analysis of GPR179 in DNA extracted 
from patients with cCSNB identified GPR179-inactivating mutations in two patients. We 
developed an antibody against mouse GPR179, which robustly labeled DBC dendritic 
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terminals in wild-type mice. This labeling colocalized with the expression of GRM6 and 
was absent in Gpr179nob5/nob5 mutant mice. Our results demonstrate that GPR179 
plays a critical role in DBC signal transduction and expands our understanding of the 
mechanisms that mediate normal rod vision. 
Congenital stationary night blindness (CSNB) is a severe disability that impairs 
night vision.  Complete CSNB (cCSNB) is a genetically heterogeneous form of the 
disorder that is caused by mutations in genes that are required for signal transduction 
through retinal depolarizing bipolar cells (DBCs).1–8 The function of photoreceptors and 
DBCs can be assessed noninvasively with the electroretinogram (ERG), and their light-
induced activities are reflected in the a-wave and b-wave, respectively.9 Individuals with 
cCSNB and animal models of the disorder have an ERG waveform that lacks the b-wave 
because of a failure to transmit the photoreceptor signal through the DBCs. 
Depolarization of the DBCs is initiated by a metabotropic glutamate receptor-mediated 
(GRM6)10 modulation of a transient receptor potential melastatin 1 cation channel 
(TRPM1).11–13 This G protein signal transduction cascade utilizes Gαo,1,14 Gβ5,15 and 
depends on the auxiliary protein nyctalopin.16,17 Mutations GRM6 (MIM604096), TRPM1 
(MIM 613216), or NYX (MIM 300278), which encodes nyctalopin, all can cause cCSNB 
in humans.1–8 Mice with mutations in Grm6, Trpm1, Gna0, and Gnb5 or Nyx also have a 
no b-wave (nob) ERG phenotype.10–16,18–20 In this report, we define a critical role for 
GPR179, a previously uncharacterized orphan G protein receptor, in the DBC signal 
transduction cascade and in human cCSNB. Specifically, mutations in GPR179 in 
humans are responsible for a form of cCSNB. Consistent with this result, nob5 mice 
have a mutation in Gpr179 (Gpr179nob5/nob5) and a nob ERG phenotype. Finally, 
zebrafish, whose Gpr179 expression is knocked down via morpholino injection, have a 
reduced ERG b-wave amplitude.  
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The nob5 mouse arose as a spontaneous mutation in a colony of C3H mice and 
was identified via ERG when this line was crossed to a line of C3H mice lacking the rd1 
mutation (C3H-fþ/þ). To identify the causative mutation, we crossed affected nob5 mice 
to wild-type (WT) C57BL/6J mice and the resulting F1 mice were intercrossed to 
generate a segregating mapping cross. We identified F2 progeny homozygous for the 
nob5 locus by ERG and used them to map the phenotype by using a genome-wide 
screen with 103 simple sequence length polymorphic markers distributed throughout the 
genome.21 Initial mapping localized the gene to chromosome 11. Subsequently, > 600 
additional informative meiosis refined the map location of the nob5 locus to between 
D11Mit54 and D11Mit67. This 1.3 Mb region contains over 90 genes, none of which 
were known to be involved in DBC signal transduction or had been identified in 
molecular analyses of enriched pools of DBCs.22–24 To identify the mutation 
underlying the nob5 phenotype we used genome capture and high-throughput 
sequencing. Comparison of the sequence encompassing the critical region in nob5/nob5 
and WT C3H mice revealed the presence of an insertion in intron 1 of Gpr179 (Figure 
1A). The next-generation sequence data provided only 10 bp of sequence on either side 
of the insertion, but these data suggested the insertion was a transposable element. To 
examine this directly, we used PCR to amplify the insertion and its flanking intronic DNA. 
This revealed the presence of the predicted 1.3 kb fragment in WT mice and a 7.8kb 
fragment in homozygous affected littermates, indicating the insertion is ~6.5 kb (Figure 
1A). Both bands were seen in heterozygotes. Henceforth, the mutant nob5 allele will be 
referred to as Gpr179nob5. Sequence analyses of the ends of the insertion indicated it 
was an endogenous retroviral element of the ERV2 class (Figure 1B). To evaluate the 
impact of this insertion on Gpr179 expression, we used a quantitative intronspanning 
Taqman RT-PCR assay to determine Gpr179 mRNA levels of WT and Gpr179nob5/nob5 
retinas (Figure 1C). The expression of mRNA representing Gpr179 in the Gpr179nob5/nob5 
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retina was decreased more than 800-fold compared to the expression of mRNA in the 
WT retina. These data indicate that the Gpr179nob5/nob5 phenotype is caused by a large 
insertion mutation in intron 1 of Gpr179; this insertion dramatically reduces gene 

























Figure 2: Transposable Element Disrupts Gpr179 Expression in nob5 Mouse (A) 
PCR fragments from Gpr179nob5/nob5 (lane 1), Gpr179nob5/+. (lane 2), and WT C3H 
(lane 3). The insertion is ~6.5 kb. (B) Schematic exon map of Gpr179 indicating 
location of nob5 insertion mutation. The arrows indicate location of PCR primers 
used in (A). (C) Quantitative PCR of Gpr179 cDNA generated from mRNA isolated 
from retinas of WT and Gpr179nob5/nob5 mice. Expression of Gpr179 was normalized 
to that of 18S RNA and is relative to the Gpr179 expression in WT. The error bars 
indicate mean ± standard deviation for three mice. Gpr179 expression in 
Gpr179nob5/nob5 retina is significantly  reduced (p < 0.0005). All animal studies were 
approved by the local institutional animal care and use committees and 
conformed to all regulatory standards. 
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A series of dark-adapted ERGs obtained from representative WT, Gpr179nob5/þ, 
and Gpr179nob5/nob5 mice are shown in (Figure 2A). Throughout the stimulus range 
examined, WT ERGs are dominated by a positive polarity b-wave, which increases in 
amplitude with increasing flash luminance and reflects the light-induced activity of 
DBCs.25 At higher flash luminance, the b-wave was preceded by a negative polarity a-
wave, reflecting the light-induced closure of cation channels along rod photoreceptor 
outer segments.26 ERG responses in heterozygous Gpr179nob5/+ mice resembled the 
responses of WT mice, consistent with autosomal-recessive inheritance. In contrast, 
whereas large a-waves are obtained from homozygous Gpr179nob5/nob5 mice, these
 responses lack the b-wave component, revealing slow PIII, an ERG component 
generated by the radial Müller glial cells.27 Summary plots for the major components of 
the dark-adapted ERGs are shown in Figure 2B. ERG a-wave amplitudes were 
comparable across the three genotypes and the b-waves of Gpr179nob5/+ and WT mice 
were indistinguishable. The b-wave component is absent in Gpr179nob5/nob5 mice, and 
therefore, these data are not plotted. This ERG phenotype, in which the b-wave is 
absent while the a-wave is preserved, indicates that rod phototransduction is unaffected 
in Gpr179nob5/nob5 mice, whereas synaptic transmission between photoreceptors and 
DBCs, or DBC activity itself, is grossly abnormal.28 Light-adapted ERGs obtained from 
representative WT, Gpr179nob5/+, and Gpr179nob5/nob5 mice are shown in Figure 2C. In WT 
mice, the cone ERG was dominated by the positive polarity b-wave and higher 
frequency oscillatory potentials, which reflect activity through the DBC pathway.29 In 
contrast, cone ERGs of Gpr179nob5/nob5 mice are electronegative. Summary plots for cone 
ERGs recorded from all three genotypes are shown in Figure 2D. When cone ERG 
amplitude is measured from the negative trough to the following positive peak, the 
Gpr179nob5/nob5 response is reduced in amplitude, whereas those from WT and 
Gpr179nob5/+ heterozygotes are comparable. The Gpr179nob5/nob5 ERG phenotype is 
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essentially indistinguishable from those of mouse mutants for other proteins involved 
DBC signal transduction, GRM6,10,19,20 TRPM1,11–13 and NYX,16,18 protein required for 






























Figure 3: ERG Phenotype of Gpr179nob5/nob5 Mice ERGs were recorded from mice 
anesthetized with ketamine (80 mg/kg) and xylazine (16 mg/kg) after overnight 
dark adaptation via a published procedure.16 (A) Dark-adapted ERG series 
obtained from representative WT (left), Gpr179nob5/+ (middle), and Gpr179nob5/nob5 
(right) littermates at 6 months of age. The scale bars indicates 100 ms and 500 mV. 
Values to the left of each row of waveforms indicate flash luminance in log cd 
s/m2. (B) Luminance- response functions for the major components of the dark-
adapted ERG. The b-wave component is absent in Gpr179nob5/nob5 mice and 
therefore these data are not plotted. (C) Cone-mediated ERG series obtained from 
WT (left), Gpr179nob5/+ (middle), and Gpr179nob5/nob5 (right) littermates at 6 months of 
age. Scale bar indicates 100 ms and 100 mV. (D) Luminance- response functions 
for the cone ERG b-wave. Values to the left of each row of waveforms indicate 
flash luminance in log cd s/m2. 
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GPR179 encodes a predicted orphan G protein-linked receptor that has not been 
previously characterized in any cell or tissue. The nob5 phenotype predicts that the 
GPR179 gene product is required for DBC function and therefore should be present in 
DBCs. Because DBCs receive input from photoreceptors via ribbon synapses in the 
outer plexiform layer (OPL), we initially characterized gross retinal morphology and OPL 
ultrastructure of the Gpr179nob5/nob5 retina. However, all cellular and synaptic layers 
appeared normal in the Gpr179nob5/nob5 retina (Figure 3A). Furthermore, Gpr179nob5/nob5 
ribbon synapses are indistinguishable from WT (Figure 3B). A normal retinal morphology 
is typical of all other mouse models of cCSNB.10,12,13,18,30 
To examine the cellular localization of GPR179 in the mouse retina, we 
developed a polyclonal sheep antibody to a peptide (KVQEETPGEDLDRPVLQKR) 
located within the amino terminal extracellular domain. Retinal cryosections from 
Gpr179nob5/+ and Gpr179nob5/nob5 littermates were reacted with our antibody to GPR179 
and an antibody against PKCα to label rod DBCs. In Gpr179nob5/+ retina, PKCα labeled 
the entire rod DBC (Figures 3C and 3E), whereas the GPR179 antibody produced a 
punctuate-labeling pattern (Figures 3D and 3E), which corresponds to the location of the 
OPL. In the Gpr179nob5/nob5 retina, labeling for PKCα (Figures 3F and 3H) is comparable 
to Gpr179nob5/nob5 and labeling for GPR179 is absent (Figures 3G and 3H), consistent 
with decreased Gpr179 mRNA expression in Gpr179nob5/nob5 retinas (Figure 1C). The 
punctuate-labeling pattern of GPR179 in the OPL is typical of proteins that are localized 
to the dendritic tips of DBCs, including GRM6, TRPM1 and NYX.12,16 To confirm this 
localization, we double-labeled retinal sections with antibodies to GPR179 (Figure 3I) 
and GRM6 (Figure 3J) The punctate labeling for GPR179 colocalizes with GRM6 (Figure 
3L), the glutamate receptor known to mediate signaling in DBCs. These data show that 
GPR179 is expressed on the dendritic terminals of DBCs. GPR179 is not expressed 
elsewhere in the retina (data not shown). The combined ERG, genetic and 
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immunohistochemical data argue strongly that the Gpr179nob5/nob5 mouse phenotype is 











































Figure 4: Anatomical Phenotype of Gpr179nob5/nob5 Retina (A) Retinal cross-
sections obtained from Gpr179nob5/+ and Gpr179nob5/nob5 mouse retinas fixed 
with 2.5% glutaraldehyde/2% paraformaldehyde and prepared according to 
published procedures.35 (B) Electron micrographs of ribbon structures in 
Gpr179nob5/+ and Gpr179nob5/nob5 mouse retinas prepared according to 
published procedures. (C–K) Confocal immunohistochemistry of retinas 
fixed with 4% paraformaldehyde for 15 min and prepared according to 
published procedures.16 The scale bar indicates 5 µm. (C–E) Gpr179nob5/+ 
retina labeled with antibodies against (C) PKCα, (D) GPR179, and (E) merge 
of (C) and (D). (F–H) Gpr179nob5/nob5 retina labeled with antibodies against (F) 
PKCα, (G) GPR179, and (H) merge of (F) and (G). (I–K) Gpr179nob5/+ retina 
labeled with antibodies for (I) GPR179, (J) GRM6, and (K) merge of I–J. The 
following antibodies were used: GPR179; affinity purified polyclonal sheep 
anti-GPR179 peptide (KVQEETPGEDLDRPVLQKR), 1:1,000; mouse 
monoclonal anti-ctbp2/Ribeye, 1:1,000 (BD Biosciences); guinea pig anti-
GRM6, 1:1000 (see Koike et al.12); rabbit anti PKCa (1:1,000, Sigma). The 
following secondary antibodies were used: Alexa-488 donkey anti-sheep, 




To directly determine whether reduced GPR179 expression could recapitulate 
the reduced b-wave phenotype, we used morpholino knockdown in zebrafish, which 
have a single copy of gpr179 in their genome. We injected 1 cell stage zebrafish 
embryos with morpholinos (MOs) targeted against the Gpr179 translation start site (MO-
Gpr179 50-GCCCATACTTTTAGCAACTGCTTCT-30), and recorded ERGs at 4-6 days 
post fertilization. As comparisons, MOs against either the nyx translation start site (MO-
Nyx 50-GATGAAACACATCACTGGCTTC-30)31 or control (C-MO 50-
CCTCTTACCTCAGTTACAATTTATA-30) were injected. Embryos injected with MO 
Gpr179 had a significantly reduced ERG b-wave amplitude, similar to embryos injected 
with MO-Nyx (positive control) (Figures 4A and 4B). The b-wave was unaffected 
following injection of the control MO (Figure 4B). The b-wave/a-wave ratio decreased 
from 3.79 ± 0.46 (n = 4) in control to 0.75 ± 0.11 (n = 7) in Gpr179-MO (p = 0.005). 















Figure 4:  GPR179 Knockdown in Zebrafish Decreases ERG b-Wave Injected MOs 
(Gene Tools) were designed against the gpr179 translation site (MO 50-
GCCCATACTTTTAGCAACTGCTTCT-30), which occurs as a single copy in the 
zebrafish genome, or the nyx translation site (MO 50-
GATGAAACACATCACTGGCTTC-30) or were a standard control (MO 50-
CCTCTTACCTCAGTTACAATTTATA-30). In each case, 30 ng of MO was injected 
into the chorions of onecell- stage zebrafish embryos. ERGs were recorded from 
larvae at 4–6 days post fertilization with a 1 s stimulus after 30 min of dark 
adaption, as previously described.36 (A) ERGs from embryos injected with control 
(left column) or MOgpr179 (right column) MOs and tested at four flash intensities. 
Flash intensity at 0 log is 9.3 W/m2. Neutral density (ND) filters reduced the 
intensity by the indicated amount in log units. The b-wave amplitudes obtained 
from MO-gpr179 injected embryos were strongly reduced at all intensities. The b-
wave/a-wave ratio decreased from 3.79 ± 0.46 (n = 4) in control to 0.75 ± 0.11 (n = 
7) in MO-gpr179 (p = 0.005), showing that a specific knockdown of gpr179 reduces 
DBC function. (B) The magnitude of b-wave reduction for MO-gpr179 and MO-nyx 
were comparable. Injections of MO-control did not affect the ERG (data not 
shown). 
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Mutations in NYX, GRM6 or TRPM1 have been identified in patients with 
cCSNB.1–8 However, a small number of individuals with cCSNB did not bear mutations in 
any of these genes.8 To evaluate the potential involvement of GPR179 in cCSNB 
patients lacking DBC function, we sequenced the 11 exons and flanking splice sites of 
the human gene in 44 patients (see Table 1 for primers). All human studies were 
undertaken with the approval of the appropriate institutional review board. We identified 
two probands with inactivating mutations in the GPR179 gene. Proband 1 had no family 
history of night blindness or consanguinity and was 10 years old at the time of diagnosis. 
He presented with 20/70 best corrected visual acuities, mild myopic refractive error, 
congenital nystagmus, a history of early onset nightblindness, a normal retinal 
appearance and full Goldmann visual fields. ERGs obtained under ISCEV standard 
conditions from proband 1 are shown in Figure 5A. Under darkadapted conditions (upper 
traces), the ERG b-wave recorded to a low luminance stimulus was markedly reduced in 
amplitude, whereas the ERG obtained to a high flash luminance had a robust a-wave 
without the subsequent b-wave seen in controls (middle traces). Under light-adapted 
conditions (lower pair of traces), the ERG waveform showed a square a-wave but 
retained a late positive ERG component. ERGs of proband 2 showed a similar selective 
absence of the dark-adapted b-wave and a square light-adapted ERG a-wave (data not 
shown). These ERG abnormalities have been uniquely associated with human cases of 
DBC dysfunction32–34 and readily cCSNB from other retinal disorders with a reduced b-
wave, such as incomplete CSNB (MIM 300071 and 610427).33 
Proband 1 was a compound heterozygote for two frameshift mutations in 
GPR179, c.187delC and c.984delC (NM_001004334.2) resulting in predicted protein 
truncations p.Leu63Serfs*12 and p.Ser329Leufs*4, respectively (Figure 5B). The 
premature chain termination is expected to result in functional null alleles. The probands’ 
unaffected parents were each heterozygous for one of the mutations (Figure 5B). 
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Proband 2 was 20 years old at the time of diagnosis. She is of Norwegian 
descent and presented with rotatory nystagmus, a very unusual blond fundus, and 
congenital nightblindness and was able to see 20/30 with a -12.00 D prescription. 
Although not known to be related, proband 2 also carried the c.984delC frameshift 
mutation identified in proband 1, suggesting that this might be a founder mutation. 
Proband 2 carried a second mutation, c.659A>G, that would result in missense mutation, 
p.Tyr220Cys. (Figure 5C). The three variants in probands 1 and 2 were not present in 
210 healthy control chromosomes. Two out of three Alamut analyses, which predict 
mutation impact on function, classified the p.Tyr220Cys as potentially pathogenic. 
Moreover, by introducing a new cysteine into the GRP179 protein, the mutation is likely 
to impact its structure. The functional importance of Tyr220 is supported by its 
conservation across species ranging from human to Tetraodon (Figure 5D). DNA of 















Figure 5: GPR179 Mutations Are Present in Two Probands with Autosomal-
Recessive cCSNB (A) ERGs obtained from a control subject and proband 1 for a 
standard series of stimulus conditions that allow rod- and cone-mediated 
responses to be evaluated. For proband 1 (patient 06-130), the two records 
indicate ERGs obtained from the two eyes. Under dark-adapted conditions, ERGs 
obtained from the proband had markedly reduced b-waves. Under light-adapted 
conditions (30 cd/m2), the cone ERG had a squared a-wave (arrow). Values 
indicate flash luminance in log cd s/m2. (B and C) GPR179 (accession number 
NM_001004334.2) exons were sequenced from DNA samples isolated from 44 
patients with cCSNB. Chromatograms containing the mutant sequences found in 
probands 1 (B) and 2 (C). In addition to the chromatogram, each subsection 
shows the mutation, the predicted impact on the amino acid sequence, and the 
segregation pattern. The pedigree for proband 1 shows that he inherited one 
mutant GPR179 allele from each parent (c.187delC and c.984delC), who had 
normal vision (data not shown). The parents of proband 2 were not available for 
analyses. (D) Comparison of the region of GPR179 containing the amino acid 
substitution (p.Tyr220Cys) identified in proband 2 across phyla. With the 
exception of Drosophila melanogaster, Tyr220 is conserved for every species for 
which data were available. In general, this region of the protein is highly 
conserved (the shade of blue indicates the amount of conservation; dark blue 
indicates the most conserved). The study followed the tenets of the Declaration of 
Helsinki and was approved by the ethics committee of the Academic Medical 
Centre, Amsterdam. All participants provided signed informed consent for 
participation in the study. 
!! 184!
The combined data indicate that GPR179 is required for DBC signal transduction 
and that mutations that disrupt the function of GPR179 cause a recessive form of 
cCSNB. Although Gpr179nob5/nob5 mice lack expression of GPR179, we have not 
detected any anatomical defect in the retina, and the mice have no apparent health 
problem. Similarly, the two human patients we have identified with cCSNB and 
mutations in GPR179 have no other known health problems. Given the ERG phenotype 
in mice, zebrafish, and humans, as well as the colocalization of GPR179 with GRM6, we 
postulate that GPR179 plays a critical role in DBC signal transduction, possibly by 
forming heterodimers with GRM6. Future studies will be required to define the specific 
role of GPR179 in this process. The availability of the Gpr179nob5/nob5 mouse model will 
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APPENDIX II: GPR158/179 regulate G protein signaling by controlling localization 
and activity of the RGS7 complexes. 
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The extent and temporal characteristics of the GPCR signaling is shaped by the 
Regulator of G protein Signaling (RGS) proteins that promote G protein deactivation. 
With hundreds of the GPCRs and dozens of RGS proteins, compartmentalization plays 
key role in establishing signaling specificity. However, the molecular details and 
mechanisms of this process are poorly understood. Here we report that the R7 group of 
RGS regulators is controlled by the interaction with previously uncharacterized orphan 
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GPCRs: GPR158 and GPR179. We show that GPR158/179 recruit RGS complexes to 
the plasma membrane and augment their ability to regulate GPCR signaling. The loss of 
GPR179 in a mouse model of night blindness prevents targeting of RGS to the 
postsynaptic compartment of bipolar neurons in the retina, illuminating the role of 
GPR179 in night vision. We propose that the interaction of RGS proteins with orphan 
GPCRs serves as a mechanism that aids establishing signaling selectivity in G protein 
pathways.     
Introduction 
Signal transduction via heterotrimeric G proteins is fundamental for mediating a 
wide range of the cellular responses to changes in the extracellular environment 
(Offermanns, 2003). In these pathways, the signaling is initiated upon binding of ligand 
to a G protein coupled receptor (GPCR) that catalyzes the GDP/GTP exchange on the G 
protein, which leads to their dissociation into active Ga-GTP and Gbg subunits. Control 
of the kinetics and extent of the signaling in the G protein pathways is realized through 
the action of the RGS proteins that inactivate the signaling by promoting the GTP 
hydrolysis on G protein a subunits (Hollinger and Hepler, 2002; Ross and Wilkie, 2000). 
In mammalian nervous systems, the R7 family of RGS proteins (RGS6, RGS7, RGS9 
and RGS11) play key roles in synaptic transmission, light perception and sensitivity to 
addictive drugs by regulating several GPCR pathways (Anderson et al., 2009; Slepak, 
2009). The function of the R7 RGS proteins depends on the formation of the 
macromolecular complexes with other proteins that dictate their catalytic activity and 
compartmentalization and allows achieving signaling specificity. Two homologous 
membrane-anchoring subunits have been previously shown to form complexes with R7 
RGS proteins: RGS9 anchor protein (R9AP) and R7 Binding Protein (R7BP) (Jayaraman 
et al., 2009). Knockout of R9AP or R7BP in mice has been shown to dramatically affect 
the localization and expression of RGS9 and RGS11 (Anderson et al., 2007a; Cao et al., 
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2009; Keresztes et al., 2004). However, the protein levels of RGS6 and RGS7 were not 
affected upon the elimination of R7BP and only minor changes in the membrane 
recruitment of these proteins was observed in neurons lacking R7BP (Anderson et al., 
2007a; Cao et al., 2008; Panicker et al., 2010). These observations suggest the 
presence of other, yet unidentified membrane anchor(s) for R7 RGS proteins. However, 
homology searches of genomic sequences revealed no proteins with sufficient similarity 
to R7BP/R9AP.   
In this report we used an unbiased proteomic approach to identify additional 
membrane anchors for RGS7 in the nervous system. We demonstrate that the 
previously uncharacterized orphan GPCRs, GPR158 and GPR179, control localization 
and activity of RGS7/Gb5 complexes both in reconstituted cells and in vivo. These 
findings for the first time describe the role of orphan GPCRs GPR158 and GPR179 in 
the regulation of G protein signaling.  
Results and Discussion 
Identification of GPR158 as a binding partner of RGS7 in the brain 
We conducted an unbiased screen aimed at identifying novel binding partners of 
RGS7. RGS7 was immunoprecipitated from the total brain lysates followed by the mass-
spectrometric sequencing of pulled down proteins. Gb5 knockout mice, which show 
dramatically reduced expression of RGS7 (Chen et al., 2003), were used as a negative 
control to exclude non-specific interactions. We found only 2 proteins with confidence 
similar to RGS7 (Fig. 1A). The first protein was Gb5, a well-known binding partner of 
RGS7, validating our identification strategy. The second protein was identified as an 
orphan G protein coupled receptor 158, or GPR158 (Fig. 1B; Supplemental Table 1). 
Tandem mass-spectrometry analysis of the identified peptides revealed high confidence 
of sequence assignment (Supplemental Fig. S1).  
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Based on amino acid sequence similarity, GPR158 belongs to the class C GPCR 
family (Bjarnadottir et al., 2005). Our bioinformatics analysis indicates that the GPR158 
(accession NP_065803.2) is conserved across multiple species and contains several 
conserved residues in the intracellular face of the TM3 and TM6 (Fig. 1 B). However, 
GPR158 lacks the extracellular venus-flytrap module that plays an essential role in 
ligand binding and receptor activation in all known class C receptors (Bjarnadottir et al., 
2005; Jingami et al., 2003). Instead, GPR158 features two other conserved elements 
that are not found in typical class C receptors: a calcium binding EGF-like domain (aa 
314-359) and leucine repeat region (aa 108-136). The expression of GPR158 is 
detected in many tissues, but the protein is particularly prominent in the nervous system 
(Fig. 1C).  
GPR158 specifically interacts with RGS7/Gb5 complex and competes with R7BP 
To validate the interaction of RGS7 with GPR158 we first verified their co-
immunoprecipitation from the brain lysates by Western blotting. As illustrated in Fig. 1D 
precipitation of RGS7 pulls down GPR158 from wild type but not from Gb5 knockout 
tissues confirming the specificity of the interaction. Conversely, antibodies against 
GPR158 but not non-immune IgG effectively co-precipitate RGS7 from the brain (Fig. 
1D). We next examined interaction between GPR158 and RGS7 in transfected HEK293. 
Immunoprecipitation of GPR158 by the engineered affinity myc-tag resulted in efficient 
pull-down of RGS7 together with Gb5 when the proteins were co-expressed (Fig. 1E). 
Similarly, reciprocal immunoprecipitation of HA-tagged-RGS7 led to co-precipitation of 
GPR158 when both proteins were present in the cells (Fig. 1E).  
Since RGS7 shares high degree of similarity with other R7 RGS proteins we 
tested if GPR158 interacts with RGS6/Gb5, RGS9-2/Gb5 and RGS11/Gb5 complexes. 
We found that GPR158 could only co-precipitate with RGS6 but not with RGS9-2 or 
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RGS11 (Fig. 1F). Although interaction with RGS6 was specific, it was apparently less 
efficient relative to RGS7 binding.  
RGS7/Gb5 dimer has been previously shown to bind membrane anchor R7BP 
(Drenan et al., 2005; Martemyanov et al., 2005). Therefore, we next explored whether 
RGS7/Gb5 can simultaneously bind to both GPR158 and R7BP. Co-immunoprecipitation 
studies following the reconstitution in HEK293 cells show that the interaction of RGS7 
with GPR158 and R7BP is mutually exclusive (Fig. 1G). R7BP pulls down only RGS7 
but not GPR158. Conversely, GPR158 pulls down RGS7 but not R7BP. This mutually 
exclusive nature of R7BP and GPR158 binding to RGS7/Gb5 was further confirmed in 
the competition experiments (Fig. 1H). The interaction of RGS7 with GPR158 was 
progressively reduced upon increase in R7BP expression. Similarly, the binding of 
RGS7 to R7BP decreased when more GPR158 was supplied to the cells.   
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Figure 1. GPR158 is a novel binding partner of RGS7. A, Summary of the mass-
spectrometric analysis of proteins present in the eluates from the preparative 
immunoprecipitation reaction (IP) using RGS7 antibodies. Positive identification 
criteria were set to 95% confidence. Yellow field shows hits above this threshold 
while red- below. In addition, only proteins with the number of identified unique 
peptides similar to the target protein (RGS7) were considered (green field). B, 
Bioinformatic analysis of GPR158 organization. Predicted transmembrane 
domains and conserved features are depicted as cylinders. Cytoplasmic surface 
of GPR158 features conservation of key residues important for the G protein 
activation in class C GPCRs, including Lys 502 and Arg 505 at the cytoplasmic 
end of the TM3 and Glu 609 in the third intracellular loop. C, Regional specificity of 
GPR158 expression as evidenced by Western blotting analysis of tissue lysates. 
D, RGS7 and GPR158 co-immunoprecipitate from native brain lysates. Whole brain 
tissue was extracted and used for the immunoprecipitation experiments using 
either RGS7 or GPR158 specific antibodies.  E, RGS7 and GPR158 form complex 
upon co-expression in HEK293 cells. Cells were transfected with the indicated 
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constructs and proteins were immunoprecipitated using antibodies directed 
against affinity tags. F, GPR158 binds to RGS6 but not to RGS9 or RGS11. GPR158 
was co-transfected into HEK293 cells with indicated RGS constructs, and co-
precipitating RGS proteins were revealed by Western blotting. G, GPR158 does 
not co-immunoprecipitate with R7BP in the presence of RGS7/Gb5 complex in 
transfected HEK293 cells. H, GPR158 and R7BP compete for binding to RGS7. 
Transfection of increasing amounts of R7BP reduced co-immunoprecipitation of 
GPR158 with RGS7 and conversely, increasing concentrations of GPR158 reduced 






















GPR158 targets RGS7/Gb5 complex to the plasma membrane via the interaction 
with the DEP domain 
Since GPR158 is a membrane protein we next asked whether it can change the 
localization of RGS7 complex in the cells. We found that when expressed in HEK293 
cells, GPR158 is efficiently targeted to the plasma membrane (Fig. 2A). In contrast, as 
previously noted (Drenan et al., 2006; Zhang et al., 2001), localization of RGS7/Gb5 was 
mostly cytoplasmic. However, co-expression of RGS7/Gb5 with GPR158 resulted in its 
efficient translocation to the plasma membrane (Fig. 2A). We further confirmed 
recruitment of RGS7/Gb5 to the plasma membrane biochemically (Fig. 2B). Consistent 
with the immunocytochemistry data, most of RGS7 was found in the cytosolic fraction 
upon sedimentation analysis but moved to the membrane pellet when co-expressed with 
GPR158 (Fig. 2B). These results suggest that GPR158 serves as a membrane anchor 
for RGS7/Gb5 complex.   
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Figure 2. GPR158 recruits RGS7 to the plasma membrane in a DEP domain 
dependent manner. A, Analysis of GPR158 and RGS7 localization in transfected 
HEK293 cells by immunocytochemistry followed by confocal microscopy. 
RGS7/Gb5 and GPR158 were expressed alone or together and their localization 
was examined. B, RGS7 fractionates with the plasma membrane fraction in the 
presence of GPR158. Following transfection cells were disrupted and fractionated 
by sedimentation into membrane and cytosol portions. Band densities were 
quantified from 3 independently conducted experiments. **, p<0.01, t-test. C, full-
length RGS7, but not RGS7 mutant with the deleted DEP domain (DEPless RGS7) 
binds to GPR158. HEK293 cells were co-transfected with the indicated constructs 
and interaction of proteins was studied by the immunoprecipitation. D, DEPless 
RGS7 does not co-segregate with GPR158 in the membrane fraction upon 
sedimentation analysis. E, DEPless RGS7 fails is not recruited to the plasma 
membrane of the transfected HEK293 cells that express GPR158. Cells were co-




Competition between GPR158 and R7BP for binding to RGS7 suggests that their 
interactions are mediated by the same or overlapping determinants. Since binding to 
R7BP requires the presence of the DEP domain of RGS7 (Anderson et al., 2009) we 
hypothesized that this domain also mediates the interaction of RGS7 with GPR158. 
Indeed, a truncated mutant of RGS7 lacking the DEP domain (DEPless), while 
preserving the interaction with Gβ5 did not co-immunoprecipitate with GPR158 upon co-
transfection in HEK293 cells (Fig. 2C). Consequently, DEPless-RGS7 failed to be 
recruited to the plasma membrane by GPR158 as evidenced by either biochemical 
fractionation (Fig. 2D) or immunocytochemistry (Fig. 2E).  
GPR158 augments GAP activity of RGS7 towards Gao  
The identification of the novel interaction of RGS7/Gb5 complex with GPR158 
raises the question about its physiological significance. Members of the R7 RGS family 
are efficient GAPs for the Go class of the proteins, downstream from multiple GPCRs 
including m-opioid receptor (Anderson et al., 2009). We therefore used a cell based 
BRET assay to monitor the effects of RGS7/Gb5 on Gao activated by the m-opioid 
receptor (Fig. 3A; (Hollins et al., 2009). We primarily focused on analyzing the 
deactivation kinetics of G protein signaling that reflect the catalytic activity of RGS 
proteins. Consistent with the previous reports, we found that RGS7/Gb5 complex 
accelerated Gao deactivation kinetics (Fig. 3B). Co-transfection of GPR158 resulted in 
further acceleration of signaling termination. Notably, GPR158 did not influence the 
kinetics of µ-opioid signaling when supplied without RGS7/Gb5 complex, indicating that 
it acts via increasing the activity of RGS7 (Fig. 3C). Indeed, the catalytic activity of 
RGS7/Gb5 as measured by the kGAP parameter was increased by GPR158 by ~ 2 fold 
(from 0.081±0.016 s-1 to 0.152±0.022 s-1). We found no effect of GPR158 on either the 
activation kinetics of Gao that reflects MOR activity in the cells (Fig. 3D) or the 
expression of reporter constructs (Supplemental Figure S2). Furthermore, no 
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significant effect of GPR158 on the expression of RGS7 was detected under the 
conditions and concentrations of components used for the BRET assays (Fig. 3E). This 













Figure 3. GPR158 potentiates the ability of RGS7/Gb5 to deactivate Gao signaling. 
A, Schematic representation of the BRET-based assay to monitor G protein 
signaling cycle. Activation of the m-opioid receptor (MOR) causes the G protein 
heterotrimer to dissociate into Ga and Gbg subunits. Released Gbg subunits 
tagged with Venus fluorescent protein interact with luciferase (Rluc) –tagged 
reporter GRK to produce BRET signal. Upon termination of MOR activation by 
antagonist naloxone, Gao subunit hydrolyses GTP and re-associates with Gbg 
subunits quenching the BRET signal. B, Time-course of the normalized BRET 
responses recorded in a representative experiment. Individual data points show 
BRET values averaged from 6 replicates. Application of MOR agonist (morphine) 
and antagonist (naloxone) is indicated by the upper bars. Deactivation phase of 
the response was fitted with the single exponent (solid line). C, Quantification of 
the deactivation time constant following the addition of naltrexone. Exponential 
fits of the data shown in panel B were used to derive time constant t. Asterisks 
indicate statistical significance of the differences (**, p<0.01 and ***, p<0.001; 
Mann-Whitney Rank Sum Test; n=18) as compared to control experiment with no 
regulators added (black bar).  D, Quantification of the activation time constant 
derived from the exponential fitting of the onset kinetics (fits not shown). Note no 
significant differences between experimental conditions. E, Analysis of the 
GPR158 effect on expression level of RGS7. The HEK293 cells were transfected 
with all constructs used for the BRET experiments using the same ratios and 
conditions. Proteins of interest were detected by Western blotting using specific 
antibodies.   
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GPR158-like protein, GPR179 targets RGS/Gb5 complexes to the dendritic tips of 
ON-bipolar cells 
Regulation of RGS7/Gb5 complex localization and activity by GPR158 prompted 
us to ask whether the interaction with the GPCR-like proteins is a general mechanism for 
controlling RGS7 function in neurons and whether proteins similar to GPR158 might also 
be engaged in this process. Our analysis shows that GPR158 shares substantial 
sequence similarity with another orphan receptor GPR179 (Fig 4A). We found that 
GPR179 (accession NP_001004334.2), just like GPR158, also forms specific complexes 
with RGS7 (Fig. 4B). However, unlike GPR158, it could interact with all members of the 
R7 RGS subfamily (Fig. 4C). Interestingly, GPR179 exhibited much more restricted 
expression and was detected only in the retina (Fig. 4D). Two recent studies showed 
that mutations in GPR179 gene cause congenital stationary night blindness (CSNB) in 
humans indicating GPR179 is required for normal synaptic transmission between 
photoreceptors and ON-bipolar cells in the retina (Audo et al., 2012; Peachey et al., 
2012). Furthermore, a mouse mutant nob5 lacks an ERG b-wave and is a model for this 
form of cCSNB (Peachey et al., 2012). Earlier studies showed that RGS7/Gb5 and 
RGS11/Gb5 complexes co-localize with the essential components of the signaling 
cascade at the dendritic tips of the ON-bipolar cells and play an important role in normal 
transmission at this synapse (Chen et al., 2010; Mojumder et al., 2009; Zhang et al., 
2010). We therefore asked whether GPR179 could influence localization and function of 
RGS proteins in these neurons. Indeed, our examination revealed that RGS7 and 
RGS11 co-localizes with GPR179 at the dendritic tips of the ON-bipolar cells (Fig. 4E). 
Remarkably, loss of GPR179 in the nob5 mice resulted in loss of the punctate staining 
for both RGS7 and RGS11 (Fig. 4 G,H), although their protein levels were unchanged 
(Fig. 4F). These data suggest that GPR179 is essential for the postsynaptic targeting of 
the RGS/Gb5 complexes in retinal ON-bipolar neurons.  
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Figure 4. GPR179 is a paralogue of GPR158 required for subcellular targeting of 
RGS7/Gb5 complex in vivo. A, GPR158 shares considerable sequence homology 
and conservation among species with GPR179 as revealed by phylogenic 
analysis. B, GPR179 forms complexes with RGS7 in transfected cells. Forward 
and reverse immunoprecipitation experiments were carried using indicated 
antibodies following co-transfection of GPR158 with RGS7 in HEK293 cells. C, 
Interaction of GPR179 with members of the R7 RGS subfamily. RGS/Gb5 
complexes were co-expressed with GPR179 in HEK293 cells and the interactions 
between proteins were studied by the co-immunoprecipitation assays. D, 
Expression profile of GPR179 across nervous tissues as determined by the 
Western blotting of total tissue lysates. Ponceau S staining for total protein 
indicates equal sample loading. E, GPR179 co-localizes with RGS7 and RGS11 at 
the dendritic tips of the ON-bipolar cells in the outer plexiform layer of the retina. 
Retina cross-sections were immunolabeled for GPR179 (green) and RGS7 (red). 
Note characteristic punctate pattern of staining that indicates synaptic localization 
of both proteins. F, Loss of GPR179 in nob5 retinas does not affect the expression 
of RGS7 and RGS11. Western blot analysis of RGS7 and RGS11 expression in 
total retina lysates from wild type mice (WT) or mice lacking GPR179 (nob5). G 
and H, Elimination of GPR179 prevents targeting of RGS7 and RGS11 but not 
TRPM1 to the dendritic tips. Retina cross-sections were double immunostained 
for RGS7 (red) and GPR179 in panel G or RGS7/RGS11 (red) and TRPM1 (green) in 
panel H.  Cell nuclei are labeled with DAPI (blue). 
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GPR158/179 and G protein signaling 
The results of our study reveal the existence of a new family of membrane 
anchors and activity modulators for the R7 RGS proteins that belong to the group of 
orphan GPCRs and contain two members GPR158 and GPR179. Two other membrane 
anchors for the R7 RGS family have been described previously (Jayaraman et al., 
2009). R9AP was found to form complexes with RGS9 and RGS11 but not with RGS6 or 
RGS7 and was demonstrated to play key role in controlling posttranslational stability, 
subcellular targeting and activity of its RGS partners (Anderson et al., 2009; Jayaraman 
et al., 2009). Subsequently, R9AP homologue, R7BP, was identified as universal partner 
for all members of the R7 RGS subfamily (Drenan et al., 2005; Martemyanov et al., 
2005). Similarly to R9AP, R7BP was demonstrated to play role in stabilization, 
localization and activity regulation for some, but not all R7 RGS proteins in some, but not 
all neurons (Anderson et al., 2009; Jayaraman et al., 2009). For example, R7BP was 
shown to be important for achieving the high expression level of RGS9-2 in the striatum, 
but did not affect the expression of RGS7 in the same region (Anderson et al., 2007a). 
Likewise, while R7BP is important for the recruitment of RGS7/Gb5 complex to the 
nucleus (Panicker et al., 2010), it was not required for the delivery of the same complex 
to the dendritic tips of the ON-bipolar neurons in the retina (Cao et al., 2008) and only 
mildly affected RGS7/Gb5 recruitment to the plasma membrane in the brain (Panicker et 
al., 2010). These observations suggested the existence of additional targeting 
mechanisms for the R7 RGS complexes, particularly for the RGS7/Gb5. The 
identification of GPR158 and GPR179 as RGS membrane anchors, suggests a new 
mechanism for achieving subcellular targeting of this important class of GPCR regulatory 
proteins.  
Our findings provide a new example for the interaction between R7 RGS proteins 
with the GPCRs. Previous studies found that RGS9 can form complexes with m-opioid 
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(Garzon et al., 2005) and D2 dopamine receptors (Kovoor et al., 2005). Furthermore, 
RGS7/Gb5 complexes have been shown to bind to the third intracellular loop of M3 
muscarinic receptor, via a direct protein-protein interaction involving the DEP domain of 
the molecule (Sandiford et al., 2010). As in case of the GPR158, this binding was 
mutually exclusive with R7BP recruitment, and R7BP prevented the interaction. 
Similarly, the DEP domain of the primordial yeast RGS protein Sst2 mediates its 
recruitment to the pheromone sensing GPCR Ste2 (Ballon et al., 2006). These 
observations indicate that in addition to specialized membrane anchoring subunits, the 
DEP domains of R7RGS proteins are recruited to elements found in some GPCRs. Yet, 
no common motifs are detected across any DEP domain interacting proteins reinforcing 
an idea that these modules potentially recognize a diverse set of targets.  
The interaction with GPR158 results in translocation of RGS7/Gb5 complexes to 
the plasma membrane compartments and augmentation of their catalytic activity. In the 
case retinal ON-bipolar cells, GPR179 is required for the localization of both RGS7 and 
RGS11. Since these RGS proteins in complex with the Gb5 are essential for the 
synaptic transmission at the ON-bipolar synapse (Chen et al., 2003), their mistargeting 
in mice with GPR179 deletion or human patients with mutations in GPR179 gene (Audo 
et al., 2012; Peachey et al., 2012) may account for their no b-wave phenotype and night 
blindness, respectively.  What remains unexplored however is whether GPR158 and 
GPR179 only serve as RGS anchor proteins, or whether they can act as bona fide 
GPCRs. Both are distant members of the class C GPCRs (Bjarnadottir et al., 2005) and 
our bioinformatics analysis shows that the amino acids that are critical for the ability of 
the class C receptors to activate G proteins (Binet et al., 2007) also are conserved in 
GPR158 and GPR179. This suggests a possibility that these orphan receptors can, in 
principle, activate G proteins. However, the lack of typical class C ligand binding domain 
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in GPR158/GPR179 suggests that if they can in fact activate G proteins the mechanism 
must be substantially different.  
 
Materials and Methods 
Mice, antibodies and genetic constructs 
Generation of sheep anti-RGS6, sheep anti-RGS9-2 and sheep antiRGS11 
antibodies was described (Cao et al., 2008; Martemyanov et al., 2005). Rabbit anti-Gβ5, 
rabbit anti-RGS7 (7RC1) and rabbit anti-R7BP (TRS) were generous gifts from Dr. 
William Simonds (National Institute of Diabetes and Digestive and Kidney Disease, 
National Institutes of Health, Bethesda, MD). Mouse anti-HA (Millipore), rabbit anti-myc 
(Genscript), rabbit anti-GPR179 (Sigma) and rabbit anti-GPR158 (Sigma) were 
purchased. The GPR179nob5/nob5 mice are described elsewhere (Peachey et al., 2012).  
Cloning of full-length RGS7, DEPless-RGS7, RGS6, RGS9-2, RGS11, Gβ5, 
R7BP and N-terminal HA-tagged RGS7 in pcDNA3.1/V5-His-TOPO was described 
(Anderson et al., 2007b; Martemyanov et al., 2003; Martemyanov et al., 2005; Panicker 
et al., 2010; Porter et al., 2010). Human myc-tagged-GPR158 and myc-tagged-GPR179 
were purchased from OriGene. BRET sensor constructs Venus155-239-Gb1, Venus1-
155-Gg2 and masGRKct-Rluc8 were kindly provided by Dr. Nevin A. Lambert (Medical 
College of Georgia). 
Cell culture, Transfection, Immunoprecipitation and Western blotting 
HEK293T cells were cultured at 37°C and 5% CO2 in DMEM supplemented with 
10% FBS, MEM non-essential amino acids, 1 mM sodium pyruvate, and antibiotics (100 
units/ml penicillin and 100 µg/ml streptomycin. Cells were transfected using 
Lipofectamine LTX (Invitrogen), harvested 24 h later, lysed in ice-cold IP buffer (300 mM 
NaCl, 50 mM Tris-HCl pH 7.4, 1% Triton X-100 and complete protease inhibitor cocktail) 
by sonication. For immunoprecipitation, lysates were cleared by centrifugation at 14,000 
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rpm for 15 min, and the supernatants were incubated with 20 µl of Dynabeads 
(Invitrogen) and 2 µg of antibodies on a rocker at 4°C for 1 h. After three washes with IP 
buffer, proteins were eluted with 50 µl of 4X SDS sample buffer. Samples were analyzed 
by SDS-PAGE followed by Western blotting using HRP-conjugated secondary 
antibodies and an ECL West Pico (Thermo Scientific) detection system.  
Preparative immunoprecipitation and mass spectrometry 
Whole brains were removed from mice, homogenized in IP buffer (1xPBS, 0.3 
mM NaCl, 1% Triton X-100, protease inhibitor cocktail (Roche)) with a series of needles 
with increasing gauge and lysed for 30 min at +4 °C. Samples were centrifuged (30,000 
g, 20 min) to remove debris, and supernatants were incubated for 45 min with 5 mg of 
anti-RGS7 antibody covalently coupled to Protein G beads as previously described 
(Martemyanov et al., 2005). Protein complexes were eluted with 5% ammonium 
hydroxide and vacuum-dried.  
Proteins were dissolved in 0.5 M triethylammonium bicarbonate (pH 8.5) 
containing 0.1% SDS, reduced with 5 mM tris-(2-carboxyethyl) phosphine for 1 h at 60 
°C and alkylated with 10 mM methyl methanethiosulfonate for 10 min at room 
temperature. Proteins were digested with 20 µg of modified porcine trypsin (Promega) in 
the presence of 3mM CaCl2 at 37 °C for 16 h. Peptide mixtures were vacuum-dried, 
reconstituted in 0.2% formic acid (Pierce, Rockford, IL) and applied to a MCX cartridge 
(Waters, Milford, MA) pre-equilibrated with methanol/water (1:1, v/v). The cartridge was 
washed with 0.1% formic acid in 5% methanol, followed by a 100% methanol wash. 
Peptides were eluted from the MCX resin in 1 ml of 1.5% NH4OH in methanol and 
vacuum-dried. The resulting peptide mixtures were desalted, resolved by liquid 
chromatography and analyzed by LTQ-Orbitrap XL mass spectrometry as described 
(Cao et al., 2011).   
Membrane/cytosol fractionation 
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HEK293T transfected cells were lysed in lysis buffer (50 mM Tris-HCl pH 7.4, 2.5 
mM MgCl2, 1 mM EDTA, 1 mM DTT, complete protease inhibitor cocktail) by 10 
passages through a 27-gauge needle and then centrifuged at 400 x g for 5 min at 4°C to 
remove nuclei and intact cells. Supernatants were ultracentrifuged at 150,000 x g for 20 
min at 4°C. The cytosolic soluble fraction was collected from the supernatant while the 
pellet containing the membrane fraction was resuspended in an equal amount of lysis 
buffer. Samples were then sonicated and 4X SDS sample buffer added for Western blot 
analysis. 
Immunocytochemistry 
HEK293T transfected cells or retina cross-sections were fixed for 15 min with 4% 
paraformaldehyde, permeabilized for 5 min with 0.2% Triton X-100/PBS, blocked with 
10% donkey serum for 1 h, and incubated with primary antibody in 2% donkey serum for 
1 h. After three washes, sections were incubated with AlexaFluor488 or 546-conjugated 
secondary antibodies for 1 h. Cells were stained 5 min with DAPI before mounting in 
Fluoromount (Sigma). Images were taken by the LSM 780 Zeiss confocal microscope. 
Monitoring G protein cycle in live cells by fast kinetic BRET assay 
Agonist-dependent cellular measurements of bioluminescence resonance energy 
transfer (BRET) between masGRKct-Rluc8 and Gb1g2-Venus were performed to 
visualize the action of G protein signaling in living cells as previously described 
with slight modification (Hollins et al., 2009; Lambert et al., 2010). HEK293T/17 were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS), MEM non-essential amino acids, 1 mM sodium pyruvate, and 
antibiotics (100 units/mL penicillin and 100  µg/mL streptomycin) at 37°C in a humidified 
incubator containing 5% CO2. For transfection, cells were seeded into 6-cm dishes at a 
density of 4×106 cells/dish. After 4 h, expression constructs (total 5 µg/dish) were 
transfected into the cells using Lipofectamine LTX (8 µL/dish) and PLUS (5 µL/dish) 
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reagents. MOR, Gao, Venus155-239-Gb1, Venus1-155-Gg2, masGRKct-Rluc8, RGS7, 
Gb5, and GPR158 constructs were transfected using equal DNA amounts. Empty vector 
was used to balance the amount of transfected DNA. The cells were used for 
experiments at 16-24 h after transfection. BRET measurements were made using a 
micro plate reader (POLARstar Omega; BMG Labtech) equipped with two emission 
photomultiplier tubes, allowing to detect two emissions simultaneously with resolution of 
50 milliseconds for every data point. All measurements were performed at room 
temperature. The BRET signal is determined by calculating the ration of the light emitted 
by the Gb1g2-Venus (535 nm) over the light emitted by the masGRKct-Rluc8 (475 nm). 
The average baseline value recorded prior to agonist stimulation was subtracted from 
BRET signal values, and the resulting difference (R) was normalized against the 
maximal value (Rmax) recorded upon agonist stimulation. 
Statistical analyses 
We used Student’s t-test to analyze densitometry data from biochemical 
fractionation experiments. For the analysis of the non-parametric data reporting 
differences in the exponential rate constant of the G protein deactivation kinetics 
observed in BRET experiments we used Mann-Whitney rank-sum test. The confidence 
values below p<0.05 were considered to be statistically significant.  
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ABSTRACT  
The two visual parallel pathways are initiated at the first retinal synapse by 
signaling between the photoreceptors and two types of bipolar cells. For normal function, 
ON or depolarizing bipolar cells (DBCs) require the G protein-coupled receptor, mGluR6, 
its G protein-coupled cascade and the transient receptor potential melastatin 1 (TRPM1) 
cation channel. Another seven transmembrane protein, GPR179, also is required for 
DBC function and recruits the regulators of G-protein signaling (RGS) proteins, RGS7 
and RGS11, to the dendritic tips of the DBCs. Here we show that GPR179 and 
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RGS7/RGS11 play different roles in modulation of the mGluR6 mediated gating of 
TRPM1. We show that expression of several mGluR6 cascade components including, 
mGluR6, TRPM1 and nyctalopin are independent of GPR179 expression and GPR179 
interacts with TRPM1. In Gpr179nob5 mice a small dark-adapted electroretinogram b-
wave is present that can be enhanced with long flashes, indicating some rod DBC 
function. Patch clamp recordings demonstrate that Gpr179nob5 and RGS7-/-/RGS11-/- rod 
DBCs retain mGluR6-mediated gating of TRPM1 when strong stimuli are used. In 
contrast, the two mutants differ in that direct gating of TRPM1 by capsaicin in RGS7-/-
/RGS11-/- and WT rod DBCs is similar, but severely compromised in Gpr179nob5 rod 
DBCs. Noise and standing current analyses indicate that TRPM1 channels in Gpr179nob5 
rod DBCs have a lower open probability than in WT, presumably from G protein 
suppression. We propose that the GPR179 not only localizes RGS7 and RGS11 to the 
dendritic tips of DBCs, but alters the “state” of the TRPM1 channel by direct interactions. 
INTRODUCTION  
Visual processing in the mammalian retina is initiated through two parallel vertical 
pathways that are established at the synapse between photoreceptors and bipolar cells 
(BCs). In the dark, photoreceptors constantly release glutamate and in response to a 
light increment they hyperpolarize, decreasing glutamate release. Two general classes 
of BCs form synapses with cone photoreceptor terminals and are defined by their 
response to a light increment. Hyperpolarizing BCs (HBCs) signal via ionotropic 
glutamate receptors of the AMPA/Kainate type (Kaneko and Saito, 1983; Saito and 
Kaneko, 1983; Slaughter and Miller, 1983) and DBCs signal via the metabotropic 
glutamate receptor 6 (mGluR6) (Masu et al., 1995). A single class of DBC, the rod DBC 
is postsynaptic to rod photoreceptors (Boycott et al., 1969). As a result defects at this 
synapse lead to complete congenital stationary night blindness (cCSNB). This defect is 
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detected by the absence of the b-wave in the electroretinogram (ERG) in both humans 
and animal models (Miyake et al., 1986; McCall and Gregg, 2008). 
The rod light response is initiated when a decrease in glutamate occupancy of 
mGluR6 signals the opening of the TRPM1 channel (Audo et al., 2009; Li et al., 2009; 
Morgans et al., 2009; Shen et al., 2009; Koike et al., 2010b; Morgans et al., 2010; 
Peachey et al., 2012a). This cascade also includes proteins of known function: the 
heterotrimeric G proteins Gαo and Gβ3 (Dhingra et al., 2000; Dhingra et al., 2002; Koike 
et al., 2010b; Dhingra et al., 2012), and the regulators of G proteins Gβ5, RGS7 and 
RGS11 (Morgans et al., 2007; Jeffrey et al., 2010; Cao et al., 2012). Other known 
components with unresolved function include nyctalopin, GPR179 and LRIT3 (Gregg et 
al., 2003; Audo et al., 2012; Peachey et al., 2012b; Zeitz et al., 2013).  
GPR179 is a seven transmembrane receptor that interacts with RGS7 and 
RGS11 and is critical for proper localization of these proteins to the DBC dendritic tips 
(Orlandi et al., 2012). GPR179 expression is required for normal mGluR6 signaling 
(Peachey et al., 2012b) and mutations in Gpr179 in mouse and human patients cause a 
no b-wave ERG phenotype (Audo et al., 2012; Peachey et al., 2012b). To gain further 
insight into the role of GPR179 in the rod DBC light response we studied Gpr179nob5 and 
RGS7-/-/RGS11-/- mice. 
We show that expression of both mGluR6 and TRPM1 are independent of 
GPR179 expression and that GPR179 and TRPM1 proteins interact. Functional analysis 
using ERG and whole cell patch clamp recording of rod DBCs confirm that TRPM1 is 
present in both Gpr179nob5 and RGS7-/-/RGS11-/- rod DBCs, although the sensitivity of 
the cascade is significantly lower in each compared to WT. However, the two mutants 
differ in that direct gating of TRPM1 by capsaicin is similar in WT and RGS7-/-/RGS11-/- 
rod DBCs and severely compromised in Gpr179nob5 rod DBCs. Taken together, our 
results suggest that the GPR179/RGS7/RGS11 complex sets the sensitivity of the 
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mGluR6 signaling cascade and that the GPR179/TRPM1 interaction sets the sensitivity 
of gating of the TRPM1 channel to light stimuli. 
Materials and Methods 
Animals 
All procedures were performed in accordance with the Society for Neuroscience 
policies on the use of animals in research and each local Institutional Animal Care Use 
Committees. Descriptions of all mice used have been published previously (Masu et al., 
1995; Pardue et al., 1998; Pearring et al., 2011; Cao et al., 2012; Peachey et al., 2012b) 
and every line was either generated on a C57BL/6J background or backcrossed onto 
this background for at least 6 generations. All mice were housed in local AALAC 
approved facilities under a 12 h/12 h light/dark cycle. Trpm1-/- (Trpm1tm1Lex) mice can be 
obtained from the European Mouse Mutant Archive (emmanet.org) and were originally 
generated by Lexicon Genetics. 
Antibodies 
In experiments to examine the pattern of protein expression in the outer plexiform 
layer (OPL), the following primary antibodies (and their concentrations) were used: 
sheep anti-GPR179 (peptide KVQEETPGEDLDRPVLQKR), 1:2,000 (Peachey et al., 
2012b); mouse monoclonal anti-ctbp2/Ribeye (BD Bioscience), 1:1,000; guinea pig anti-
mGluR6 1:1,000 (Koike et al., 2010b); sheep anti-TRPM1 1:1,000 (Cao et al., 2011); 
rabbit anti-GFP (MBL), 1:800 and Rhodamine Peanut Aglutinin (PNA) conjugate 566 
(Vector Labs), 1:1,000. Secondary antibodies (Invitrogen, 1:1,000) appropriate to each 
primary antibody included: donkey anti-sheep Alexa-488, donkey anti-rabbit Alexa-680, 
donkey anti-rabbit Alexa-546, donkey anti-mouse Alexa-647 and donkey anti-guinea pig 
Cy3 (Millipore, 1:1,000). In lieu of an antibody specific to nyctalopin, we used Tg(Gabrr1-
YFP/nyx)Rgg1 transgenic mice that express a yellow fluorescent protein (YFP) tagged 
nyctalopin (Gregg et al., 2007). They are labeled WT in the figures.  
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Immunohistochemistry 
Mice were anesthetized, their eyes were enucleated and the lens was removed. 
Eyecups were washed in phosphate buffered saline (PBS) then fixed for 30 minutes in 
4% paraformaldehyde PBS solution (pH 7.4). Eyecups were washed 3 times in PBS 
then cryoprotected in increasing concentrations of sucrose in PBS (10%, 15% for 1 h 
each and 20% overnight). Eyecups were embedded in 2:1 OCT/ 20% sucrose PBS 
solution frozen in a liquid nitrogen cooled bath of isopentane. Eyecups were sectioned 
(18 µm) using a Leica 1850 cryostat, mounted on glass slides and stored at -70°C. 
Sections were warmed to 37°C and washed with PBS and PBS containing 0.05% Triton 
X-100 (PBX) for 5 min each, then blocked in PBX 5% normal donkey serum blocking 
solution for 1 h. Sections were incubated overnight at room temperature in the presence 
of the primary antibody diluted in blocking solution, then washed 3 times for 10 min each 
with PBX followed by incubation in secondary antibody in PBX for 1 h at room 
temperature. Sections were washed for 10 min in PBX twice and in PBS once and 
cover-slipped using Immu-Mount (Thermo Scientific). Slides were imaged using an 
Olympus FV1000 confocal microscope. Images were universally adjusted for brightness 
using Photoshop. 
Mass Spectrometry 
Retinas were isolated from WT mice and homogenized in lysis buffer (1% 
Nonidet P-40, 2 mM EDTA, 20 mM HEPES pH 7.4, supplemented with protease 
inhibitors cocktail) by rotating at 4°C for 45 min. Samples were centrifuged at 17,000 g 
for 20 min to remove the debris and supernatant was precleaned with Dynabeads 
(Invitrogen) for 1 h at 4°C. Samples were incubated with TRPM1 or GPR179 antibody 
overnight at 4°C. Lysates and antibody complexes were incubated with Dynabeads for 
1.5 h at 4°C. Protein complexes were eluted with Nupage LDS sample buffer (Invitrogen) 
and electrophoresed on Nupage gel (Invitrogen) until the highest molecular weight 
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standard (260 kDa) had moved ~5 mm into the gel. Electrophoresed gel pieces were cut 
from the top of the gel and an in-gel tryptic digestion was performed as described 
previously (Rood et al., 2010).  
The resulting peptide mixture was resolved by liquid chromatography (LC) using 
an EASY n-LC (Thermo Scientific) UHPLC system with buffer A = 2% v/v acetonitrile / 
0.1% v/v formic acid and buffer B = 80% v/v acetonitrile / 0.1% v/v formic acid as mobile 
phases. The mass spectrometry data from LC elutes was collected using an Orbitrap 
Elite – ETD mass spectrometer (Thermo Scientific). A decision tree was used to 
determine whether CID or ETD activation was used. Proteome Discoverer v1.3.0.330 
was used to analyze the data collected by the mass spectrometer. Scaffold v3.6.5 was 
used to calculate the false discovery rate using the Peptide and Protein Prophet 
algorithms. 
Cell culture, transfection and immunoblotting: 
HEK293T (Human Embryonic Kidney) cells were cultured in high glucose DMEM 
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 IU/ml penicillin and 
50 µg/ml streptomycin. One day prior to transfection, cells were seeded on 60 mm 
culture dishes. Gpr179 and Trpm1 expression plasmids were transfected into HEK293T 
cells using JetPrime reagent (Polyplus-transfection) or Lipofactamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. After 24-48 h of transfection, cells were 
harvested in NP-40 lysis buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1% Nonidet 
P40, pH 8.0, supplemented with protease inhibitors cocktail (Sigma-Aldrich) by rotating 
for 45 min at 4°C and centrifuged at 17,000 g for 15 min at 4°C. Protein content was 
quantified by Bradford reagent (BioRad). Protein lysates were analyzed on 4-12% 
Nupage gels (Invitrogen) or 6% SDS-PAGE gels, transferred to PVDF membranes and 
immunoblotted using HRP-conjugated secondary antibodies and ECL West Pico 
detection system (Thermo Scientific). 
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Co-immunoprecipitation 
Dissected mouse retinas were homogenized in lysis buffer (1% Nonidet P-40, 2 
mM EDTA, 20 mM HEPES pH 7.4, supplemented with protease inhibitors cocktail) by 
rotating at 4°C for 45 min. Homogenates were cleared by centrifugation at 17,000 g for 
20 min at 4°C. For co-immunoprecipitation, retinal lysates or transfected HEK cells 
lysates were precleared by incubating with 12 µl Dynabeads protein G (Invitrogen) at 
4oC for 1 h. Precleared lysates were incubated with 2-5 µg of anti-GPR179 or anti-Flag 
antibodies overnight at 4°C on an orbital rocker. 45 µl of Dynabeads protein G were 
added and incubated for 1-2 h at 4°C. Dynabeads were collected and washed 4 times 
with Tris-buffered saline containing 0.3% Tween-20. Protein complexes were eluted with 
40 µl of 4X LDS loading buffer by incubation at 70oC for 10 min, separated by SDS-
PAGE and analyzed by immunoblotting. 
Electroretinography 
Mice were tested in two recording protocols in which either a strobe flash or 
variable duration stimuli were used to evoke ERG responses. For both, animals were 
dark-adapted overnight and anesthetized with ketamine (80 mg/kg) and xylazine (16 
mg/kg). Eyedrops were used to dilate the pupil (1% tropicamide, 2.5% phenylephrine 
HCl) and to anesthetize the corneal surface (1% proparacaine HCl). ERGs were 
recorded using a stainless steel (strobe flash) or gold (variable duration) electrodes 
contacting the corneal surface wetted with 1% methylcellulose. Platinum needle 
electrodes in the cheek and tail serve as reference and ground, respectively. Strobe 
flash ERGs were recorded using an LKC UTAS E-3000 signal averaging system to 
stimuli that ranged in luminance from -3.6 to 1.4 log cd sec/m2. ERGs were also 
recorded using a Diagnosys Espion system with a -1.2 log cd/m2 stimulus that ranged in 
duration from 10 – 1000 msec. 
Retinal Slice Preparation and Whole Cell Patch Clamp Recording 
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Mice were anesthetized with an intraperitoneal injection of Ringer’s solution 
containing ketamine/xylazine (127/12 mg/kg, respectively) and sacrificed by cervical 
dislocation. The eyes were enucleated and the retinas removed and placed in fresh 
Ames solution (Sigma-Aldrich). The retina was adhered to nitrocellulose paper (Millipore) 
and then sliced perpendicular to the retinal layers using a tissue slicer. The slices were 
then placed in a recording chamber. Recording electrodes were pulled from borosilicate 
glass (FHC, Inc., Bowdoin, ME) on a P-97 Flaming/Brown Micropipette Puller (Sutter 
Instruments Co., Novato, CA). Electrode resistance measured between 6-9 MΩ. Glass 
electrodes were filled with intracellular solution that contained Cs-gluconate solution (20 
mM CsCl, 107 mM CsOH, 107 mM D-Gluconic Acid, 10 mM NaHEPES, 10 mM BAPTA, 
4 mM ATP, and 1 mM GTP). The intracellular solution contained 1% sulforhodamine to 
visualize the cell and classify its morphology (Ghosh et al., 2004). Rod DBC somas were 
targeted for whole cell patch clamp recording. A 2-4 GΩ seal was created on the cell 
body and cells with an input resistance ~ 1 GΩ and access resistance < 25 MΩ were 
used for recording. The recording chamber was maintained at 34-35°C. 
To block inhibitory inputs, Ames solution was supplemented with: 1µM 
strychnine, 100 µM picrotoxin and 50 µM 6-tetrahydropyridin-4-yl methylphosphinic acid 
(TPMPA). Four µM L-AP4 was added to the bath solution to saturate mGluR6 receptors. 
The mGluR6 receptor antagonist α-cyclopropyl-4-phosphonophenylglycine (CPPG) was 
dissolved in Ames medium to a working concentration of 0.6 mM or 3 mM. CPPG was 
applied by pressure application using a Picospritzer II (Parker Instrumentation, 
Cleveland, OH) onto the rod DBC dendritic tips in the outer plexiform layer (OPL). In 
separate experiments, capsaicin (10 µM), a TRPM1 agonist, was puffed onto the rod 
DBC dendrites to gate the opening of the TRPM1 channel. Reagents were purchased 
from Sigma-Aldrich, except for L-AP4, CPPG, and capsaicin, which were purchased 
from Tocris Bioscience.  
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Voltage Clamp Protocols 
Rod DBC responses were recorded via a Multiclamp 700A amplifier with a 
Digidata 1440A digitizer (MDS Analytical Technologies, Union City, CA) and filtered at 
2.4 kHz with a four-pole Bessel low pass filter, sampled at 10 kHz. Clampex 10.2 
software (MDS Analytical Technologies, Sunnyvale, CA) was used to generate 
command outputs and acquire and analyze analog whole cell current. Rod DBCs were 
voltage clamped at +50mV (Nawy, 2004; Shen et al., 2009). CPPG was puffed at rod 
DBC dendrites for either 200 msec or 1 sec. For capsaicin experiments 200 msec and 1 
sec puffs were applied. Three to five responses were recorded from each cell and then 
averaged. Variance and standing current were measured across the first 1.5 sec of the 
recording for each rod DBC. Offline analyses of data were performed using Clampfit 
10.2. Prism 5.04 software (Graphpad Software, Inc., La Jolla, CA) was used to perform 
two-way repeated measures ANOVAs, two-way ANOVAs, one-way ANOVAs, or t-tests 
as suited for the necessary comparison. Statistical significance = P < 0.05. 
RESULTS 
The localization of mGluR6, TRPM1 and NYX to the DBC dendritic tips is 
independent of GPR179 expression 
 Since GPR179 is critical to localization of the RGS7 and RGS11 (Orlandi et al., 
2012), we examined if it plays a similar role for other proteins in the DBC cascade. We 
compared expression and localization of mGluR6, the receptor that initiates signaling 
and TRPM1 the channel that is ultimately gated by the cascade in the outer retina of WT 
and Gpr179nob5 mice. We also examined the expression pattern of nyctalopin (EYFP-
Nyx), a protein critical to expression/localization of TRPM1 (Pearring et al., 2011). Fig. 1 
shows representative transverse retinal section reacted with antibodies to label these 
three proteins in WT (A) and Gpr179nob5 retina. The expression pattern is 
indistinguishable between WT and Gpr179nob5. The merged images in triple labeled 
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retinal sections show that TRPM1, mGluR6 and nyctalopin expression overlaps on the 








Figure 1. mGluR6, TRPM1 and NYX expression is independent of GPR179 
expression. Representative confocal images of cross sections of the OPL and INL 
of WT (A) and Gpr179nob5 (B) retinas reacted with antibodies to TRPM1 (green), 
mGluR6 (blue) and EYFP-Nyc (red). The merged images (bottom) show that in 
both WT and in Gpr179nob5 retinas expression patterns are similar and that TRPM1, 
mGluR6 and nyctalopin expression co-localize at the dendritic tips of DBCs. Scale 
bars, 5 µm.  
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To determine if GPR179 expression depends on expression of mGluR6, 
Nyctalopin and TRPM1, we reacted retinal sections from WT and knockout or mutant 
mice: Grm6-/-(Grm6 encodes mGluR6), Nyxnob and Trpm1-/- with an antibody to GPR179 
(Peachey et al., 2012b). We co-labeled these sections with the lectin, PNA, to mark the 
cone pedicles in the OPL. Fig. 2 shows that the pattern of GPR179 expression is 
indistinguishable in representative sections from all four mouse strains. As expected, 




Figure 2. GPR179 expression at the dendritic tips of the DBCs is independent of 
mGluR6, TRPM1 and nyctalopin expression. Representative confocal images of 
cross sections of the OPL and INL of a series of WT and mutant mouse retinas 
reacted with an antibody to GPR179 (green) and the cone pedicle marker, PNA 
(red). (A) In WT retinas expression of GPR179 colocalizes with PNA (yellow puncta 
in merged image). (B-D) GPR179 expression also is localized at the dendritic tips 
of DBCs even in the absence of expression of: mGluR6 (B), nyctalopin (C) and 
TRPM1 (D). As shown here (E) and previously (Peachey et al., 2012b) GPR179 
expression is absent from Gpr179nob5 mouse retina. Green puncta in the merged 
images represent GPR179 expression at the dendritic tips of rod DBCs. Scale 





Independence of localization of GPR179, mGluR6, TRPM1, and nyctalopin 
Although not evident in Figs 1 and 2, we observed what might be subtle 
differences in the level of GPR179 expression across these mutants. We used western 
blotting from retinal lysates of each to examine and to quantify expression levels of 
GPR179 relative to WT (Fig. 3A,B). As expected, the negative control, Gpr179nob5 
mutant retina showed no expression. In Grm6-/- and Trpm1-/- mutant retina, expression 
levels of GPR179 were reduced, by ~50% and ~20%, respectively. In addition, we 
examined and quantified TRPM1 expression levels in Gpr179nob5 and Grm6-/- retinas 
(Fig. 3C,D). Again, the negative control shows no expression in the TPRM1-/-. In 
Gpr179nob5 retinas, TRPM1 expression is decreased by ~30%, but is similar to WT in 
Grm6-/- retina. Others have reported that TRPM1 is mislocalized in Grm6 mutant retina 
(Morgans et al., 2009; van Genderen et al., 2009; Cao et al., 2011; Pearring et al., 2011; 
Peachey et al., 2012a; Xu et al., 2012) and it has been shown that TRPM1 expression is 
decreased ~30% in the Grm6nob3 mutant (Cao et al., 2011). The discrepancy between 
our results and previously published results could be due to animal age or variation in 
the Grm6 mutant (Maddox et al., 2008; McCall and Gregg, 2008). In summary, our data 
show that GPR179 is localized correctly in the OPL independent of mGluR6, TRPM1, 
and nyctalopin and that the localization of these proteins is independent of GPR179, 
although expression levels may change. 
GPR179 and TRPM1 are part of the same protein complex 
We have previously shown a physical interaction between TRPM1 and nyctalopin 
(Cao et al., 2011; Pearring et al., 2011) and between GPR179 and RGS7 and RGS11 
(Orlandi et al., 2012). Using an affinity purification by immunoprecipitation (IP) approach, 
we examined GPR179 interactions with TRPM1. Using antibodies to GPR179, we 
immunoprecipitated protein complexes from WT mouse retinal lysates. The identity of 
co-immunoprecipitated proteins was characterized using mass spectroscopy. IP with 
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antibodies to GPR179 (a positive control) yielded 121 peptides identified as GPR179 
and giving a coverage of 55%. Two peptides were identified as TRPM1. IP with 
antibodies to TRPM1 yielded 48 peptides matching TRPM1 (57% coverage). Twelve 
peptides were identified as GPR179 (9% coverage). As a negative control for the 
specificity of the assay, we used an identical IP approach with a non-specific IgG. None 
of the peptides in the resulting data set matched either GPR179 or TRPM1. Additional 
negative controls included IPs from GPR179nob5 retinas with GPR179 antibodies and IPs 
from Trpm1-/- retinas with TRPM1 antibodies. In these latter two controls, neither TRPM1 
nor GPR179 were identified in the resulting data sets. Combined these data indicate our 
IPs were specific and that GPR179 and TRPM1 are part of the same protein complex.  
To test the validity of the mass spectrometry results, and to determine whether 
GPR179 and TRPM1 interact directly, we used IP from HEK293T cells co-transfected 
with Gpr179 and FLAG-Trpm1 expression vectors (Pearring et al., 2011) and from WT 
mouse retinas (Fig. 3 E,F). Western blot analyses of singly (Fig. 3E, lanes 1,2) and 
doubly (Fig. 3E, Lane 3) transfected HEK293T cells show that both proteins were 
expressed as expected. IP with the FLAG antibody (Fig. 3E, lanes 4-6) shows on the 
singly transfected cells (Fig. 3E, lanes 4,5) that it precipitates FLAG-TRPM1 only, as 
expected. IP from the double transfected cells shows that the FLAG antibody co-IPs 
GPR179 and FLAG-TRPM1 (Fig. 3E, lane 6), indicating that the two proteins interact. To 
control for the possibility that this interaction occurs during the lysis procedure, we 
transfected GPR179 and FLAG-TRPM1 expressing into different HEK293T cell cultures, 
lysed the cells and mixed the lysates. IP with FLAG antibodies and subsequent western 
blotting for GPR179 showed that GPR179 is absent from the immunoprecipitates (data 
not shown), supporting the conclusion that GPR179 and TRPM1 when expressed in 
HEK293T cells interact directly. 
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When we repeated the IP experiments using retinal lysates (Fig. 3F), both 
GPR179 and TRPM1 were present in WT as expected (Fig. 3F, lane 1), and GPR179 
was absent in Gpr179nob5 retinal lysate (Fig. 3F, lane2). IP from WT retinal lysates with 
an antibody to GPR179 and subsequent western blotting of the precipitates shows that 
TRPM1 is co-immunoprecipitated, along with GPR179 (Fig. 3F, lanes 3,5). As controls, 
we repeated the IP experiments using lysates from Gpr179nob5 (Fig. 3F, lane 4) and 
Trpm1-/- (Fig. 3F, lanes 6) retinas. Both GRP179 and TRPM1 were absent in precipitates 
from the Gpr179nob5 retinas (Fig. 3F, lane 4) and only GPR179 was present in 
precipitates from Trpm1-/- retinas (Fig. 3F, lane6). Combined the mass spectrometry and 
IP studies support the conclusion that GPR179 and TRPM1 are part of the same 












Figure 3. GPR179 interacts with TRPM1. Western blots of total retinal lysates 
probed with antibodies to (A) GPR179 and (C) TRPM1. Each blot was reprobed 
with antibodies to β-actin to determine total protein and for use as an internal 
standard. Band intensities were analyzed and quantified with NIH ImageJ software 
and normalized to the β-actin expression level in the same sample. The 
histograms (B, D) plot the mean expression from four experiments on 
independent samples. (B) GPR179 expression was lower in Grrm6-/- and Trpm1-/- 
retinas compared to WT. (D) TRPM1 expression was similar to WT in Grm6-/- and in 
GRP179nob5 retinas. Errors bars represent standard error  *P<0.05, ***P<0.001. (E) 
Western blot of HEK293T cells transfected with plasmids expressing GPR179 
(lane 1), FLAG-TRPM1 (lane 2) or both (lane 3) and probed with GPR179 and FLAG 
antibodies. The presence of a specific expression construct is indicated by “+” 
above the lane on the blot. Lysates from HEK293T samples (lanes 1-3) were 
immunoprecipated with antibodies to GPR179 and the precipitates analyzed by 
western blotting, using antibodies to GPR179 (lanes 4-6, top row) or TRPM1 (lanes 
4-6, bottom row). These data show that TRPM1 is co-immunoprecipitated with 
GPR179 (lane 6). (F) Western blot of retinal lysates from WT (lane 1) and 
GPR179nob5 (lane 2) retinas, probed for presence of GPR179 (top row) or TRPM1 
(bottom row). Western blots of proteins co-immunoprecipated with antibodies to 
GPR179 from WT (lanes 3 and 5), GPR179nob5 (lane 4) and Trpm1-/- (lane 6) probed 
for GPR179 (top row) or TRPM1 (bottom row). Immunoprecipitation with GPR179 
antibody from retinal lysates of Gpr179Nob5 and Trpm1-/- mice served as controls 
for nonspecific binding. These data were representative of at least three 
independent experiments using independent samples. Data show that GPR179 









Gpr179nob5 mice have ERG b-waves absent in other cCSNB mouse models  
Previously we compared the ERG responses of WT and Gpr179nob5 and showed 
a significant reduction in the Gpr179nob5 b-wave and interpreted this result as a no b-
wave phenotype (Peachey et al., 2012b). When ERG responses from Gpr179nob5 and 
Trpm1-/- mice were compared to WT (Fig. 4A) their positive polarity b-waves appear to 
be completely missing. However, upon closer inspection of these mutant responses at 
two low flash luminances (-3.6, -2.4 log cd sec/m2), where the a-wave and slow PIII are 
small in amplitude, we found a b-wave like response, albeit small (~15-20µV), that was 
consistently present in Gpr179nob5 but not in Trpm1-/- mice (Fig. 4B). When quantified, 
the b-wave like response was significantly larger in Gpr179nob5 than Trpm1-/- mice (t-test; 












Figure 4. Gpr179nob5 rod ERGs have a small b-wave. (A) Representative rod ERGs 
recorded from WT (black), Gpr179nob5 (blue) and Trpm1-/- (red) mouse retinas to 
strobe flash stimuli presented to the dark-adapted retina. Note that the positive 
polarity b-wave of the WT ERG is missing in Gpr179nob5 and Trpm1-/- mice. Values 
to the left of the waveforms indicate flash luminance in log cd sec/m2. (B) ERG 
responses obtained from Gpr179nob5 and Trpm1-/- mice to a -3.6 log cd sec/m2 
flash. Colored traces indicate the responses from 5 different Gpr179nob5 mice (left) 
and 7 different Trpm1-/- mice (right). The offset black trace in each panel is the 
average of all mice. (C) Average (± sem) b-wave amplitude (difference between 
pre-stimulus baseline and the largest positive deviation from the baseline 
recorded between 100 and 300 msec after flash presentation) of responses shown 















GPR179 sets the sensitivity of mGluR6 cascade modulation of TRPM1 
Our observations that both mGluR6 and TRPM1 proteins are expressed in the 
OPL of Gpr179nob5 retina (Fig. 1), as well as the presence of a small b-wave in these 
mice (Fig. 3), suggest that mGluR6 and its cascade still gate the TRPM1 channel, 
although the sensitivity of the system is significantly reduced. To address this question, 
we tested several elements of this hypothesis using whole cell patch clamp recordings of 
rod DBCs in a retinal slice preparation. We used the methods described by Nawy and 
colleagues (Nawy, 2004; Shen et al., 2009) in which retinal slices were bathed in 4 µM 
L-AP4 to maximally activate the mGluR6 cascade and close TRPM1 channels. Puffs of 
CPPG, a mGluR6 antagonist, then were used to deactivate the cascade, mimicking the 
events evoked by light. We held rod DBCs at +50mV to minimize run-down and, as a 
consequence, outward currents are evoked by CPPG puffs. 
We examined whether the TRPM1 channel could be gated by the mGluR6 
cascade by exogenous application (puffs) of CPPG onto the dendritic terminals of 
synaptically isolated Gpr179nob5 rod DBCs. Fig. 5A shows representative responses from 
WT and Gpr179nob5 rod DBCs to 0.6mM CPPG puffs 200 msec in duration. In WT rod 
DBCs there is a robust outward current. The response, while present in Gpr179nob5 rod 
DBCs was significantly smaller than WT (Fig. 5B; two-way ANOVA: P < 0.001). 
Increasing puff duration to 1 sec produced no discernible change in WT responses (two-
way ANOVA: P > 0.05; data not shown), but significantly increased the response in 
Gpr179nob5 rod DBCs (Fig. 5B; two-way ANOVA: P < 0.001). Despite this increased 
Gpr179nob5 response, the amplitude was still significantly smaller than in WT (two-way 
ANOVA: P < 0.001; Fig. 5A, B). We attempted to increase stimulation further by 
increasing the concentration of CPPG to 3mM. At both 200 msec and 1 sec puff 
duration, WT responses remained similar to those evoked by 0.6mM CPPG (Fig. 5C,D), 
indicating that the mGluR6 cascade was maximally activated by 0.6mM and 200 msec 
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puffs. In Gpr179nob5 rod DBCs, increasing the CPPG concentration to 3mM yielded 
responses similar in magnitude, regardless of puff duration. They also were similar to the 
response evoked by 0.6mM/1 sec CPPG puffs. This suggests that the Gpr179nob5 rod 
DBC response can be saturated at the same concentration as WT but requires longer 
duration puffs (Fig. 5B,D). Regardless of the conditions, the Gpr179nob5 rod DBC 
responses never reached the amplitude recorded in WT (Fig. 5C,D; two-way ANOVA: 
200 msec: P < 0.001; 1 sec: P < 0.001). Together these data suggest that while GPR179 
is not required to gate TRPM1, it sets the sensitivity of the mGluR6 cascade and 










Figure 5. CPPG evokes a small amplitude response in Gpr179nob5 rod DBCs, which 
increases with stimulus intensity. (A) Representative voltage clamp responses of 
WT and Gpr179nob5 rod DBCs evoked by puff application of the mGluR6 antagonist 
CPPG (0.6 mM; 200 msec or 1 sec). (B) Histogram compares the average peak 
response amplitudes of WT and Gpr179nob5 rod DBCs. WT responses to 200 msec 
and 1 sec puffs did not differ and were combined. Regardless of duration 
Gpr179nob5 response amplitudes were significantly smaller than WT. Gpr179nob5 
response amplitudes significantly increase when puff duration increased from 200 
msec to 1 sec. (C) Representative voltage clamp responses of WT and Gpr179nob5 
rod DBCs evoked by puff application of 3 mM CPPG for either 200 msec or 1 sec. 
(D) Histogram compares the average peak response amplitudes of WT and 
Gpr179nob5 rod DBCs. WT responses did not increase with increased puff duration 
(200msec to 1 sec).  Regardless of duration Gpr179nob5 response amplitudes were 
significantly smaller than WT.  Increased puff duration did not produce larger 
response amplitudes in Gpr179nob5 rod DBCs suggesting that they are saturated 
under these conditions. (E) Representative voltage clamp responses of WT and 
Gpr179nob5 rod DBCs evoked by a 1 sec puff of the TRPM1 channel agonist, 
capsaicin (10 µM). (F) Histogram compares the average peak response amplitudes 
of WT, Gpr179nob5 and Trpm1-/-rod DBCs. Gpr179nob5 response amplitudes are 
significantly larger than Trpm1-/- although significantly smaller than WT rod DBCs. 
The number of rod DBCs in each experimental group is shown within each bar of 
the histograms. 
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Because TRPM1 is expressed in Gpr179nob5 retina we characterized whether the 
channel could be gated directly by examining rod DBC responses in WT and Gpr179nob5 
to the TRPM1 agonist capsaicin. As observed previously (Shen et al., 2009), capsaicin 
evoked robust responses in WT rod DBCs (Fig. 5E). In contrast, capsaicin evoked 
responses in Gpr179nob5 rod DBCs were significantly smaller than WT. As a control, we 
examined capsaicin evoked responses in Trpm1-/- rod DBCs and found they were 
significantly smaller than present in Gpr179nob5 rod DBC (Fig. 5F; one-way ANOVA: vs 
WT: P < 0.001; vs Trpm1-/-: P < 0.05). These data are consistent with our 
immunohistochemical results and suggest that the TRPM1 channel is present in 
Gpr179nob5 rod DBCs and can be modulated either by the mGluR6 cascade or directly by 
capsaicin. Because strong stimuli (both pharmacological and light in the ERG results) 
are required and the response never reaches the amplitude seen in WT cells we 
conclude that GPR179 modulates the sensitivity of the cascade. The data also address 
an issue noted previously, that the rod DBC response to capsaicin is primarily via 
modulation of TRPM1 channels with a minor contribution from an “off-target” non-
TRPM1 channel (Morgans et al., 2009).  
In the above recordings, we noted that spontaneous currents in WT appeared 
noisier than in Gpr179nob5 rod DBCs (Fig. 6A), This suggested that the open probability 
of the TRPM1 channel might differ between WT and Gpr179nob5 rod DBCs, as we had 
noted for Nyxnob rod DBCs (Gregg et al., 2007). To evaluate this question, we measured 
both the standing outward current and the current variance of rod DBCs (Vhold +50mV). 
The outward holding currents as well as the variance were significantly larger in WT rod 
DBCs compared to Gpr179nob5 (Fig. 6B,C; one-way ANOVA: holding current: P < 0.001; 
variance: P < 0.01). As a control we analyzed the holding current and variance in  
Trpm1-/- rod DBCs and found that they were similar to Gpr179nob5 cells (Fig. 6; one-way 
ANOVA: holding current: P > 0.05; variance: P > 0.05). These results support the idea 
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that while the TRPM1 channels are correctly expressed and localized, they are in a 
functionally closed state compared to those in WT rod DBCs. The results continue to 
support the hypothesis that GPR179 is required for the high sensitivity of the modulation 






















Figure 6. Gpr179nob5 rod DBCs have decreased standing currents and TRPM1 
channel open probability. (A) Representative traces of spontaneous currents from 
two WT and two Gpr179nob5 rod DBCs. Rod DBCs were held at +50 mV and 1.5 sec 
sections of each recording were analyzed to yield the data in B and C. Histograms 
show average (B) standing current and (C) current variance for WT, Gpr179nob5 and 
Trpm1-/- rod DBCs. Gpr179nob5 and Trpm1-/- have similar standing currents (C) and 
current variance (D) and both are significantly lower than WT. Combined these 
data indicate that theTRPM1 channel in Gpr179nob5 rod DBCs has a low open 
probability that is similar to TRPM1-/- rod DBCs where the channel is absent. The 


















Long duration light increments evoke an ERG b-wave in Gpr179nob5  
Since rod DBCs can response to strong pharmacological manipulation, we 
hypothesized that long duration full-field light flash stimuli also might evoke an ERG b-
wave. To test this we recorded ERGs from WT, Gpr179nob5 and Trpm1-/- mice using an 
LED-based stimulation system to present a -1.2 log cd/m2 stimulus for durations that 
ranged from 10 to 1000 msec. WT responses were dominated by the b-wave (Fig. 7A), 
which grew in amplitude with increasing stimulus duration (Fig. 7B). The same stimuli 
evoked a slow b-wave in Gpr179nob5 mice, whose amplitude also increased with stimulus 
duration. In contrast, none of the stimulus configurations evoked a b-wave in Trpm1-/- 
mice (Fig. 7) or in two other mouse models of cCSNB, Nyxnob and Grm6nob3 (data not 
shown). Compared to WT, the amplitude of the response from the Gpr179nob5 retina was 
significantly smaller (two-way ANOVA; P < 0.001). Whereas the WT response saturated 
to a ~50 msec stimulus duration, the Gpr179nob5 response continued to increase through 
stimulus durations of ~500 msec (Fig. 7). These ERG results are consistent with the 
mGluR6 mediated gating of TRPM1 we observe in the patch clamp recordings of 




Figure 7. Increasing flash duration increases the ERG b-wave amplitude in 
Gpr179nob5 mice. (A) Representative ERG responses recorded from WT (black), 
Gpr179nob5 (blue) and Trpm1-/- (red) mice to  -1.2 log cd/m2 stimuli of increasing 
duration (top to bottom; and, indicated by the stimulus trace below each set of 
waveforms). Note that as stimulus duration increases, a slow positive wave 
becomes apparent in Gpr179nob5 mice that is absent in Trpm1-/- mice. Waveforms 
indicate the average of: WT (n = 3), Gpr179nob5 (n = 12) and Trpm1-/- (n = 7) mice. 
(B) Average (± sem) b-wave amplitude evoked by flash stimuli of different 
durations for the same mice. Note that the amplitude of the Gpr179nob5 response 
increases across a range of flash durations (20-500 msec) whereas WT response 














GPR179 and RGS7/11 provide unique functional roles in the DBC cascade  
Because the DBC dendritic tips of Gpr179nob5 mice lack expression of RGS7 and 
RGS11 (Orlandi et al 2012) and RGS7-/-/RGS11-/- DBCs also show very small light 
evoked responses (Cao et al 2012), it is possible that all of our observations result from 
the absence of the RGS7/11 complex. Because GPR179 is expressed and normally 
localized in RGS7-/-/RGS11-/- DBCs (Fig. 8A), we repeated our characterizations (Fig. 5 
and 6) in RGS7-/-/RGS11-/- rod DBCs and determined similarities and differences to 
differentiate the role of GPR179 from RGS7 and RGS11. The response amplitude 
evoked by 0.6 mM 1 sec CPPG puffs in RGS7-/-/RGS11-/- and Gpr179nob5 rod DBCs were 
similar (Fig. 8B; P = 0.45). In addition, both the standing outward current and current 
variance were similar in RGS7-/-/RGS11-/- and Gpr179nob5 rod DBCs (Fig. 8C-E, one way 
ANOVA: P > .05), and these parameters in the RGS7-/-/RGS11-/- cells were significantly 
lower than in WT cells (one way ANOVA: P < 0.0001; P < 0.01). We conclude that RGS7 
and RGS11 are responsible for modulation of the sensitivity through the mGluR6 
cascade.  
When we tested the ability of capsaicin to directly open the TRPM1 channel in 
RGS7-/-/RGS11-/- we found a surprising result. Unlike the significantly smaller capsaicin 
evoked response found in Gpr179nob5 rod DBCs (Fig. 5E), capsaicin evoked responses 
in RGS7-/-/RGS11-/- rod DBCs were similar in amplitude to WT (Fig. 8F,G; one-way 
ANOVA: 200msec: Gpr179nob5 vs. RGS7-/-/RGS11-/-: P < 0.001; WT vs. RGS7-/-/RGS11-/-
: P > .05). These data suggest that GPR179-/- and RGS7-/-/RGS11-/- double knockouts 
phenocopy each other for several characteristics, including response to CPPG, standing 
current and current variance. However, the presence of GPR179 even in the absence of 
RGS7 and RGS11 results in setting the “state” of TRPM1 such that the capsaicin 




Figure 8. Capsaicin modulation of the TRPM1 channel differentiates the roles of 
Gpr179nob and RGS7-/-/RGS11-/- in the mGluR6 signaling cascade. (A) 
Representative confocal images of retina sections from WT and RGS7-/-/RGS11-/- 
double knockouts labeled with antibodies to GPR179 and PNA (a cone terminal 
marker) show that GPR179 is localized normally in RGS7-/-/RGS11-/- retina. (B) 
Representative voltage clamp responses of RGS7-/-/RGS11-/- and Gpr179nob5 rod 
DBCs evoked by a 1 sec, 0.6 mM CPPG puff. The histogram compares the 
response amplitudes and shows that RGS7-/-/RGS11-/- and Gpr179nob5 are similar. 
(C) Representative traces from voltage clamp recordings of WT, RGS7-/-/RGS11-/- 
and Gpr179nob5 rod DBCs held at +50 mV. Analyses are similar to those described 
in Figure 6. (D) Both standing current and (E) current variance are similar in RGS7-
/-/RGS11-/- and Gpr179nob5 rod DBCs and significantly smaller than in WT. (F) 
Representative voltage clamp responses WT, RGS7-/-/RGS11-/- and Gpr179nob5 rod 
DBCs to capsaicin puffs (200 msec; (10 µM). (G) Histograms compare peak 
response amplitudes for rod DBCs and show that WT and RGS7-/-/RGS11-/- are 
similar, whereas Gpr179nob5 rod DBC responses are significantly smaller. The 




Visual function in starlight depends on the modulation of mGluR6, which gates 
the TRPM1 channel in rod DBCs. While the last four years, have seen more growth in 
this area than the previous 40, many details of the cascade mechanism remain poorly 
understood. Our results show that a new seven transmembrane protein, GPR179 along 
with RGS7/11 are required for maximal sensitivity of the cascade and that GPR179 is 
required for modulation of TRPM1 gating. Our immunohistological and protein 
biochemistry results support our functional assessments. GPR179 colocalizes with 
mGluR6 (Peachey et al., 2012b), TRPM1 and nyctalopin (Fig. 1) placing it in a prime 
location to be part of the gating mechanism controlling TRPM1 activity, and GPR179 and 
TRPM1 physically interact (Fig. 3). 
At low light levels, the concentration of glutamate in the synaptic cleft is high and 
the mGluR6 receptor is maximally activated, which maximally activates a G-protein 
cascade that results in the exchange of Gα0-GDP to the active Gα0-GTP bound form, 
which releases the Gβγ dimer. The exact mechanism of TRPM1 gating, and whether this 
is accomplished by Gα0-GTP or Gβγ, is an active research area (Koike et al., 2010a; 
Koike et al., 2010b; Shen et al., 2012). Application of Gβγ or activated Gα0 directly via 
the patch pipette to mouse rod DBCs in a retinal slice suggest that Gβγ closes the 
channel while addition of activated Gαo has minimal impact (Shen et al., 2012). These 
authors argue that Gβγ either directly or indirectly closes TRPM1 channels. This model 
predicts the light response deactivates Gβγ, presumably by reformation of the trimeric G 
protein complex. This would suggest that a large pool of Gα0-GDP must be available to 
rapidly reform the trimeric G-protein complex once Gβγ ceases the interactions needed 
to inhibit TRPM1. This could explain why RGS7 and RGS11 are required and present in 
excess, indicated by the fact that a mouse without RGS11 and a hypomorphic allele of 
RGS7 had near normal ERG b-waves (Mojumder et al., 2009; Chen et al., 2010). A 
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significant change in the ERG b-wave was only demonstrated when both genes were 
completely eliminated (Cao et al., 2012; Shim et al., 2012). The competing model of 
TRPM1 gating is that activated Gα0 closes the channel, and that the RGS proteins are 
required to rapidly inactivate Gα0-GTP. 
The Gβγ model predicts that the standing inward current seen in DBCs reflects a 
balance between the constant activation of Gβγ due to tonic activation of mGluR6 and its 
inactivation by rebinding to Gα0-GDP. In the Gpr179nob5 mutants, which lack RGS7 and 
RGS11 at the DBC tips (Orlandi et al., 2012), and the RGS7-/-/RGS11-/- mutants, the 
model predicts an increase in active Gβγ because there is reduced ability to hydrolyze 
GTP to GDP bound to Gα0. The consequence of this would be a decrease in TRPM1 
open probability and in the DBC standing current. Under our experimental conditions of 
maximal activation of mGluR6, mimicking “dark” adapted conditions, we see both of 
these features, a dramatically decreased standing current and decreased open 
probability of TRPM1 in rod DBCs from Gpr179nob5 and RGS7-/-/RGS11-/- rod DBCs (Fig. 
6 and Fig. 8). This effect is not the result of the absence of TRPM1 from the rod DBC 
signal transduction complex because; 1) immunohistochemistry shows TRPM1 is 
localized normally in Gpr179nob5 and in RGS7-/-/RGS11-/- retinas (Fig. 1 and Cao et al. 
(2012)); 2) there are responses evoked in rod DBCs by: (a) long duration flashes in the 
ERG of Gpr179nob5 mice and (b) high concentration/long application of CPPG in 
Gpr179nob5 rod DBCs (Fig. 5 and Fig. 8 B); and 3) activation of TRPM1 by capsaicin in 
Gpr179nob5 rod DBCs. The rod DBCs of Gpr179nob5 and RGS7-/-/RGS11-/- mice share 
many characteristics and one pivotal difference; the RGS7-/-/RGS11-/- DBCs have a 
normal response to capsaicin. There are two possibilities that could explain this result. 
First, there could be more TRPM1 channels present on the DBC dendrites. Second, the 
presence of GPR179, which interacts with TRPM1, could by a currently unknown 
mechanism set the “state” of the TRPM1 channel such that capsaicin is able to 
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maximally activate the channel and that this is different than the requirements of gating 
by the mGluR6 cascade. We favor the latter hypothesis for several reasons. An 
apparently simple test of the first mechanism would be to quantify, using western blots, 
the level of TRPM1 in the GPR179-/- and the RGS7-/-/RGS11-/- retinas. However, this 
does not assess the amount of channel at the tips of the DBCs because TRPM1 is 
present in intracellular compartments throughout the DBCs (Fig. 1) and (Morgans et al., 
2009; van Genderen et al., 2009; Cao et al., 2011; Pearring et al., 2011; Peachey et al., 
2012a; Xu et al., 2012). The fact that the maximal CPPG response in Gpr179nob5 and the 
RGS7-/-/RGS11-/- rod DBCs is similar suggests similar levels of TRPM1 are linked to the 
mGluR6 cascade in these mutants. Therefore in the RGS7-/-/RGS11-/-, which express 
GPR179, we propose that the state of the TRPM1 channel is fundamentally different 
than in the GPR179nob5 DBCs and this allows capsaicin to activate it to normal levels. 
What this means at the molecular level is currently unclear but likely critical to 
understanding how TRPM1 is gated in DBCs.  
Experiments described here and elsewhere show that the known components of 
the mGluR6/TRPM1 cascade are closely associated and many physically interact (Cao 
et al., 2011; Pearring et al., 2011; Orlandi et al., 2012). These interactions are likely to 
be critical to system performance and understanding the details of these interactions and 
how they likely change during light stimulation will be critical to a full understanding of 
the DBC signaling system. The importance of the physical arrangement of the cascade 
components is highlighted by the fact that RGS7 and RGS11 are still expressed in 
Gpr179nob5 mice, but are not localized correctly to the tips of the DBCs (Orlandi et al., 
2012). There are likely to be many other proteins critical to complex function. One such 
molecule is LRIT3, a protein of unknown function, but when absent results in cCSNB in 
humans (Zeitz et al., 2013) with a phenotype consistent with disrupted DBC signal 
transduction.  
!! 246!
In conclusion, we show that GPR179 interacts with TRPM1 and one of its 
functions is to localize RGS7 and RGS11 near the signaling complex (Orlandi et al., 
2012). A second critical function is to set the “state” of TRPM1 such that it responds 
optimally to deactivation of the mGluR6 cascade. Understanding this “state” at the 
molecular level may provide important clues as to how TRPM1 is gated by the mGluR6 
cascade. 
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